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Orobanchaceae plant family is one of the most interesting plant families in our region. It is represented by small number of plants and some 
of them attracted major interest while others have been almost completely neglected. Even the ethnobotanical uses of these plants in the 
reviewed region are very limited. The present day knowledge about these plants indicates contradicting research tendencies, interesting 
natural products that were isolated from some of these plants, along with massive lack of information about the chemical and medicinal 
properties of others. Many review articles were published about this family, but each one of them lacks some essential information or 
includes ambiguities. This article will present the known information in helpful tables and figures, but will mainly emphasize the areas 
where intensive research efforts are needed. In the discussion section, the parasitic nature of these plants will be elaborated, and some 
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INTRODUCTION 
Orobanchaceae plant family includes around 2060 species, 
classified in 90 genera.1 In the reviewed region, it is 
represented by 17 species, and this number is debated 
among scholars.2 For example, G. Domina and A. Danin 
have defined a new species in 2014, and they named it 
Orobanche cohenii.2 But searching the website “Flora of 
Israel Online”, that was established by Prof. A. Danin 
himself and still has his name on homepage, shows that this 
species is not included in the 18 species presented there.3 
Interestingly, ancient human societies did not utilize these 
plants for their needs. 
The major botanical property of Orobanchaceae plants is 
their parasitic nature, which was very extensively studied. 
Many aspects of this parasitism were investigated, such as 
the genetics of this property,4 and the chemical basis of it.5 
For example, the cyclohexene oxide-type sphaeropsidone 
(Figure 1), induces parasitism of Orobanche plants, which is 




Figure 1. Sphaeropsidone, natural parasitism inducer of Orobanche 
plants 
Among the four genera that are represented in the 
reviewed region, Orobanche plants are the most parasitic, 
and many attempts were made to control them. An extensive 
presentation of this topic will be introduced in the discussion 
section, but we will indicate here some of these publications. 
Orobanche crenata and Orobanche aegyptiaca are among 
the most harmful species of this genus, and a method of 
controlling them (Imazapic, C14H17N3O3) in parsley crops 
was reported.6 Another study that investigated the 
mechanism of parasitic activity of O. aegyptiaca, revealed 
the involvement of horizontal genes transfer.7 O. crenata is 
harmful to many crops, especially Fabaceae plants, and so, 
it causes many agricultural damages to Vicia faba 
production, which is a major food source in the Middle East, 
particularly in Egypt. So, a method of biocontrol of this 
parasitic plant was developed based on the allelopathic 
property of Euroca sativa seed powder.8 But as we 
mentioned above, all genera of this plant family are parasitic, 
and a notable study of this property of one of the most 
studied plants of this family, Cistanche tubulosa, was 
performed and it revealed the mechanism that this parasite 










Figure 2. Bellardia trixago (Orobanchaceae) 
Finally, in the reviewed region, the Orobanchaceae plant 
family is represented by four genera that include 17 species 
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Cistanche tubulosa, Odontites aucheri, Orobanche 
aegyptiaca, Orobanche cernua, Orobanche crenata, 
Orobanche cumana, Orobanche hermonis, Orobanche 
lavandulacea, Orobanche mutelii, Orobanche palaestina, 
Orobanche pubescens, Orobanche schultzii, Parentucellia 
flaviflora and Parentucellia viscosa. 
ETHNOBOTANICAL USES 
Generally, cultures of the Middle East and particularly 
these of reviewed region, have almost ignored the 
Orobanchaceae plant family. There is very partial 
documentation of ethnobotanical uses of these plants, 
contrary to some nations in the Far East or Europe. But 
these peoples mostly used species that do not grow in Israel 
and Palestine, so we will not cite these reports here. And yet, 
some of the literature that we will cite about the species that 
grow here, were published about other regions in the world. 
In Table 1, we summarized these published uses. 
Table 1. Ethnomedicinal and ethnobotanical uses of 
Orobanchaceae plants 
Species Region, uses, methods, references 
Bellardia trixago Spain. Flowers are sucked as food.10 
Cistanche salsa Korea. As part of a traditional 
formulation named PJBH, to activate 
brain function, promote memory and 
lengthen life span.11 
Cistanche 
tubulosa 
Pakistan. Whole plant powder used 
against diarrhea,12 blood purifier, 
epistasis, cough, fever, bleeding nose, 
laxative, digestive, remove the pain of 
stomach, flavoring agent in pot herbs,13,14 
aprodisiac.15 
India. Fertility of males and females, 
jaundice, whooping cough, stomach 
aches, diabetes.16 
Ethiopia. Whole plant powder with butter 
to treat burns.17 
Orobanche 
aegyptiaca 
Nepal. Seeds are used as toys.18 
Orobanche 
crenata 
Italy. Food. Young shoots are prepared 
and consumed in various ways.19 
Orobanche 
mutelii 
Turkey. Harmful to melon crops.20 
SELECTED PUBLISHED REVIEW ARTICLES: 
PRESENTATION AND DISCUSSION  
Aside from very few review articles about the parasitic 
properties of the entire Orobanchaceae plant family, there 
are no reviews about its medicinal, ethnobotanical and 
chemical composition of the plants.  Different genera, 
species or even natural products contained in the plants, 
were reviewed, and in our humble opinion, some of them 
have high quality. So, the need for a comprehensive article 
like this one is felt. 
The most recent review article was published by R. Shi 
and her colleagues.21 This article is outstanding in terms of 
the very good photos, tables, listing of traditional uses of the 
plants, citation of modern research published results and 
numerous structures of natural products that were isolated 
from the plants of the genus of Orobanche. Another strength 
that this article is its global presentation of the plants of this 
genus. But it showed some shortcomings also, especially in 
the cited literature, particularly if an interested reader is 
interested to follow, and learn more about some presented 
woek. For example, the work of “Han, 2017” has been cited 
no less than 27 times. When reading the references part of 
the article, it is cited as “Studies on the Chemical 
Composition, Content Determination and Antioxidant 
Activity of Orobanche Aegyptiaca Pers, Inner. Mongolia. 
Med. Univ.”. Searching the internet for this work or any 
other citations of it, did not lead to a single result. But as we 
mentioned earlier, this review is one of the best published 
about this genus, due to its comprehensiveness. Another 
outstanding review about the genus of Orobanche natural 
products was published by F. Scharenberg and C. Zidorn.22 
It is a vast article that focuses on these compounds and some 
of their medicinal activities. 
The genus of Cistanche was even more covered than 
Orobanche. L-l. Wang and her colleagues published a short 
review about the composition and the pharmacological 
activities of the Chinese traditional medicine formulation 
named Cistanches Herba, which contains five species of this 
genus.23 Despite the fact that only two of them grow in the 
reviewed region (C. salsa and C. tubulosa), this review is 
highly informative. Z. Li and his colleagues published a 
short review article about the same formulation.24 They 
name it Herba Cistanches (Rou Cong-Rong, in Chinese), 
and they presented its ancient use in traditional Chinese 
medicine, that go back to 250 BC, its composition and 
medicinal activities. The most recent review article about 
this formulation was published by H. Lei et al.25 It is 
comprehensive, with two clear advantages over previous 
review articles. First, it indicates the plant species from 
which each natural product was isolated. Secondly, the 
natural products are arranged in general structure that 
presents each one of them as a derivative of this structure. 
Along with the three cited review articles (ref. 23-25), the 
publication of Y. Jiang and P-F. Tu, give a comprehensive 
view of the chemical composition and the medicinal 
activities of this unique formulation.26 
But this formulation was reviewed not just in general 
scope as in references 23-26, but some reviews elaborated 
on some specific activities. An excellent review article of 
this type was published by C. Gu et al. that presented 
various medicinal activities of this formulation but focused 
on neuropharmacological aspects.27 N. Wang and her 
colleagues focused on antiaging activity in their excellent, 
comprehensive review article about this formulation.28 Their 
review has more advantages which are, linking to traditional 
medicine, presenting various activities and showing the 
structures of major active ingredients. 
Review articles about single species of the 
Orobanchaceae plant family, in our region, are very limited. 
Among these species, only Cistanche tubulosa and 
Orobanche crenata have been reviewed. C. tubulosa was 
reviewed by A. E. Al-Snafi, and the article presents many 
medicinal activities that this plant showed.29 This good 
article lacks two topics: traditional medicine and structures 
of at least major active natural products, even though some 
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of them are indicated. C. Genovese and his colleagues 
reviewed the chemical composition and the biological 
activities of O. crenata.30 This very good review is very 
informative, with excellent tables and figures but lacks 
introduction to use in traditional medicine. 
Finally, R. Halouzka and his colleagues summarized in a 
very useful review article the analytical methods of isolation 
and quantification of strigolactones (see general structure in 
Figure 3).31 These natural products are found in Orobanche 
and Striga genera, but the second one is not represented in 





Figure 3. General structure of Striglactone (ref. 31) 
MEDICINAL ACTIVITIES AND CHEMICAL 
COMPOSITION 
Scanning the published literature about the plants of 
Orobanchaceae family that grow in the reviewed region, 
revealed an interesting but not completely understood result. 
Few species are extensively studied, others are very 
limitedly studied and many have been completely ignored. 
Moreover, some “classical” medicinal properties that are 
usually tested and published for other plant families, are not 
mentioned at all. For example, there are no publications that 
report antidiabetic or related activities, for any of these 
plants. On the contrary, there is relatively considerable 
amount of publications that reported isolation and 
characterization of structurally interesting natural products 
and of brain related activities. 
Summary of these findings are shown in the following 
tables, that appear according to alphabetical order of the 
names of the species. An absence of published reports has 
been clearly indicated.  
Bellardia trixago 
Table 2. Biological, medicinal and other properties of Bellardia 
trixago 
Activity/Property Major Findings/Reference 
Antifungal Resin of the plant was analyzed, and 8 
known flavonoids were identified. Some 
of these compounds were methylated and 
found active against the fungus 
Cladosporium herbarum.32 
Insecticidal Essential oil of whole plant was prepared 
and analyzed by GC-MS. A detailed list 
of compounds is presented. New natural 
products are not reported, but this EO 
showed antifeedant activity against 
Spodoptera littoralis.33 Aerial parts were 
extracted with dichloromethane and 
extract showed weak antifeedant activity 
against Spodoptera litura. Extract was 
analyzed and detailed list of (known) 
compounds and structures are provided.34 
Chemical 
composition 
Isolation and characterization of new 
compounds have been reported. The 
structures of most of them are shown in 
Figure 4.35,36 Malonate ester of compound 
A in Figure 4.37 Isolation of known, 
active, interesting natural products found 









Figure 4. New compounds isolated from Bellardia trixago 
Cistanche fissa. 
There are no publications relevant to this review article. 
Cistanche salsa 
Table 3. Biological, medicinal and other properties of Cistanche 
salsa 
Activity/Property Major Findings/Reference 
Analgesic Stems were extracted with 80% aqueous 
ethanol, assisted with microwave 
radiation. Extract showed antinociceptive 




Whole plant was extracted with 50 % 
aqueous ethanol, and this extract showed 
anti-proliferative activity against prostate 
cancer cells in rats.41 
Bones related 
activities 
Whole plant was extracted with methanol 
and extract was fractionized by several 
organic solvents, yielding and new 
compound [R-HDOA, see Chemical 
composition below]. This compound 




Phenylethanoid glycoside-rich extracts 
were prepared by extracting different 
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These extracts showed activity against 
neurotoxicity of MPTP in mice.43-46 
Echinacoside (phenylethanoid glycoside) 
was isolated from stem methanolic 
extract, and it alleviated hypobaric 
hypoxia-induced memory impairment in 
mice.47 
Hepatoprotection Phenylethanoid-rich (mainly 
Echinacoside) stem methanolic extract 
showed protective activity against 
ethanol-induced hepatotoxicity in mice.48 
Enzyme inhibition Whole plant was extracted with methanol 
and extract was chromatographed 
obtaining five new compounds (see 
Chemical composition below). These 
compounds inhibited the production of 
NO that was induced by LPS.49 
Immune system 
related activities 
Three studies that were published in the 
same year by the same research group, 
reporting immunomodulatory and 




R-HDOA (Figure 5) was isolated and its 
structure was confirmed by spectroscopic 
analyses and by laboratory synthesis of 
it.42 Five new phenylpropanoid-
substituted diglycosides were isolated 
(Figure 5).49 Six new Salsasides were 
isolated from the stems of the plant. Their 
structures are presented in the review 
article that we cited earlier (ref. 25).53 
This publication did not report new 
compounds, but it is interesting since it 
presents the HPLC method of isolation of 





Figure 5. New compounds isolated from Cistanche salsa 
Cistanche tubulosa 
Table 4. Biological, medicinal and other properties of Cistanche 
tubulosa 
Activity/Property Major Findings/Reference 
Anticancer and 
related activities 
Commercial mixture of phenylethanoids 
that was isolated from the plant, showed 
activity against B16-F10 cancer cells.55 
Whole plant aqueous extract showed 
activity against human colon cancer 
cells.56 Commercial mixture of 
phenylethanoids that was isolated from 
the plant, showed activity against H22 
hepatocellular carcinoma cells.57 
Antidiabetic, anti-
hyperlipidemic 
Stem ethanolic extract showed 
antidiabetic and hypolipidemic activities 
in db/db mice model.58 Roots were 
extracted with 70 % aqueous ethanol and 




Commercial Echinacoside (Figure 6), a 
major compound in the extracts of the 
plant, and various extracts, showed 
antioxidant (DPPH, trolox) and anti-
inflammatory activity in STZ-
nicotineamide-induced diabetic rats59 
Ultrasonic-assisted extraction of aerial 
parts yielded new polysaccharide 
(rhamnose, mannose, glucose, and 
galactose), which showed in vitro 
antioxidant activity.60 
Bone, muscle, eye, 
growth and hair 
related activities 
Commercial echinacoside and acteoside 
(Figure 6) showed anti-osteoporotic 
activity in rat model.62 Commercial 
extract (no other details) showed novel 
eye protection against blue light emission, 
that was confirmed by 6 methods, in vitro 
and in vivo.63 Stems were extracted with 
30 % aqueous ethanol and this extract 
enhanced muscles activity, in forced 
immobilized rats.64 Commercial mixed 
extract of the plant with Laminaria 
japonica, was orally (pills) administered 
to healthy female human who suffered 
hair loss and unhealthy scalp. This 
supplementation improved both 
conditions.65 Stems aqueous extract was 
chromatographed to obtain nearly pure 
echinacoside, with small amount of 
acteoside and tubuloside A (Figure 6). 
This powder was fed to rats and it 




Commercial echinacoside and acteoside 
showed anti-Alzheimer activity in rat 
model.62 Patented phenylethanoid 
glycosides pills produced from plant 
extract found efficient for treating 
moderate Alzheimer disease (AD).67 
Phenylethanoid glycosides-rich stem 
aqueous extract was showed anti-
Alzheimer disease-like activity in rat 
model, and slowed memory loss and 
improved other brain functions.68 Stem 
aqueous extract that contained mainly 
echinacoside, acteoside and isoacteoside 
(Figure 6), inhibited aggregation of 
amyloid-β in AD-like model in rats.69 A 
decoction was prepared from Herb 
Cistanche, a traditional Chinese medicine, 
which is a mixture of C. tubulosa and C. 
deserticola (not included in this review). 
This decoction was rich with 
phenylethanoid glycosides, and it was 
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several stress methods. The decoction 
showed antidepressant and cognitive 
improvement activities.70 Aqueous extract 
of Herb Cistanche that contained mainly 
C. tubulosa, was supplied to rats that were 
subjected to various depression inducers. 
The extract showed clear antidepressant 
activity, confirmed by behavioral and 
brain chemical tests.71,72 Plant nano-
powder was orally supplied to rats that 
were exposed to various stress methods. 
Results showed antidepressant and 





Echinacoside and acteoside that were 
extracted with water from the stems of the 
plant, showed blood glucose lowering and 
hypotensive effect in vitro.74 
Hepatoprotection Methanolic extract from fresh stems have 
hepatoprotective effects against D-
galactosamine/lipopolysaccharide (LPS)-
induced liver injury in mice. The extract 
was rich with phenylethanoid glycosides 
and their acetyls.75 Roots were extracted 
with 70 % aqueous ethanol, to obtain 
phenylethanoid glycosides-rich extract. It 
showed activity against hepatic fibrosis in 
rats.76 
Nutrition, toxicity The group that published Ref. 68 tested 
the safety of their capsules 
(Memoregain®) and found it safe.77 
Reproductive 
system, sex 
Commercial Echinacoside, and various 
extracts, showed steroidogenisis in STZ-
nicotineamide-induced diabetic rats59 
Stems were extracted with 70 % aqueous 
ethanol and this extract enhanced sex 
hormone levels in rats.78 
Chemical 
composition 
Four new tubulosides were isolated and 
characterized. One of them, tubuloside A 
is shown in Figure 6.79 New iridoid 
glycosides, kankanosides A-D, kankanol 
and kankanoside E (Figure 6) were 
isolated from the methanolic extract of 
dried stems.80 Interesting studies of 
chemical composition and methods for 
their determination have been reported 
though no new compounds were 
detected.81-84 
Odontites aucheri 
There are no publications relevant to this review article. 
Orobanche aegyptiaca 
Whole plant aqueous extract showed hypotensive 
activity.85 
Orobanche cernua  
A new phenylethanoid, 3'-O-methyl isocrenatoside, was 
isolated from fresh whole plant and characterized (Figure 7). 
This compound, along with other two known compounds 
were active against human lung cancer cell lines.86 Stems of 
the plant were extracted with 70 % aqueous ethanol and this 
extract showed strong antioxidant activity (DPPH),87 and 
their ethanolic extract showed protective effect against 











Figure 7. 3’-Omethyl isocrenatoside isolated from Orobanche 
cernua 
Orobanche crenata 
Table 5. Biological, medicinal and other properties of Orobanche 
crenata  
Activity/Property Major Findings/Reference 
Analgesic Whole plant was successively extracted 
with chloroform and 70 % aqueous 
methanol, and the organic solvent was 
removed. The water solution was 
fractionized with ethyl acetate and 
chloroform. The ethyl acetate fraction 
showed analgesic activity in hot plate 
method in mice.89  
Antibacterial, 
antifungal 
Acetone extract of leaves showed 
activity against several bacteria and 
fungi species.90 Aerial parts were 
separately extracted with methanol and 
water. Both extracts showed antioxidant 
activity (DPPH, ABTS).91 Leaves were 
extracted with 80 % aqueous methanol 
and extract was fractionized to obtain 
phenolics-rich fraction. This fraction 
showed activity against 8 fungi 
species.93  
Anticancer Methanolic extract of the plant (parts 
not indicated) was prepared and showed 
activity against several cancer cell 








































































































































Orobanchacea Plants of Israel and Palestine            Section C-Review  
Eur. Chem. Bull., 2021, 10(1), 1-12  https://doi.org/10.17628/ecb.2021.10.1-12 6 
extracted with n-hexane, ethyl acetate, 
acetone, methanol and water. Essential 
oil was also prepared. All products 
were tested for general chemical 
composition and activity against 
B16F10 melanoma cancer cells.94 
Antioxidant Acetone extract of leaves showed 
antioxidant activity (DPPH).90 Aerial 
parts were separately extracted with 
methanol and water. Both extracts were 
tested against 18 bacteria species. 
Methanolic extract was active in 17 
cases, but aqueous extract was not.91 
Methanolic extract of the plant (parts 
not indicated) was prepared and 
antioxidant activity (FRAP, DPPH) was 
tested.92 Whole plant was successively 
extracted with n-hexane, ethyl acetate, 
acetone, methanol and water. Essential 
oil was also prepared. All products 
were tested for antioxidant activity 




Whole plant ethyl acetate fraction (see 
analgesic) showed smooth muscles 
relaxation effect and antispasmodic 
activity in mice.89 
Diuretic Whole plant ethyl acetate fraction (see 
analgesic) showed diuretic activity in 
mice.89 
Hypotensive Whole plant ethyl acetate fraction (see 




Crenatoside was isolated and 
characterized from aerial parts of the 




Figure 8. Crenatoside isolated from Orobanche crenata 
Orobanche cumana and Orobanche hermonis 
There are no publications relevant to this review article. 
Orobanche lavandulacea 
Whole plant was successively extracted with n-hexane, 
ethyl acetate, acetone, methanol and water. Essential oil was 
also prepared. All products were tested for general chemical 
composition and activity against B16F10 melanoma cancer 
cells.94Whole plant was successively extracted with n-
hexane, ethyl acetate, acetone, methanol and water. 
Essential oil was also prepared. All products were tested for 
antioxidant activity (DPPH, FRAP, TEAC).94 
Orobanche mutelii, Orobanche palaestina, Orobanche pubescens, 
Orobanche schultzii, and Parentucellia flaviflora 
There are no publications relevant to this review article. 
Parentucellia viscosa 
Aerial parts were extracted with dichloromethane and 
extract showed notable antifeedant activity against 
Spodoptera litura. Extract was analyzed and detailed list of 
(known) compounds and structures are provided.34 
General chemical composition and analysis of polar 
compounds in the plant, in order to compare with other 
plants of the Orobanchaceae family. New compounds are 
not reported, but the study confirmed the presence of known 
active compounds found in other plants of this family.96 
Other authors found a new compound, gardoside methyl 
ester (Figure 9).97 
 
 
Figure 9. Gardoside methyl ester isolated from Parentucellia 
viscosa 
DISCUSSION 
The previous section of “Medicinal activities and 
chemical composition” reveals a dismal picture about the 
medicinal and chemical research of the Orobanchaceae 
family in the reviewed region of Israel and Palestine. A 
minority of them was sufficiently studied and published, 
while the majority was not. Nine species out of 17 have no 
medicinal activities-type articles and their chemical 
composition is unknown. Some other species were very 
limitedly studied. 
Although the Cistanche genus is represented by 3 species 
and the Orobanche genus by 10, the number of publications 
about Cistanche is way higher, and they are much more 
frequent. This is due to the massive use of Cistanche plants 
in East Asian traditional medicines, and especially, the 
successful medicinal formulation “Cistanches Herba” in 
Chinese traditional medicine. So, the interest of East Asian 
researchers in the species Cistanche tubulosa yielded many 
important publications (see previous section and discussion 
below). 
One of the major research finding was that of the active 
natural products in the Cistanche plants and study the 
various conditions of growth or cultivation that affect the 
qualities and the quantities of these compounds in the plants. 
In this regard, Y. Wang et al. published one of the most 
comprehensive works.98 Geographically, they sampled 
plants from all over the world but mainly focused on China 
and Mongolia. They tested the presence and concentrations 
of seven phenylethanoid glycosides and found several 
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Even though Cistanche salsa was moderately studied for 
medicinal activities, its chemical composition drew major 
interest of researchers. On this basis, many works about its 
cultivation conditions were published, such as the study of 
X. Sun et al.99 In addition, J-Y. Liu et al. developed a 
method to increase the production of phenylethanoid 
glycosides (echinacoside, acteoside, 2′-acetylacteoside) by 
feeding the plants with precursors such as tyrosine, 
phenylalanine, caffeic acid and cucumber juice.100 J. Chen et 
al. reported that cultivation of the plant under administration 
of hydrogen peroxide, upregulated the genes responsible for 
the production of these important natural products, and their 
biosynthesis was enhanced.101 
As we mentioned above, Cistanche tubulosa was and still 
extensively investigated, since it is an important ingredient 
of “Cistanches Herba”. An early, interesting botanical study 
of this plant was published by T. S. Rangan and N. S. 
Rangaswamy, focusing on the parasitic nature of this species, 
and biochemical parasite-host relationship.102 T. Deyama et 
al. published an outstanding work of isolation of 
phenylethanoid glycosides from this plant, and a 
comprehensive spectroscopic identification of them. 
Moreover, their major biological activities are presented.103 
S-Y. Zhao et al. reported that microwave processing of the 
plant increased the production of acteoside.104 They report 
that this treatment activates β-glucosidase that hydrolyses 
echinacoside to acteoside, and for this purpose, several β-
glucosidases were tested. C. Xei et al. developed a very 
efficient method (high-speed counter-current 
chromatography) for isolation of echinacoside and acteoside 
from this plant.105 Y. Li et al. developed a unique method 
using ultraperformance liquid chromatography-quadrupole 
time-of-flight mass spectrometry to identify echinacoside 
metabolites, produced by human intestinal bacteria.106 Q. 
Cui et al. reported the development of very similar method 
to identify metabolites of echinacoside and acteoside in rat 
plasma, bile, urine and feces.107 
Attempts to achieve an increase in the amount of the 
important phenylethanoids found in Cistanche tubulosa, 
were not limited to growing the plant under various 
conditions, which promoted their production. G. Guchhait 
and A. K. Misra reported a short synthesis of the 
trisaccharide major unit in these compounds (see Figure 





Figure 10.Trisaccharide prepared by Guchhait & Misra (ref. 108) 
 
In the reported synthesis, R1=R2=H, meaning that the 
aromatic ring is not substituted in positions 3, 4. Authors 
claim that they prepared the core trisaccharide of 
Kankanoside F. But in this compound, which was first 
isolated by M. Yoshikawa and his colleagues, the aromatic 
ring is doubly hydroxylated (R3=OH).109 Additional 
synthetic steps are needed to hydroxylate the aromatic ring. 
M. Yoshikawa and his colleagues report that these 
compounds (the isolated kankanosides F and G) have 
vasorelaxant activity. Finally, in this regard, this research 
group published an excellent review article about the active 
natural products of Cistanche tubulosa.110 
A detailed and relatively easy to perform synthesis of 
trixagol (Figure 4) found in Bellardia trixago was published 
by R. J. Armstrong and Larry Weiler.111 A. F. Barrero and 
his colleagues published a unique report on the use of this 
plant for the synthesis of enantiospecific odorant 
products.112 For example, the important natural product 
dihydro-γ-ionone is present only in small amounts in 
Bellardia trixago and other plants. So, this group reported 
its synthesis from another natural product present in the 




Figure 11. Synthesis of dihydro-γ-ionone.  
Relying on the success previous synthesis (60 % isolated 
yield) of dihydro-γ-ionone, this group used that compound 
to prepare other natural products present in small quantities 
in the same plant, such as Siccanochromene F.113 Finally, a 
comprehensive work of the synthesis and use of this 
compound and its closely related structures, was published 
by A. Barakat and his colleagues.114 
Among the plants of the Orobanchaceae family, species 
of the Orobanche genus are more parasitic than other genera, 
and among these, O. crenata is the most aggressive.115 The 
research of this species is ranging between two 
contradictions: on one hand, attempts to use it as food and 
utilize its medicinal properties (Table 5), and on the other 
hand, efforts to understand its parasitic mechanism, and 
develop methods to control it. 
Strigolactones (Figure 3) are produced by different host 
plants and they play major role of growth stimulation of O. 
crenata. On this basis, I. Trabelsi and her colleagues 
published their research about various factors that affect the 
production of strigolactones, and consequently, possible 
methods to control O. crenata.116 R. Matusova and her 
colleagues investigated the biosynthetic paths of 
strigolactones, and discovered the involvement of 
carotenoids as starting materials.117  
As we mentioned earlier, there are no published studies 
about the medicinal/biological properties of Orobanche 
cumana. But as a harmful weed, many researches were 
published. One of them studied the effect of Heliolactone 
(Figure 12), a growth stimulant produced by sunflower 
(Helianthus annuus) on the parasitic activity of O. crenata 
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But not only sunflower is infected by O. cumana, wild 
plants of the same family (Asteraceae) are parasitized by 
this plant, such as Dittrichia viscosa (False yellowhead), 
that grows in the Mediterranean basin. The host-parasite 
relationship in this case was studied revealed that the host 
species produces a growth stimulant, Inuloxin E (Figure 
12).119 
So, Orobanche plant species are real challenge. Many 
efforts have been made to control them and the review 
article of S. Habimana is a good summary of these efforts of 
different types.120 But they are also a very rich source of 
active natural products, that have unique structures with 
useful sub-units for organic synthesis. For this reason, many 
analytical methods were developed for their isolation and 
quantification. The review article of S. V. Luca and his 
colleagues presents the structures of the major compounds 
and the various methods that were developed for their 
isolation.121 
CONCLUSIONS  
Generally, plants of the Orobanchaceae family in Israel 
and Palestine, were very limitedly studied. The medicinal 
and biological activities of most of these plants have never 
been published. These plants have parasitic activity and 
understanding these parasite-host relationships might result 
in controlling these parasites. The species that were studied 
are sources of unique natural products. 
There is a great lack of using the isolated natural products 
of these plants for synthesis of new analogues and 
modifications, thus it is a real need to investigate the 
medical uses of pure compounds isolated from these unique 
plants. 
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SYNTHESIS OF 5-SUBSTITUTED-1,3,4-OXADIAZOLE 
CLUBBED PYRAZOLE AND DIHYDROPYRIMIDINE 
DERIVATIVES AS POTENT BIOACTIVE AGENTS 
Bonny Y. Patel,[a]* Tushar J. Karkar[b] and Malay J. Bhatt[c] 
 
Keywords: Pyrazole; 3,4-dihydropyrimidin-2(1H)-one; 1,3,4-Oxadiazole; Antimicrobial; Antitubercular; MIC. 
A series of 4-fluorophenylpyrazole clubbed 1,3,4-oxadiazole and 3,4-dihydropyrimidin-2(1H)-ones were prepared by cyclization of 
Biginelli-type adducts. Their structures were assigned on the basis of known spectral techniques. All the scaffolds were evaluated for in 
vitro antimicrobial activity by broth microdilution bioassay method and in vitro antitubercular property by microplate alamar blue assay 
method. Compounds 3j and 3l containing -OH and -CH3 groups were found to act as potent antimicrobials and antitubercular candidates 
with relatively low cytotoxicity on VERO cells. 
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INTRODUCTION 
Resistance of microbes is a major hurdle for the treatment 
of several infectious diseases. The WHO has considered 
antimicrobial drug resistance (AMR) to be one of the utmost 
threats to human life. The structural modifications in 
existing drugs have shown astonishing results in the field of 
drug discovery programs. In view of this, novel scaffold 
architecture by molecular hybridization approach is 
considered as the best tool for the development of newer 
potent agents.1,2 Nowadays, Biginelli type reaction has 
captured the attention of numbers of medicinal chemists for 
dihydropyrimidines (DHPMs) synthesis having varied 
bioactivity.3-5 Pyrazoles engage a diverse alcove in synthetic 
heterocycles as a chief motif in medicinal chemistry because 
of their wide array of biological effects, including 
antimicrobial, antidepressant, anticonvulsant, antipyretic, 
anti-influenza and anticancer activities.6-8 Various catalysts 
such as Sc(OTf)3, Mg(ClO4)2 and H2SO4 were used to 
synthesize pyrazole derivatives in multicomponent 
reaction.9-11  
In recent years, oxadiazole is a frequently utilized 
pharmacophore due to its metabolic profile and capability to 
engage in hydrogen bonding with the receptor site. The 
presence of azole group in oxadiazole uplifts lipophilicity 
and influences the easy ability of the drug to target leads to 
generate numerous biological activities like hypoglycaemic, 
anti-HIV, analgesic, anti-inflammatory, antitubercular.12,13 
oxadiazole have displayed remarkable inhibitory potential 
against important biological targets like tyrosinase, 
monoamine oxidase (MAO) and cathepsin K.14-19   
Recognizing these particulars and our continuing 
endeavours toward the development of bioactive agents,20-22 
emphasis is given to the development of new prototypes as 
potent antimicrobial as well as antitubercular molecules. 
These include the lead of the three medicinally important 
pharmacophores - DHPMs, pyrazole and 1,3,4-oxadiazole in 
one hybrid molecular framework. 
EXPERIMENTAL 
The required chemicals were purchased from Aldrich and 
E. Merck and used without further purification. Buchi 
Rotavapor was used for distillation. Melting points were 
determined in the Gallenkamp apparatus and are uncorrected. 
The completion of the reaction and the purity of all 
compounds was checked on aluminum-coated TLC plates 
G60, F245 (E. Merck) using hexane and ethyl acetate (7:3) as 
eluent and visualized under UV light (λ 254 and 365 nm), or 
iodine vapor. Elemental analysis was carried out by a 
Perkin-Elmer 2400 CHN analyzer. 1H NMR spectra were 
recorded on a Bruker Avance II 400 MHz and 13C NMR 
spectra on Varian Mercury-400, 100 MHz in DMSO-d6 as a 
solvent and TMS as a reference standard for chemical shifts. 
IR spectra were recorded on a Perkin-Elmer FT-IR 
spectrophotometer, while mass spectra were scanned on a 
Shimadzu LCMS 2010 spectrometer. 
Ethyl-4-(3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-6-meth-
yl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (1) 
Compound 1 was prepared according to the literature 
method.23 
4-(3-(4-Fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-6-methyl-2-
oxo-1,2,3,4-tetrahydro-pyrimidine-5-carbohydrazide (2)  
Compound 1 (0.01 mol) was dissolved in 1,4-dioxane (20 
mL) and to this, hydrazine hydrate (99 %, 0.01 mol) was 
added, followed by the addition of a catalytic amount of 
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conc. H2SO4 and allowed to stir for 5 h at 100 °C. After 
cooling, the reaction mixture was poured into ice-cold water. 
Product, obtained as off-white precipitate, was filtered, 
washed with water, dried and recrystallized from ethanol 
(95 %) to obtain compound 2. 
Yield: 73 %, m.p. 224-225 ºC. IR  (KBr): 3454, 3340 (N-
H), 3060 (C-Harom), 1689 (C=O), 1582 (C=N), 1512 (C=C), 
1124 (C-F) cm-1. 1H NMR (400 MHz, DMSO-d6, δ ppm): 
1.95 (s, 2H, NH2), 2.34 (s, 3H, -CH3), 5.16 (s, 1H, 
CHpyrimidine), 5.87 (s, 1H, -NHNH2), 6.91 (s, 1H, NH-C-Ph), 
7.30-7.89 (m, 10H, Ar-H), 9.03 (s, 1H, NH-C-CH3). 13C 
NMR (100 MHz, DMSO-d6, δ ppm): 17.9 (-CH3), 50.6 (-
CHpyrimidine), 123.3 (-CHpyrazole), 118.5-149.1 (Ar-C), 150.3 
(C=O, NHCONH), 166.2 (C=O). LCMS (ESI) m/z: 406.16 
[M]+. Anal. calcd. for C21H19FN6O2: C, 62.06; H, 4.71; N, 
20.68. Found: C, 62.00; H, 4.62; N, 20.73 %. 
General procedure of synthesis of 4-(3-(4-fluorophenyl)-1-phe-
nyl-1H-pyr-azol-4-yl)-6-methyl-5-(5-aryl-1,3,4-oxadiazol-2-yl)-
3,4-dihyd-ropyrimidin-2(1H)-ones (3a-o) 
Compound 2 (0.01 mol) with various derivatives of 
aromatic acids (0.01 mol) were dissolved and stirred in one 
pot having phosphoryl chloride (POCl3) (20 mL). The 
mixture was refluxed at 80 °C for 6 h. After completion of 
the reaction (TLC), the mixture was slowly quenched on 
crushed ice. The precipitates were filtered, washed with 
NaHCO3 to remove excess POCl3 trace followed by water, 





Yield: 71 %, m.p. 241-242 ºC. IR (KBr): 3223 (NH), 3061 
(C-Harom), 2983 (H-C=C<), 2848 (C-H, CH3), 1685 (C=O), 
1598 (C=N), 1527 (C=C), 1281 (C-O-C), 1122 (C-F) cm-1. 
1H NMR (400 MHz, DMSO-d6, δ ppm): 2.36 (s, 3H, -CH3), 
5.18 (s, 1H, CHpyrimidine), 6.88 (s, 1H, NH-C-Ph), 7.28-8.06 
(m, 14H, Ar-H), 8.14 (s, 1H, CHpyrazole), 9.10 (s, 1H, NH-C-
CH3). 13C NMR (100 MHz, DMSO-d6, δ ppm): 15.1 (-CH3), 
53.6 (Cpyrimidine), 123.2 (Cpyrazole), 113.5-149.5 (Ar-C), 150.4 
(C=O), 160.3, 164.1 (Coxadiazole), 161.6 (C-F). LCMS (ESI) 
m/z: 492.17 [M]+. Anal. calcd. for C29H21FN6O2: C, 68.28; H, 




Yield: 65 %, m.p. 218-220 ºC. IR (KBr): 3221 (NH), 3062 
(C-Harom), 2981 (H-C=C<), 2850 (C-H, CH3), 1691 (C=O), 
1597 (C=N), 1514 (C=C), 1288 (C-O-C), 1107 (C-F), 754 
(C-Cl) cm-1. 1H NMR (400 MHz, DMSO-d6, δ ppm): 2.28 (s, 
3H, -CH3), 5.18 (s, 1H, CHpyrimidine), 6.89 (s, 1H, NH-C-Ph), 
7.28-8.20 (m, 13H, Ar-H), 8.28 (s, 1H, CHpyrazole), 9.16 (s, 
1H, NH-C-CH3). 13C NMR (100 MHz, DMSO-d6, δ ppm): 
15.2 (CH3), 53.5 (Cpyrimidine), 123.6 (Cpyrazole), 135.3 (C-Cl), 
113.2-149.7 (Ar-C), 150.6 (C=O), 160.1, 164.4 (Coxadiazole), 
161.4 (C-F). LCMS (ESI) m/z: 526.13 [M]+. Anal. calcd. for 
C28H20ClFN6O2: C, 68.82; H, 3.83; N, 15.95. Found: C, 




Yield: 59 %, m.p. 186-188 ºC. IR (KBr): 3222 (NH), 3063 
(C-Harom), 2980 (H-C=C<), 2852 (C-H, CH3), 1691 (C=O), 
1599 (C=N), 1517 (C=C), 1280 (C-O-C), 1110 (C-F), 754 
(C-Cl) cm-1. 1H NMR (400 MHz, DMSO-d6, δ ppm): 2.30 (s, 
3H, -CH3), 5.16 (s, 1H, CHpyrimidine), 6.85 (s, 1H, NH-C-Ph), 
7.29-8.16 (m, 13H, Ar-H), 8.24 (s, 1H, CHpyrazole), 9.15 (s, 
1H, NH-C-CH3). 13C NMR (100 MHz, DMSO-d6, δ ppm): 
15.0 (CH3), 53.3 (Cpyrimidine), 123.4 (Cpyrazole), 135.2 (C-Cl), 
113.3-149.5 (Ar-C), 150.7 (C=O), 160.3, 164.6 (Coxadiazole), 
161.2 (C-F). LCMS (ESI) m/z: 526.13 [M]+. Anal. calcd. for 
C28H20ClFN6O2: C, 68.82; H, 3.83; N, 15.95. Found: C, 




Yield: 63 %, m.p. 225-227 ºC. IR (KBr): 3293 (NH), 3066 
(C-Harom), 2978 (H-C=C<), 2929 (C-H, CH3), 1680 (C=O), 
1591 (C=N), 1504 (C=C), 1219 (C-O-C), 1155 (C-F), 752 
(C-Cl) cm-1. 1H NMR (400 MHz, DMSO-d6, δ ppm): 2.31 (s, 
3H, CH3), 5.26 (s, 1H, CHpyrimidine), 6.82 (s, 1H, NH-C-Ph), 
7.20-8.05 (m, 13H, Ar-H), 8.16 (s, 1H, CHpyrazole), 9.04 (s, 
1H, NH-C-CH3). 13C NMR (100 MHz, DMSO-d6, δ ppm): 
15.3 (CH3), 53.9 (Cpyrimidine), 123.8 (Cpyrazole), 135.6 (C-Cl), 
113.0-149.7 (Ar-C), 150.5 (C=O), 160.6, 164.4 (Coxadiazole), 
161.7 (C-F). LCMS (ESI) m/z: 526.13 [M]+. Anal. calcd. for 
C28H20ClFN6O2: C, 68.82; H, 3.83; N, 15.95. Found: C, 




Yield: 58 %, m.p. 233-235 ºC. IR (KBr): 3224 (NH), 3063 
(C-Harom), 2981 (H-C=C<), 2862 (C-H, CH3), 1687 (C=O), 
1606 (C=N), 1531 (C=C), 1508 (-N=O), 1234 (C-O-C), 
1150 (C-F) cm-1. 1H NMR (400 MHz, DMSO-d6, δ ppm): 
2.37 (s, 3H, CH3), 5.20 (s, 1H, CHpyrimidine), 6.85 (s, 1H, NH-
C-Ph), 7.22-8.15 (m, 13H, Ar-H), 8.20 (s, 1H, CHpyrazole), 
9.04 (s, 1H, NH-C-CH3). 13C NMR (100 MHz, DMSO-d6, δ 
ppm): 15.2 (CH3), 54.0 (Cpyrimidine), 122.9 (Cpyrazole), 113.0-
149.7 (Ar-C), 147.3 (C-NO2), 150.4 (C=O), 160.2, 164.1 
(Coxadiazole), 161.5 (C-F). LCMS (ESI) m/z: 537.16 [M]+. 
Anal. calcd. for C28H20FN7O4: C, 62.57; H, 3.75; N, 18.24. 




Yield: 60 %, m.p. 250-252 ºC. IR (KBr): 3221 (NH), 3060 
(C-Harom), 2985 (H-C=C<), 2854 (C-H, CH3), 1680 (C=O), 
1603 (C=N),   1533  (C=C),  1507  (-N=O),  1231  (C-O-C),  
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1155 (C-F) cm-1. 1H NMR (400 MHz, DMSO-d6, δ ppm): 
2.35 (s, 3H, CH3), 5.23 (s, 1H, CHpyrimidine), 6.86 (s, 1H, NH-
C-Ph), 7.20-8.21 (m, 13H, Ar-H), 8.29 (s, 1H, CHpyrazole), 
9.08 (s, 1H, NH-C-CH3). 13C NMR (100 MHz, DMSO-d6, δ 
ppm): 15.1 (CH3), 54.4 (Cpyrimidine), 123.1 (Cpyrazole), 113.4-
149.9 (Ar-C), 147.6 (C-NO2), 150.5 (C=O), 160.1, 164.6 
(Coxadiazole), 161.3 (C-F). LCMS (ESI) m/z: 537.10 [M]+. 
Anal. calcd. for C28H20FN7O4: C, 62.57; H, 3.75; N, 18.24. 




Yield: 66 %, m.p. 269-271 ºC. IR (KBr): 3211 (NH), 3059 
(C-Harom), 2980 (H-C=C<), 2848 (C-H, CH3), 1693 (C=O), 
1598 (C=N), 1527 (C=C), 1504 (N=O), 1284 (C-O-C), 1157 
(C-F) cm-1. 1H NMR (400 MHz, DMSO-d6, δ ppm): 2.40 (s, 
3H, CH3), 5.21 (s, 1H, CHpyrimidine), 6.80 (s, 1H, NH-C-Ph), 
7.29-8.23 (m, 13H, Ar-H), 8.31 (s, 1H, CHpyrazole), 9.24 (s, 
1H, NH-C-CH3). 13C NMR (100 MHz, DMSO-d6, δ ppm): 
15.7 (CH3), 54.7 (Cpyrimidine), 123.4 (Cpyrazole), 113.2-149.2 
(Ar-C), 147.1 (C-NO2), 150.6 (C=O), 160.4, 164.9 
(Coxadiazole), 161.6 (C-F). LCMS (ESI) m/z: 537.13 [M]+. 
Anal. calcd. for C28H20FN7O4: C, 62.57; H, 3.75; N, 18.24. 




Yield: 68 %, m.p. 179-181 ºC. IR (KBr): 3409 (OH), 3216 
(NH), 3062 (C-Harom), 2984 (H-C=C<), 2845 (C-H, CH3), 
1697 (C=O), 1602 (C=N), 1525 (C=C), 1280 (C-O-C), 1151 
(C-F) cm-1. 1H NMR (400 MHz, DMSO-d6, δ ppm): 2.35 (s, 
3H, CH3), 5.22 (s, 1H, CHpyrimidine), 6.82 (s, 1H, NH-C-Ph), 
7.02-8.07 (m, 13H, Ar-H), 8.18 (s, 1H, CHpyrazole), 9.16 (s, 
1H, NH-C-CH3), 9.20 (s, 1H, OH). 13C NMR (100 MHz, 
DMSO-d6, δ ppm): 15.0 (CH3), 53.4 (Cpyrimidine), 123.2 
(Cpyrazole), 113.2-149.7 (Ar-C), 150.1 (C=O), 157.3 (C-OH), 
160.1, 164.4 (Coxadiazole), 161.8 (C-F). LCMS (ESI) m/z: 
508.16 [M]+. Anal. calcd. for C28H21FN6O3: C, 66.14; H, 
4.16; N, 16.53. Found: C, 66.23; H, 4.12; N, 16.58 %. 
4-(3-(4-Fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-5-(5-(3-hyd-
roxyphenyl)-1,3,4-oxadiazol-2-yl)-6-methyl-3,4-dihydropyri-
midin-2(1H)-one (3i)  
Yield: 57 %, m.p. 271-273 ºC. IR (KBr): 3412 (OH), 3217 
(NH), 3064 (C-Harom), 2987 (H-C=C<), 2848 (C-H, CH3), 
1698 (C=O), 1609 (C=N), 1528 (C=C), 1252 (C-O-C), 1151 
(C-F) cm-1. 1H NMR (400 MHz, DMSO-d6, δ ppm): 2.34 (s, 
3H, CH3), 5.19 (s, 1H, CHpyrimidine), 6.80 (s, 1H, NH-C-Ph), 
6.99-8.14 (m, 13H, Ar-H), 8.20 (s, 1H, CHpyrazole), 9.14 (s, 
1H, NH-C-CH3), 9.19 (s, 1H, OH). 13C NMR (100 MHz, 
DMSO-d6, δ ppm): 15.3 (CH3), 53.1 (Cpyrimidine), 123.4 
(Cpyrazole), 113.0-149.8 (Ar-C), 150.4 (C=O), 157.6 (C-OH), 
160.2, 164.3 (Coxadiazole), 161.2 (C-F). LCMS (ESI) m/z: 
508.16 [M]+. Anal. calcd. for C28H21FN6O3: C, 66.14; H, 




Yield: 73 %, m.p. 237-239 ºC. IR (KBr): 3418 (OH), 3219 
(NH), 3062 (C-Harom), 2981 (H-C=C<), 2853 (C-H, CH3), 
1692 (C=O), 1605 (C=N), 1526 (C=C), 1278 (C-O-C), 1160 
(C-F) cm-1. 1H NMR (400 MHz, DMSO-d6, δ ppm): 2.37 (s, 
3H, CH3), 5.22 (s, 1H, CHpyrimidine), 6.83 (s, 1H, NH-C-Ph), 
6.96-8.17 (m, 13H, Ar-H), 8.21 (s, 1H, CHpyrazole), 9.16 (s, 
1H, NH-C-CH3), 9.20 (s, 1H, OH). 13C NMR (100 MHz, 
DMSO-d6, δ ppm): 15.0 (CH3), 53.3 (Cpyrimidine), 123.0 
(Cpyrazole), 113.6-149.9 (Ar-C), 150.6 (C=O), 158.4 (C-OH), 
160.6, 164.7 (Coxadiazole), 161.8 (C-F). LCMS (ESI) m/z: 
508.16 [M]+. Anal. calcd. for C28H21FN6O3: C, 66.14; H, 




Yield: 64 %, m.p. 184-186 ºC. IR (KBr): 3216 (NH), 3063 
(C-Harom), 2985 (H-C=C<), 2944 (OCH3), 2850 (C-H, CH3), 
1698 (C=O), 1606 (C=N), 1527 (C=C), 1281 (C-O-C), 1163 
(C-F) cm-1. 1H NMR (400 MHz, DMSO-d6, δ ppm): 2.39 (s, 
3H, CH3), 3.60 (s, 3H, OCH3), 5.19 (s, 1H, CHpyrimidine), 6.84 
(s, 1H, NH-C-Ph), 7.01-8.14 (m, 13H, Ar-H), 8.20 (s, 1H, 
CHpyrazole), 9.17 (s, 1H, NH-C-CH3). 13C NMR (100 MHz, 
DMSO-d6, δ ppm): 15.2 (CH3), 53.6 (Cpyrimidine), 55.6 
(OCH3), 123.7 (Cpyrazole), 113.4-149.8 (Ar-C), 150.1 (C=O), 
160.1, 164.5 (Coxadiazole), 161.9 (C-F). LCMS (ESI) m/z: 
522.17 [M]+. Anal. calcd. for C29H23FN6O3: C, 66.66; H, 




Yield: 74 %, m.p. 213-215 ºC. IR (KBr): 3219 (NH), 3068 
(C-Harom), 2986 (H-C=C<), 2856, 2860 (C-H, CH3), 1701 
(C=O), 1602 (C=N), 1531 (C=C), 1284 (C-O-C), 1165 (C-
F) cm-1. 1H NMR (400 MHz, DMSO-d6, δ ppm): 2.37 (s, 3H, 
CH3Pyrimidine), 2.44 (s, 3H, CH3arom), 5.21 (s, 1H, CHpyrimidine), 
6.86 (s, 1H, NH-C-Ph), 7.07-8.18 (m, 13H, Ar-H), 8.22 (s, 
1H, CHpyrazole), 9.18 (s, 1H, NH-C-CH3). 13C NMR (100 
MHz, DMSO-d6, δ ppm): 15.0 (CH3Pyrimidine), 21.2 (CH3arom), 
53.2 (Cpyrimidine), 123.2 (Cpyrazole), 113.1-149.7 (Ar-C), 150.2 
(C=O), 160.2, 164.2 (Coxadiazole), 161.4 (C-F). LCMS (ESI) 
m/z: 506.19 [M]+. Anal. calcd. for C29H23FN6O2: C, 66.76; H, 




Yield: 61 %, m.p. 227-229 ºC. IR (KBr): 3221 (NH), 3061 
(C-Harom), 2984 (H-C=C<), 2921 (C-H, CH2), 2852 (C-H, 
CH3), 1703 (C=O), 1605 (C=N), 1528 (C=C), 1281 (C-O-C), 
1160 (C-F) cm-1. 1H NMR (400 MHz, DMSO-d6, δ ppm): 
2.36 (s, 3H, CH3), 4.06 (s, 2H, CH2), 5.25 (s, 1H, 
CHpyrimidine), 6.87 (s, 1H, NH-C-Ph), 7.10-8.20 (m, 14H, Ar-
H), 8.24 (s, 1H, CHpyrazole), 8.68 (s, 1H, NHCO), 9.17 (s, 1H, 
NH-C-CH3). 13C NMR (100 MHz, DMSO-d6, δ ppm): 15.4 
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(CH3), 43.4 (CH2), 53.5 (Cpyrimidine), 123.6 (Cpyrazole), 113.0-
149.1 (Ar-C), 150.7 (C=O), 160.4, 164.3 (Coxadiazole), 161.5 
(C-F), 167.5 (NHCO). LCMS (ESI) m/z: 549.19 [M]+. Anal. 
calcd. for C30H24FN7O3: C, 66.57; H, 4.40; N, 17.84. Found: 




Yield: 62 %, m.p. 195-197 ºC. IR (KBr): 3219 (NH), 3066 
(C-Harom), 2987 (H-C=C<), 2923 (C-H, CH2), 2854 (C-H, 
CH3), 1705 (C=O), 1604 (C=N), 1531 (C=C), 1284 (C-O-C), 
1166 (C-F) cm-1. 1H NMR (400 MHz, DMSO-d6, δ ppm): 
2.34 (s, 3H, CH3), 4.01 (s, 2H, CH2), 5.22 (s, 1H, 
CHpyrimidine), 6.86 (s, 1H, NH-C-Ph), 7.12-8.19 (m, 14H, Ar-
H), 8.22 (s, 1H, CHpyrazole), 9.15 (s, 1H, NH-C-CH3). 13C 
NMR (100 MHz, DMSO-d6, δ ppm): 15.1 (CH3), 31.2 (CH2), 
53.7 (Cpyrimidine), 123.3 (Cpyrazole), 113.4-149.6 (Ar-C), 150.4 
(C=O), 160.1, 164.7 (Coxadiazole), 161.7 (C-F). LCMS (ESI) 
m/z: 506.19 [M]+. Anal. calcd. for C29H23FN6O2: C, 68.76; H, 




Yield: 72 %, m.p. 275-277 ºC. IR (KBr): 3224 (NH), 3151 
(C-Harom), 3024 (H-C=C-H), 2980 (H-C=C<), 2920 (C-H, 
CH3), 1708 (C=O), 1597 (C=N), 1500 (C=C), 1217 (C-O-C), 
1178 (C-F) cm-1. 1H NMR (400 MHz, DMSO-d6, δ ppm): 
2.26 (s, 3H, CH3), 5.44 (s, 1H, CHpyrimidine), 6.42 (d, 1H, 
CH=CHarom), 6.46 (d, 1H, CH=CHoxadiazole), 7.06 (s, 1H, 
NH-C-Ph), 7.13-7.97 (m, 14H, Ar-H), 8.00 (s, 1H, 
CHpyrazole), 9.21 (s, 1H, NH-C-CH3). 13C NMR (100 MHz, 
DMSO-d6, δ ppm): 15.1 (CH3), 53.4 (Cpyrimidine), 123.1 
(Cpyrazole), 123.1 (CH=CHoxadiazole), 133.1 (CH=CHarom), 
113.4-149.8 (Ar-C), 150.1 (C=O), 159.9, 164.0 (Coxadiazole), 
161.2 (C-F). LCMS (ESI) m/z: 518.19 [M]+. Anal. calcd. for 
C30H23FN6O2: C, 69.49; H, 4.47; N, 16.21. Found: C, 69.45; 
H, 4.44; N, 16.32 %. 
RESULTS AND DISCUSSION 
Scheme 1 shows the synthesis of targeted compounds. 
Compound 2 was synthesized by adopting the well-known 
approach of Biginelli reaction by means of diaryl-pyrazole-
4-carbaldehyde followed by the addition of NH2-NH2 
(hydrazine hydrate). This adduct was treated with different 




Synthesized molecules were characterized by well known 
spectroscopic techniques before evaluating theirs in vitro 
antimicrobial activity. IR spectrum of compound 3a-o 
showed characteristic absorption band of the carbonyl group 
at 1710-1680 cm-1, while absorption band appeared at 3293-
3212 cm-1 corresponding to a secondary amine. The 
vibrations appeared at 3151-3058, 2998-2978 and 2929-
2845 cm-1 corresponding to C-H stretching of the aromatic 
ring, H-C=C< and -CH3, respectively. Absorption bands at 
1609-1592, 1533-1500 cm-1 corresponding to >C=N-, 
>C=C< stretching of the aromatic ring, while absorption 
displayed at 1289-1217 cm-1 was due to C-O-C stretching in 
oxadiazole ring.  
In 1H NMR, the appearance of three singlet peaks at δ = 
2.26-2.40, 5.17-5.45 and 9.04-9.24 ppm were due to three 
protons of the methyl group, -CH of the pyrimidine ring and 
proton of -NH of pyrimidine ring (-NH-C-CH3), respectively. 
The appearance of singlet peak at δ = 6.80-7.06 ppm was 
due to one proton of -NH of pyrimidine ring (-NH-C-Ph). 
13C NMR of compound 3a-o showed a characteristic signal 
at δ = 150.2-151.3 ppm due to carbonyl carbon of 
pyrimidine scaffold as well as the appearance of a signal 
around δ = 15.0-15.2 ppm assignable to the carbon of the 
methyl group. Moreover, the mass spectrum had shown a 
molecular ion peak corresponding to molecular formula 3a-
o along with other fragment peaks, which were in agreement 
with the proposed molecular weight and elemental analysis 












Scheme 1. Synthetic pathway of novel compounds 3a-o 
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Figure 1. Plausible mechanistic pathway of synthesized analogs 
 
A plausible mechanistic path for compounds 3a-o is 
suggested in Figure 1. Biginelli hydrazide (1) was 
transformed to targeted compounds (6) by intermolecular 
nucleophilic attack on the carbonyl carbon of different 
aromatic acids (2) followed by the cyclocondensation 
(removal of HCl) (5) in the presence of phosphorus 
oxychloride (POCl3).  
Antimicrobial activity 
Amongst the synthesized compounds 3a-o, several 
compounds revealed the antimicrobial influence that ranged 
from good to excellent. On the basis of antibacterial 
screening results given in Table 1, compounds 3j (-4-OH-
C6H4), 3k (-4-OCH3-C6H4) and 3l (-4-CH3-C6H4) displayed 
noteworthy antibacterial activities against E. coli, P. 
aeruginosa, S. aureus, S. pyogenes compared to 
chloramphenicol and Ciprofloxacin used as standard drugs. 
MIC values of antifungal activity were determined by means 
of conventional broth microdilution bioassay method using 
Nystatin and Griseofulvin as a reference standard.24 
Compounds 3h (-2-OH-C6H4) and 3l (-4-CH3-C6H4) 
unveiled remarkable inhibitory effect at MIC = 12.5 μg mL-1 
against selected fungal strains.  
Antitubercular and cytotoxic activity 
Synthesized oxadiazole hybrid molecules 3a-o were 
screened for their in vitro antitubercular activity at 6.25 μg 
mL-1 against Mycobacterium tuberculosis H37Rv strain in 
BACTEC 12B medium using the microplate alamar blue 
assay (MABA).25 In an initial screen, the compounds which 
shown more than or equal to 90 % inhibition were retested 
at and below 6.25 μg mL-1 by using 2-fold dilution to 
determine the definite MIC. In preliminary in vitro 
screening, compounds 3d, 3h, 3j, 3k and 3l inhibited Mtb in 
the range of 92-98 %. In secondary level screening, two 
compounds 3j (-4-OH-C6H4) and 3l (-4-CH3-C6H4) inhibited 
Mtb with MIC of 0.03 μg mL-1 correspond to the same MIC 
as the reference standard isoniazid.  
Compounds revealing comparatively low MICs were 
tested for cytotoxicity (IC50) in VERO cell lines. Their 
selectivity index (SI) was calculated as per the following 
formula IC50/MIC. The compounds 3h, 3j and 3l were 
somehow less toxic than 3d and 3k. Basically, the 
compounds with MIC≤6.25 μg mL-1 and SI≥10 are 
remarkable compounds and MIC≤1 μg mL-1 in the newly 
synthesized compound may be considered as excellent 
leadership, which makes compounds 3j and 3l promising 
bioactive molecules for future research. The results of the 
antitubercular studies, actual IC50 and SI of tested 
compounds were reported in Table 2.  
Determination of 50 % IC50 in VERO cells (Cytotoxicity assay) 
Compounds were tested for cytotoxicity (IC50) in VERO 
cells at concentrations less than or equal to 62.5 μg mL-1 or 
10 times the MIC for M. tuberculosis H37Rv. After 72 h of 
exposure, viability was assessed on the basis of cellular 
conversion of MTT into a formazan product using the 
Promega CellTiter 96 Non-radioactive Cell Proliferation 
Assay. The Selectivity Index (SI = IC50/MIC) was also 
determined; it was considered significant when SI >10. 
Structure-activity relationship study 
In this manuscript, 1,3,4-oxadiazole motifs were used to 
impart electronic location on the hankering of molecules. It 
is observed that the electron releasing group on the phenyl 
nucleus of 1,3,4-oxadiazole enhanced, whereas electron-
withdrawing substituent caused a substantial decrease in the 
biological potency.  
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Table 1. Antimicrobial screening of the compounds 3a-o. 
No. -Ar MINIMUM INHIBITORY CONCENTRATIONS, MIC, in μg mL-1 
Gram-negative Gram-positive Fungi 
E.C.a P.A.b S.A.c S.P.d C.A.e A.N.f A.C.g 
3a -C6H5 500 250 500 250 500 N.A.h N.A. 
3b -2-Cl-C6H4 125 250 500 100 500 NA. NA. 
3c -3-Cl-C6H4 100 100 100 500 NA. NA. 500 
3d -4-Cl-C6H4 25 62.5 25 100 500 NA. NA. 
3e -2-NO2-C6H4 1000 500 500 500 NA. 250 NA. 
3f -3-NO2-C6H4 1000 1000 500 500 250 100 250 
3g -4-NO2-C6H4 500 100 1000 1000 500 NA. NA. 
3h -2-OH-C6H4 100 1000 1000 500 NA. 100 12.5 
3i -3-OH-C6H4 1000 100 500 50 NA. 1000 NA. 
3j -4-OH-C6H4 12.5 25 1000 100 1000 1000 100 
3k -4-OCH3-C6H4 100 250 500 12.5 50 1000 1000 
3l -4-CH3-C6H4 500 500 25 1000 100 12.5 NA. 
3m -CH2NHCOC6H5 1000 1000 250 500 1000 NA. 50 
3n -CH2-C6H5 500 1000 100 500 NA. 50 1000 
3o -C2H2-C6H5 1000 500 250 1000 1000 500 1000 
S.d.i 1 Chloramphenicol 50 50 50 50 - - - 
S.d. 2 Ciprofloxacin 25 25 50 50 - - - 
S.d. 3 Nystatin - - - - 100 100 100 
S.d. 4 Griseofulvin - - - - 500 100 100 
aE.C.: Escherichia coli MTCC 443; bP.A.:Pseudomonas aeruginosa MTCC 1688, cS.A.: Staphylococcus aureus MTCC 96; 
dS.P.: Staphylococcus pyogenes MTCC 442; eC.A.: Candida albicans MTCC 227; fA.N.: Aspergillus niger MTCC 282; 
gA.C.: Aspergillus clavatus MTCC 1323; hN.A.: No activity; iS.d.: Standard drug. 
 
Table 2. In vitro antitubercular screening data of oxadiazole analogs 3a-o. 
No. -Ar % Inhibition, at 6.25 μg mL-1 MICa, μg mL-1 IC50b, VERO cells SIc=IC50/MIC 
3a -C6H5 65 n.d.f n.d. n.d. 
3b -2-ClC6H4 55 n.d. n.d. n.d. 
3c -3-ClC6H4 52 n.d. n.d. n.d. 
3d -4-ClC6H4 92 6.25 7.2 1.15 
3e -2-NO2C6H4 48 n.d. n.d. n.d. 
3f -3-NO2C6H4 71 n.d. n.d. n.d. 
3g -4-NO2C6H4 62 n.d. n.d. n.d. 
3h -2-HOC6H4 93 3.13 >10 >3.19 
3i -3-HOC6H4 82 n.d. n.d. n.d. 
3j -4-HOC6H4 98 0.03 >10 333 
3k -4-MeOC6H4 96 1.56 8.9 5.70 
3l -4-CH3-C6H4 97 0.03 >10 333 
3m -CH2NHCOC6H5 81 n.d. n.d. n.d. 
3n -CH2C6H5 73 n.d. n.d. n.d. 
3o -C2H2C6H5 84 n.d n.d. n.d. 
R.S.d INHe 99 0.03 - - 
aMinimum inhibitory concentration against H37Rv strain of M. tuberculosis (μg mL-1). bMeasurement of cytotoxicity in 
VERO cells: 50% inhibitory concentrations (μg mL-1). cSelectivity index (in vitro): IC50 in VERO cells/MIC against M. 
tuberculosis. dR.S.: Reference Standard;  eINH: Isoniazid;  fn.d.: Not determined. 
 
Compounds 3h, 3j, 3k and 3l, substituted with inductively 
electron-donating groups like methyl, methoxy (on para) 
and hydroxyl (on ortho and para), showed the maximum 
inhibitory antimicrobial as well as antitubercular influence 
with an IC50 of >10 μg mL-1. Looking at the MIC values, it 
may be concluded that electron-donating groups at the para 
position of the phenyl ring induced a positive effect on bio-
activity. 
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The pivotal point of the present work was to focus on the 
development of novel structural hybrids based on DHPMs 
and pyrazole clubbed 1,3,4-oxadiazole, which could be 
useful as effective antimicrobial as well as antitubercular 
agents. It is concluded from biological activity that the 
structural and electronic diversity of these compounds 
influences their activity. Synthesized scaffolds 3h, 3j, 3k 
and 3l having an electron-donating group such as -OH, -
OCH3, -CH3 are found as the most potent antimicrobials and 
antitubercular candidates. Moreover, most active 
compounds (i.e., 3j and 3l) were conveyed with moderately 
low cytotoxicity. Consequently, this hybrid nucleus may 
unlock a moderately simplistic route to new potent 
antimicrobials and antitubercular scaffolds. 
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NOVEL 1,2,3-TRIAZOLE-1,4-DIHYDROPYRIDINE-3,5-
DICARBONITRILE DERIVATIVES: SYNTHESIS AND 
ANTIBACTERIAL EVALUATION 
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Keywords: Antibacterial; 1,4-Dihydropyridines, 1,2,3-Triazoles. 
The purpose of this study was the synthesis of a novel series of 1,2,3-triazole-1,4-dihydropyridine-3,5-dicarbonitrile derivatives (3a-3o) via 
Cu(I) catalyzed reaction between a terminal alkyne and substituted alkyl or aryl azides.  The synthesized triazoles were characterized by 1H 
NMR, 13C NMR, and single crystal X-Ray. They were screened in vitro for antibacterial activity against a set of 10 bacterial cultures by the 
broth microdilution method. The significant antibacterial activity with MIC: 50 μg mL-1 was displayed by compounds 3j and 3h against 
Pseudomonas aeruginosa and compounds 3c and 3g against Salmonella paratyphi as well as compound 3f against Enterobacter aerogenes, 
Klebsiella pneumoniae, Proteus vulgaris, and Shigella flexneri. Compound 3e was the only compound that was found to inhibit Escherichia 
coli with MIC: 200 μg mL-1. 
 
 
* Corresponding Authors 
E-Mail: b.gauni@gmail.com 
[a] Department of Microbiology, Gujarat Vidyapith, Sadra-
382320, D; Gandhinagar, Gujarat, India 
[b] National Facility for Drug Discovery Complex, Department 
of Chemistry, Saurashtra University, Rajkot-360005, India 
[c]  Gujarat Vidyapith, Nr. Income Tax Office, Ashram Rd, 
Ahmedabad, Gujarat 380014 
[d]  Department of Microbiology, Gujarat Vidyapith, Sadra-
382320, D;Gandhinagar, Gujarat, India 
INTRODUCTION 
Antibiotic resistance is presently contemplated as a chief 
public health issue.1 As per the WHO report of April 2019, 
currently, every year, almost 700,000 people die as a result 
of drug-resistant diseases and this situation will push about 
24 million people into extreme poverty by 2030. Due to the 
re-emergence of devastating bacterial infections, 
antimicrobial resistance has left behind the relevance of 
modern medicines.2 Therefore, the development of new 
compounds with antimicrobial activity is the crucial mission 
of this century. 
The involvement of medicinal chemistry in the biological 
and pharmaceutical field is broad that accounts for drug 
development, detection, design, and recognition of bioactive 
compounds. Heterocyclic compounds are of crucial 
importance in medicinal chemistry. They are getting strong 
interest in the context to synthesize and process different 
types of compounds having pharmacological and biological 
properties.3 Currently, a general trend of research is 
synthesizing new drugs by modification of existing 
biologically active matrices and molecular design of the 
structural entities.4 In search of new antimicrobials, 
medicinal chemists generally confide in N-heterocyclic 
compounds. In this line, 1,2,3-triazoles have been 
scrutinized as a substantial class of synthetically versatile 
heterocyclic compounds. 
Azoles are a class of heterocyclic compounds having a 
five-membered ring that consists of at least one nitrogen 
atom and one more heteroatom like nitrogen, oxygen, or 
sulfur in the ring. They are present in many biologically 
active compounds as well as they are excellent ligands for 
the synthesis of coordinated polymers and metal-organic 
frameworks.5 1,2,3-Triazole is a component of this family 
and can be efficiently synthesized by the copper-catalyzed 
click reaction of azides with alkynes.6  
Triazole is a significant heterocyclic skeleton with 
extensive biological activities and 1,2,3-Triazoles are the 
influential class in the triazole series.5 These compounds are 
engaging for synthesis since they acquire diversified 
pharmacological properties functioning as 
antimicrobial,7,8,9,10,11,12 antimalarial,13 antiviral,14 
antitumoral,15 anti-inflammatory,11 antitubercular,16 anti-
HIV,17 activities.  
These diverse pharmacological activities are accredited to 
a 1,2,3-triazole moiety and it can apply various noncovalent 
interactions that can enhance the solubility and binding 
ability to biomolecular targets.18 1,2,3-Triazole can function 
as the isostere of amide, ester, carboxylic acid, and other 
heterocycles that makes it a common pharmacophore in 
several drugs.14 Thus, 1,2,3-triazole derivatives play a 
compelling role in the development of new drugs. 
There are several 1,2,3-triazole containing molecules on 
the market or are in the final stage of clinical trials. 
Promising pharmaceuticals based on 1,2,3-triazoles include 
the anticancer compound carboxyamidotriazole (CAI), the 
nucleoside derivative non-nucleoside reverse transcriptase 
inhibitor tert-butyldimethylspiroaminooxathioledioxide 
(also known as TSAO), β-lactam antibiotic Tazobactum, the 
cephalosporin Cefatrizine (Figure-1).19 
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Figure 1. Promising pharmaceuticals based on 1,2,3-triazoles 
The approach for developing an expanding set of powerful, 
selective, and modular blocks that work reliably in both 
small- and large-scale applications is called click 
chemistry.20 Copper-catalyzed azide-alkyne cycloaddition 
(CuAAC) for the reactions that are capable of building 
blocks of complex compounds has been widely applied in 
pharmacological and medicinal applications. On that 
account, CuAAC has thoroughly emerged in research within 
the past few years in the fields of organic synthesis, polymer 
chemistry as well as biochemistry.21,22 The concept of 
“click” chemistry was established by Sharpless and co-
workers in 2001.23 Click chemistry comprising good yield, 
temperature, mild reaction condition, and few by-products, 
has found applications in many research fields. The 1,2,3-
triazole having aromatic five-membered heterocyclic ring 
containing π-excessive three nitrogen atoms and two carbon 
atoms with two double bonds have attracted significant 
attention over recent decades due to their extensive 
biological activities used in the pharmacological and 
medicinal applications.20 Described more than one century 
ago behavior of 1,4-dihydropyridine derivatives (1,4-DHPs) 
is exhibiting a wide range of biological activity. 
New derivatives of 1,2,3-triazole-linked 1,2,4-
triazino[5,6-b] indole by the Cu(I)-catalyzed click reaction 
were determined for their binding modes to three enzyme 
active sites by molecular docking study. Some of these 
derivatives were found to bind to active sites of 
dihydrodipicolinate reductase of Escherichia coli, 
undecaprenyl diphosphate synthase (UPPS) of Micrococcus 
luteus and fibrinogen-binding MSCRAMM, clumping factor 
A Staphylococcus aureus via hydrogen bonds and 
hydrophobic interactions, respectively.24 
Methyl derivative of acridone-1,2,3-triazole displayed 
significant antibacterial activity against Staphylococcus 
aureus (MRSA) with MIC:19.6 µg mL-1 and it also played a 
key role in bond interaction with Ala 7 and hydrophobic 
interaction into DHFR active site of dihydropteroate 
synthase (DHPS) in methicillin-resistant Staphylococcus 
aureus (MRSA). Most of the tested compounds displayed 
moderate activity against Escherichia coli and Klebsiella 
pneumoniae with the MIC values between 56.6 - 74.0 μg 
mL-1.25 
Some vanillin-derived 1,2,3-triazoles and bis 1,2,3-
triazoles substituted with various aromatic rings synthesized 
using click chemistry concept were found to have potent 
antibacterial activity. Among them, mono 1,2,3-triazoles, 
compounds having electron-withdrawing -Br and -NO2 
groups at 3- and 4- position of aryl group were more active 
against Gram-positive bacteria (MIC: 5 μg mL-1). Methyl 
derivative of bis 1,2,3-triazoles was the most active in the 
series for most of the Gram-positive and Gram-negative 
strains (MIC: 5 μg mL-1). It was found as a lead inhibitor of 
bacterial DNA synthesis due to conformational fitting in the 
active site of targeted protein Thymidylate kinase (TMPK), 
which is an essential enzyme in bacterial DNA 
biosynthesis.26 
Among few fluorinated chalcone-triazole hybrids obtained 
from propargylated chalcones and organic azides, derivative 
with a 4-nitro group (MIC: 0.0032 μmol mL-1) was found to 
more potent than the standard Ciprofloxacin (MIC: 0.0047 
μmol mL-1) against E. coli and S. epidermidis. While 
compound with -OMe functional group was also active 
against E. coli with MIC value of 0.0032 μmol mL-1. The 
activity results displayed the synergistic effect of biological 
activity when two pharmacophoric units, i.e., chalcone and 
1,2,3-triazole are conjugated. Furthermore, the docking 
study revealed that the most potent derivative with a 4-NO2 
group was found to form the most stable binding 
confirmation into the active site of topoisomerase II DNA 
gyrase B. Thus, these chalcone triazole conjugates could be 
thought to possible inhibit DNA topoisomerase.27 
2-Chloro-6-fluorobenzyl substituted 1,2,3-triazole and 
2,4-dichlorobenzylTriazole among ten 1,4-disubstituted 
1,2,3-triazoles having benzhydryl piperazine chemical 
scaffold were found to have excellent antibacterial activity 
against Gram-positive S. aureus (zone of inhibition 16.33 
mm and 16.45 mm respectively) and Gram-negative E. coli 
(zone of inhibition 15.63 mm and 16.15 mm respectively). 
By docking study, it was also found that these two 
compounds make several hydrogen bonds with DNA Gyrase 
B of bacteria.28    
Functionalized 1,2,3-triazole nucleosides, 4-chlorophenyl 
derivative 3a, and 3-methylthiophen derivative 3b displayed 
significant antibacterial activity against many Gram-positive 
and Gram-negative organisms. The 4-chlorophenyl 
derivative of functionalized 1,2,3-triazole nucleosides 
inhibited E. coli ATCC 10536 with a zone of inhibition of 
30 mm that was nearer to zone obtained by standard 
Cefotaxime (34 mm). While 3-methylthiophen derivative 
inhibited M. luteus ATCC 10240 (35 mm) that was higher 
than standard (28 mm) at the concentration of 40 μg mL-1.29 
In the library of 1,2,3-triazolyl-1,4-dihydropyridine 
hybrids, derivatives with methyl ester, ethyl ester, cyano, 
phenacyl, and benzyl functional group showed equipotent 
activity (10 μg mL-1) to the standard Tetracycline against 
Proteus mirabilis with MIC: 10 μg mL-1. In more, cyano, 
phenacyl, and benzyl derivatives of 1,2,3-triazolyl-1,4-
dihydropyridine hybrids were equal potent against 
Escherichia coli with MIC: 30 μg mL-1a nd more potent 
against Klebsiella pneumoniae (MIC: 8 μg mL-1 
compared to reference drug (MIC: 10 μg mL-1).30 
Some 1,2,3-triazole-linked β-lactam-bile acid conjugates 
showed moderate to good antifungal and antibacterial 
activity against Candida albicans, Candida neoformans, 
Fusarium oxysporum, Escherichia coli, and Staphylococcus 
aureus.31 Between the series of 5-(4-methyl-1,2,3-
triazole)methyl oxazolidinones, the compound  with 
substitution of the isopropylcarbonyl group at the piperazine 
C4 position was found to be potent against all tested 
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susceptible and resistant Gram-positive pathogenic 
bacteria.32  In one study, octyl triazole derivatives of the 
glycal derived novel tetrahydrofuran 1,2,3-triazoles 
displayed both antibacterial and antifungal activity at MIC: 
12.5 μg mL-1.33 1,2,3-triazole-linked pentasubstituted 1,4-
dihydropyridine derivative having the presence of fluorine at 
the para and chlorine at the meta position of the aromatic 
ring inhibited B. subtilis and S. aureus at 64 μg mL-1.34 1-
benzyl/aryl-4-{[(1-aryl-1H-1,2,3-triazol-4-yl)methoxy]-
methyl}-1H-1,2,3-triazole derivative having 3-nitrophenyl 
substituent was found to be best inhibitory against E. coli 
(32 mm), P. aeruginosa (12 mm), S. aureus (31 mm) and B. 
subtilis (13 mm) compared to standard drug Amoxycillin 
(30 mm, 10 mm, 30 mm and 12 mm respectively).35 
In view of the noteworthy bio-potential of the 1,2,3-
triazole nucleus to develop novel bioactive therapeutic 
agents, we targeted our work on the synthesis and evaluation 
of the novel 1,2,3-triazole-1,4-dihydropyridine-3,5-
dicarbonitrile derivatives as antibacterial agents against ten 
bacteria. The synthesized compounds had contributed to 
some key structures with interesting antibacterial activity. 
In the present study, to improve the inhibitory function of 
1,4-dihydropyridine-3,5-dicarbonitrile, the functionalized 
derivatives 3a-3o were synthesized via CuAAC click 
chemistry from 1,4-dihydropyridine-3,5-dicarbonitrile and 
relevant aryl/alkyl azides. The biological importance 
scaffolds DHPs with 1,2,3-triazole combine install together 
in a single scaffold for increasing importance in 
pharmaceutical and biological fields. We search for the 
design and synthesis of pharmacologically important new 
heterocycles linked in antibacterial activity. The synthesized 
compounds had contributed to some key structures with 
interesting antibacterial activity. 
EXPERIMENTAL  
Compound solvents and reagents were reagent grade and 
used without purification unless otherwise noted. The 
melting points were recorded on a Fargo melting point 
apparatus and are uncorrected. Reaction progress was 
monitored using analytical thin-layer chromatography 
(TLC) on 0.25mmMerck F-254 silica gel glass plates. 
Visualization was achieved by UV light (254 nm). Mass 
spectra were recorded on the Shimadzu GC-MS-QP-2010 
model using the Direct Injection Probe technique. 1H and 
13C NMR spectra were recorded with a Bruker AVANCE 
400 MHz spectrometer; Chemical shifts are reported in parts 
per million (δ) using Tetramethylsilane (TMS) as the 
internal standard with coupling constants (J) reported in 
hertz (Hz). The peak shapes are denoted as follows: s, 
singlet; d, doublet; t, triplet; q, quartet; m, multiplet; dd, a 
double doublet. Here, Ar and Ph are representing aromatic 
ring while -OCH3(-OMe) is representing methoxy group. 
In this study, 1,2,3-triazole-1,4-dihydropyridine-3,5-
dicarbonitrile derivatives (3a-3o) were synthesized. All of 
them are reported for the first time here. The initial synthesis 
of the 1,2,3-triazole-1,4-dihydropyridine-3,5-dicarbonitrile 
derivatives is illustrated in Scheme-1. Different 1,4-
dihydropyridine-3,5-dicarbonitrile derivatives 1a-b were 
synthesized by substituted propargylated benzaldehyde 
derivatives with 3-aminocrotononitrile in glacial acetic acid 
in a stoppered flask and stirred for 1 hour at room 
temperature under nitrogen atmosphere. The 1,3-dipolar 
cycloaddition between propargylated 1,4-dihydropyridine-
3,5-dicarbonitrile derivatives and alkyl and aryl-substituted 
azides derivatives under click chemistry conditions 
produced novel 1,2,3-triazole-1,4-dihydropyridine-3,5-
dicarbonitrile derivatives 3a-3o were synthesized in 
quantitative yields. Different aromatic azides with various 
substitutions, including electron-withdrawing and electron-
donating groups, have been used. The propargylation of –
CH2 group of the different 1,2,3-triazole 1,4-
dihydropyridine-3,5-dicarbonitrile derivatives was 
confirmed by the presence of a signal at δ 5.20–5.26 s (2H, 
–CH2). The formation of 1,2,3-triazoles was confirmed by 
the resonance of the proton in the 1,2,3 triazole ring at a δ 
8.70–8.80 s (1H, –CH) as a single. The structure was further 
supported by the 13C NMR spectra, which showed the 
C˗atom signals corresponding to triazole derivatives. 
Preparation of propargylated-1,4-dihydropyridine-3,5-dicarbo-
nitrile derivatives (1a-1b) 
A mixture of propargylated benzaldehyde derivatives 
(0.01 mol) and 3-aminocrotononitrile (0.02 mol) was taken 
in glacial acetic acid in a flask and stirred for 1 hour at room 
temperature. During the reaction, progress and the 
completion of the reaction were checked by silica gel-G 
F254 thin layer chromatography using ethyl acetate: hexane 
(3:2) as a mobile phase. After the completion of the reaction, 
the crystalline product was separated which was filtered and 
washed with diethyl ether. 
General procedure for preparation of compounds 3a-3o 
To a solution of propargylated-1,4-dihydropyridine-3,5-
dicarbonitrile derivatives (1a-1b) (0.01 mol) in dry DMF (5 
mL), anhydrous sodium hydride (15 mmol) was added and 
stirred for 5 min. After adding propargyl bromide (12 mmol), 
the resulting mixture was stirred at room temperature 
overnight. Upon completion of the reaction, water (20 mL) 
was added and the whole was extracted with 
dichloromethane (3 × 30 mL). The combined organic layers 
were washed with brine and dried over Na2SO4. The organic 
layer was concentrated in vacuum and the residue was 
purified by silica gel (60–120 mesh) column 
chromatography using hexane–ethyl acetate. 
Antimicrobial activity of synthesized 1,2,3-triazole derivatives 
Minimum Inhibition Concentration (MIC) of all 1,2,3-
triazole-1,4-dihydropyridine-3,5-dicarbonitrile derivatives 
was determined by using the two-fold microdilution method, 
the standard methodology that is given by NCCLS.44 Both 
Gram-positive and Gram-negative bacterial strains used for 
the in-vitro antibacterial study were procured from culture 
collection centers. Bacterial cultures of Salmonella typhi 
(MTCC 733), Salmonella paratyphi (MTCC 735), 
Escherichia coli (MTCC 1610 T) and Proteus vulgaris 
(MTCC 1771 T) were procured from MTCC, IMTECH, 
Chandigarh, whereas cultures of Klebsiella pneumoniae 
(MCC 3094), Pseudomonas aeruginosa (MCC 3097), 
Enterobacter aerogenes (MCC 3092) and Shigella flexneri 
(MCC 3095) were procured from NCMR, NCCS, Pune. 
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Clinical isolates of Serratia marcescens and Bacillus subtilis 
were collected from a local pathology laboratory in 
Ahmedabad and identified using biochemical tests 
prescribed in Bergey’s Manual of Determinative 
Bacteriology, Sixth Edition.47 The bacterial cultures were 
maintained on nutrient agar slants at 2±4 °C. For the 
microdilution method, a standardized inoculum for each 
bacterial strain was prepared to get the inoculum size of 
approximately 5×105 CFU mL-1 in each well. A stock 
solution (10 μg mL-1) of each compound was prepared in 
DMSO. Further dilutions of stock solution were prepared in 
DMSO to get working concentration ranging from 25 μg 
mL-1 to 2000 μg mL-1. 100 µL of each dilution was 
distributed in 96 well microtiter plates with double strength 
(2X) Mueller Hinton broth (MH broth) to obtain an actual 
concentration ranging from 12.5 μg mL-1 to 1000 μg mL-1 in 
each test well of a microtiter plate.  
For standard, Penicillin and Tetracycline antibiotic 
solutions were prepared in working concentration ranging 
from 25 μg mL-1 to 2000 μg mL-1 was used which was added 
in the same way as test solutions to get actual concentrations 
ranging from 12.5 μg mL-1 to 1000 μg mL-1 in standard wells. 
These microtiter plates were then kept at 37 °C for 24-36 h 
incubation. Each test and growth control well were 
inoculated with 50 µL of a bacterial suspension having 
standard inoculum size. Following the incubation period, 
bacterial growth was detected by optical density using 
Biolog Microplate Reader. MIC values were defined as the 
lowest concentration of each compound that completely 




To a solution of 1-azido-3-nitrobenzene (1.2 mmol) and 
2,6-dimethyl-4-(3-(prop-2-yn-1-yloxy)phenyl)-1,4-dihydro-
pyridine-3,5-dicarbonitrile (1a, 1.0 mmol) were added to a 
mixture of copper(II) sulfate pentahydrate solution (0.01 
mmol) and sodium ascorbate (0.25 mmol) dissolved in t-
BuOH:H2O (1:1 mixture, 3 mL) at room temperature. The 
reaction mixture was stirred at room temperature for 3-6 h, 
and monitored by TLC. The resulting mixture was poured 
into CHCl3 (5 mL) and H2O (3 mL), and the organic layer 
was separated. The aqueous layer was extracted with CHCl3 
(5 mL) three times. The combined organic layer was 
concentrated in vacuo. The residue was purified by short 
column chromatography on silica gel (60−120 mesh) eluted 
with ethyl acetate: hexane (6:4) to give 3a;  1H NMR 
(DMSO–d6) δ 2.04 s (6H, 2×CH3), 3.76 s (3H, –OCH3), 4.36 
s (3H, –CH), 5.22 s (2H,      –CH2), 6.80–6.82 d (1H, J = 8.2 
Hz, Ar-H), 6.88–6.89 d (1H, J = 1.48 Hz, Ar-H), 7.89–7.93 
d (1H, J = 8.20 Hz, Ar-H), 8.33–8.35 t (1H, J = 6.88 Hz, Ar-
H), 8.43–8.45 t (1H, J = 7.84 Hz, Ar-H), 8.77 s (1H, Ar-H), 
9.21 s (1H, Ar-H), 9.49 s (1H, –NH); 13C NMR (DMSO–d6) 
δ 17.73, 55.50, 61.55, 82.77, 111.55, 113.90, 114.88, 119.35, 
119.81, 123.17, 123.50, 126.18, 131.51, 137.11, 137.49, 
144.30, 146.40, 146.83, 148.49, 149.02. 
By following the same procedure, the following 
compounds were synthesized. Analytical data and yields of 
1,2,3-triazole 1,4-dihydropyridine-3,5-dicarbonitrile deriva-




Compound 3b was prepared from 1-azido-3-
chlorobenzene (1.2 mmol), 2,6-dimethyl-4-(3-(prop-2-yn-1-
yloxy)phenyl)-1,4-dihydropyridine-3,5-dicarbonitrile (1a, 
1.0 mmol), copper(II) sulfate pentahydrate solution (0.01 
mmol) and sodium ascorbate (0.25 mmol); 1H NMR 
(DMSO–d6) δ 2.04 s (6H, 2×CH3), 3.76 s (3H, –OCH3), 4.39 
s (3H, –CH), 5.22 s (2H, –CH2), 6.81–6.87 d (2H, J = 24.2 
Hz, 2×Ar-H), 7.20–7.22 d (1H, J = 6.04 Hz, Ar-H), 7.58–
7.63 t (2H, J = 6.92 Hz, Ar-H), 7.95 s (2H, 2×ArH), 8.08 s 
(2H, 2×ArH), 9.03 s (1H, Ar-H), 9.49 (s, 1H, NH); 13C 
NMR (DMSO–d6) δ 17.74, 55.50, 61.58, 82.78, 111.55, 
113.88, 118.74, 119.35, 119.81, 119.96, 123.20, 128.54, 




Compound 3c was prepared from 4-azidobenzonitrile (1.2 
mmol), 2,6-dimethyl-4-(3-(prop-2-yn-1-yloxy)phenyl)-1,4-
dihydropyridine-3,5-dicarbonitrile (1a, 1.0 mmol), 
copper(II) sulfate pentahydrate solution (0.01 mmol) and 
sodium ascorbate (0.25 mmol); 1H NMR (DMSO–d6) δ 2.04 
s (6H, 2×CH3), 4.39 s (1H, –CH), 5.28 s (2H, –CH2), 6.89–
6.92 t (2H, J = 6.12 Hz, 2×Ar-H), 7.08–7.09 d (1H, J = 6.04 
Hz, Ar-H), 7.34–7.38 t (2H, J = 7.80 Hz, Ar-H), 8.10–8.12 d 
(2H, J = 8.48 Hz, 2×Ar-H), 8.16–8.18 d (2H, J = 8.56 Hz, 
2×Ar-H), 9.12 s (1H, Ar-H), 9.53 s (1H, –NH); 13C NMR 
(DMSO–d6) δ 17.13, 60.92, 82.47, 111.11, 113.25, 114.52, 
118.07, 119.24, 120.37, 120.53, 123.13, 130.01, 134.25, 




Compound 3d was prepared from 1-azido-4-
methylbenzene (1.2 mmol), 2,6-dimethyl-4-(3-(prop-2-yn-1-
yloxy)phenyl)-1,4-dihydropyridine-3,5-dicarbonitrile (1b, 
1.0 mmol), copper(II) sulfate pentahydrate solution (0.01 
mmol) and sodium ascorbate (0.25 mmol); 1H NMR 
(DMSO–d6) δ 2.04 s (6H, 2×CH3), 2.38 s (3H, CH3), 3.76 s 
(3H, –OCH3), 4.36 s (1H, –CH), 5.21 s (2H, –CH2), 6.80–
6.98 dd (2H, J = 8.16 and 1.24 Hz, 2×Ar-H), 7.21–7.23 d 
(1H, J = 8.24 Hz, Ar-H), 7.39–7.41 d (2H, J = 8.12 Hz, 
2×Ar-H), 7.79–7.81 d (2H, J = 8.24 Hz, 2×Ar-H), 8.90 s 
(1H, Ar-H), 9.49 s (1H, –NH); 13C NMR (DMSO–d6) δ 
17.74, 20.54, 55.48, 61.61, 82.79, 111.53, 113.82, 119.35, 
119.81, 120.01, 122.88, 130.21, 134.30, 137.39, 138.36, 




Compound 3e was prepared from 1-azido-4-
methoxybenzene (1.2 mmol), 4-(3-methoxy-4-(prop-2-yn-1-
yloxy)phenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-
dicarbonitrile (1b, 1.0 mmol), copper(II) sulfate 
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pentahydrate  solution (0.01 mmol) and sodium ascorbate 
(0.25 mmol); 1H NMR (DMSO–d6) δ 2.04 s (6H, 2×CH3), 
3.76 s (3H, CH3), 3.84 s (3H, –OCH3), 4.36 s (1H, –CH), 
5.20 s (2H, –CH2), 6.79-6.82 dd (2H, J = 1.60 and 1.60 Hz, 
Ar-H), 6.87–6.87 d (1H, J = 1.56 Hz, A-rH), 7.13–7.16 d 
(2H, J = 8.96 Hz, 2×Ar-H), 7.21–7.23 d (1H, J = 8.24 Hz, 
Ar-H), 7.82–7.84 d (1H, J = 8.92 Hz, Ar-H), 8.85 s (1H, Ar-
H), 9.49 s (1H, –NH); 13C NMR (DMSO–d6) δ 17.74, 30.73, 
55.48, 55.53, 61.62, 82.79, 111.52, 113.80, 114.85, 119.36, 
119.80, 121.82, 122.98, 129.96, 137.36, 143.57, 146.39, 




Compound 3f was prepared from 1-azido-4-fluorobenzene 
(1.2 mmol), 4-(3-methoxy-4-(prop-2-yn-1-yloxy)phenyl)-
2,6-dimethyl-1,4-dihydropyridine-3,5-dicar-bonitrile (1b, 
1.0 mmol), copper(II) sulfate pentahydrate  solution (0.01 
mmol) and sodium ascorbate (0.25 mmol);  1H NMR 
(DMSO–d6) δ 2.04 s (6H, 2×CH3), 3.76 s (3H, –OCH3), 4.36 
s (1H, –CH), 5.22 s (2H, –CH2), 6.80–6.82 d (1H, J = 7.80 
Hz, Ar-H), 6.88 s (1H, Ar-H), 7.21–7.23 d (1H, J = 8.08 Hz, 
Ar-H), 7.47–7.49 d (2H, J = 8.24 Hz, 2×Ar-H), 7.97 s, (2H, 
2×ArH), 8.94 s (1H, Ar-H), 9.50 s (1H, –NH); 13C NMR 
(DMSO–d6) δ 17.74, 55.48, 61.58, 82.79, 111.53, 113.84, 
116.59, 116.82, 119.36, 119.81, 122.49, 122.58, 123.26, 





Compound 3g was prepared from 4-azidobenzonitrile (1.2 
mmol), 4-(3-methoxy-4-(prop-2-yn-1-yloxy)phenyl)-2,6-
dimethyl-1,4-dihydropyridine-3,5-dicarbonitrile (1b, 1.0 
mmol), copper(II) sulfate pentahydrate  solution (0.01 
mmol) and sodium ascorbate (0.25 mmol); 1H NMR 
(DMSO–d6) δ 2.04 s (6H, 2×CH3), 3.76 s (3H, OCH3), 4.36 
s (1H, –CH), 5.25 s (2H, –CH2), 6.80–6.82 d (2H, J = 7.80 
Hz, 2×Ar-H), 6.88 s (1H, Ar-H), 7.20–7.22 d (1H, J = 7.96 
Hz, Ar-H), 8.10–8.19 dd (4H, J = 7.76 and 7.76 Hz, 4×Ar-
H), 9.12 s (1H, Ar-H), 9.50 s (1H, –NH); 13C NMR 
(DMSO–d6) δ 17.74, 55.50, 61.53, 82.77, 111.10, 111.55, 
113.91, 118.08, 119.36, 119.81, 120.54, 123.25, 134.26, 
137.50, 139.44, 144.36, 146.41, 146.81 149.02. 
2,6-Dimethyl-4-(3-((1-(3-nitrophenyl)-1H-1,2,3-triazol-5-yl)-
methoxy)phenyl)-1,4-dihydropyridine-3,5-dicarbonitrile (3h) 
Compound 3h was prepared from 1-azido-3-nitrobenzene 
(1.2 mmol), 2,6-dimethyl-4-(3-(prop-2-yn-1-yloxy)phenyl)-
1,4-dihydropyridine-3,5-dicarbonitrile (1a, 1.0 mmol), 
copper(II) sulfate pentahydrate solution (0.01 mmol) and 
sodium ascorbate (0.25 mmol); 1H NMR (DMSO–d6) δ 2.04 
s (6H, 2×CH3), 4.39 s (1H, –CH), 5.29 s (2H, –CH2), 6.89–
6.93 d (2H, J = 7.56 Hz, 2×Ar-H), 7.08–7.10 d (1H, J = 6.80 
Hz, Ar-H), 7.35–7.38 t (1H, J = 6.72 Hz, Ar-H), 7.90–7.94 t 
(1H, J = 7.68 Ar-H), 8.34–8.44 dd (2H, J = 7.68, 2×Ar-H),  
8.76 s (1H, Ar-H), 9.22 s (1H, Ar-H), 9.54 s (1H, –NH); 13C 
NMR (DMSO–d6) δ 17.73, 60.94, 82.47, 113.25, 114.54, 
114.88, 119.23, 120.36, 123.19, 123.38, 126.18, 130.01, 
131.54, 137.12, 144.25, 145.67, 146.76, 148.49, 158.26. 
4-(3-((1-Benzyl-1H-1,2,3-triazol-5-yl)methoxy)phenyl)-2,6-
dimethyl-1,4-dihydropyridine-3,5-dicarbonitrile (3i) 
Compound 3i was prepared from (azidomethyl)benzene 
(1.2 mmol), 2,6-dimethyl-4-(3-(prop-2-yn-1-yloxy)phenyl)-
1,4-dihydropyridine-3,5-dicarbonitrile (1a, 1.0 mmol), 
copper(II) sulfate pentahydrate solution (0.01 mmol) and 
sodium ascorbate (0.25 mmol);  1H NMR (DMSO–d6) δ 
2.04 s (6H, 2×CH3), 4.38 s (1H, –CH), 5.15 s (2H, –CH2), 
5.62 s (2H, –CH2), 6.87–6.89 d (2H, J = 7.44 Hz, 2×Ar-H), 
7.01–7.03 d (1H, J = 8.60 Hz, Ar-H), 7.34–7.40 m (6H, 
6×Ar-H), 8.32 s (1H, Ar-H), 9.54 s (1H, Ar-H), 9.54 s (1H, 
–NH); 13C NMR (DMSO–d6) δ 17.74, 52.84, 60.98, 82.49, 
113.15, 114.49, 119.27, 120.17, 124.77, 127.94, 128.14, 
128.75, 129.91, 135.95, 145.65, 146.76, 158.38. 
2,6-Dimethyl-4-(3-((1-(p-tolyl)-1H-1,2,3-triazol-5-yl)meth-
oxy)phenyl)-1,4-dihydropyridine-3,5-dicarbonitrile (3j) 
Compound 3j was prepared from 1-azido-4-
methylbenzene (1.2 mmol), 2,6-dimethyl-4-(3-(prop-2-yn-1-
yloxy)phenyl)-1,4-dihydropyridine-3,5-dicarbonitrile (1a, 
1.0 mmol), copper(II) sulfate pentahydrate solution (0.01 
mmol) and sodium ascorbate (0.25 mmol);   1H NMR 
(DMSO–d6) δ 2.04 s (6H, 2×CH3), 2.38 s (3H, –CH3), 4.39 s 
(1H, –CH), 5.25 s (2H, –CH2), 6.89–6.93 d (2H, J = 7.48 Hz, 
2×Ar-H), 7.07–7.09 d (1H, J = 6.92 Hz, Ar-H), 7.36–7.41 t 
(3H, J = 12.44 Hz, 3×Ar-H), 7.79–7.80 d (2H, J = 7.20 Hz, 
2×Ar-H), 8.91 s (1H, Ar-H), 9.55 s (1H, –NH); 13C NMR 
(DMSO–d6) δ 17.73, 20.55, 24.22, 61.00, 82.49, 113.21, 
114.51, 119.25, 120.02, 120.28, 122.76, 129.98, 130.20, 




Compound 3k was prepared from 1-azido-2-nitrobenzene 
(1.2 mmol), 4-(3-methoxy-4-(prop-2-yn-1-yloxy)phenyl)-
2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbonitrile (1b, 1.0 
mmol), copper(II) sulfate pentahydrate  solution (0.01 
mmol) and sodium ascorbate (0.25 mmol); 1H NMR 
(DMSO–d6) δ 2.04 (s, 6H, 2×CH3), 3.76 (s, 3H, –OCH3), 
4.36 (s, 3H, –CH), 5.22 (s, 2H, –CH2), 6.80–6.82 (d, 1H, J = 
8.2 Hz, ArH), 6.88–6.89 (d, 1H, J = 1.48 Hz, ArH), 7.89–
7.93 (d, 1H, J = 8.20 Hz, ArH), 8.33–8.35 (t, 1H, J = 6.88 
Hz, ArH), 8.43–8.45 (t, 1H, J = 7.84 Hz, ArH), 8.77 (s, 1H, 
ArH), 9.21 (s, 1H, ArH), 9.49 (s, 1H, –NH); 13C NMR 
(DMSO–d6) δ 17.73, 55.50, 61.55, 82.77, 111.55, 113.90, 
114.88, 119.35, 119.81, 123.17, 123.50, 126.18, 131.51, 
137.11, 137.49, 144.30, 146.40, 146.83, 148.49, 149.02. 
4-(4-((1-Benzyl-1H-1,2,3-triazol-4-yl)methoxy)-3-methoxyphe-
nyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbonitrile (3l) 
Compound 3l was prepared from (azidomethyl)benzene 
(1.2 mmol), 4-(3-methoxy-4-(prop-2-yn-1-yloxy)phenyl)-
2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbonitrile (1b, 1.0 
mmol), copper(II) sulfate pentahydrate  solution (0.01 
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mmol) and sodium ascorbate (0.25 mmol);  1H NMR 
(DMSO–d6) δ 2.05 s (6H, 2×CH3), 3.77 s (3H, –CH3), 4.35 s 
(1H, –CH), 5.12 s (2H, –CH2), 5.62 s (2H, –CH2), 6.77–6.85 
t (2H, J = 6.88 Hz, 2×Ar-H), 7.14–7.16 d (1H, J = 8.24 Hz, 
Ar-H), 7.33–7.40 m (5H, 5×Ar-H), 8.29 s (1H, Ar-H), 9.49 
(s, 1H, –NH);  13C NMR (DMSO–d6) δ  17.74, 52.81, 55.43, 
61.66, 82.80,, 111.46, 113.68, 119.35, 119.75, 124.81, 




Compound 3m was prepared from  1-azido-4-
bromobenzene (1.2 mmol), 2,6-dimethyl-4-(3-(prop-2-yn-1-
yloxy)phenyl)-1,4-dihydropyridine-3,5-dicarbonitrile (1a, 
1.0 mmol), copper(II) sulfate pentahydrate solution (0.01 
mmol) and sodium ascorbate (0.25 mmol); 1H NMR 
(DMSO–d6) δ 2.05 s (6H, 2×CH3), 4.39 s (1H, –CH), 5.25 s 
(2H, –CH2), 6.89–6.92 t (2H, J = 6.20 Hz, 2×Ar-H), 7.08–
7.09 t (1H, J = 6.96 Hz, Ar-H), 7.34–7.38 t (1H, J = 7.56 Hz, 
Ar-H), 7.80–7.82 d (2H, J = 8.16 Hz, 2×Ar-H), 7.89–7.91 d 
(2H, J = 8.24 Hz, 2×Ar-H), 9.00 s (1H, Ar-H), 9.54 s (1H, –
NH);  13C NMR (DMSO–d6) δ 17.74, 60.95, 82.48, 113.23, 
114.51, 119.24, 120.32, 121.40, 122.06, 122.93, 129.99, 
132.76, 135.74, 143.97, 145.67, 146.75, 158.30. 
4-(3-((1-(Cyanomethyl)-1H-1,2,3-triazol-5-yl)methoxy)phenyl)-
2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbonitrile (3n) 
Compound 3n was prepared from  2-azidoacetonitrile (1.2 
mmol), 2,6-dimethyl-4-(3-(prop-2-yn-1-yloxy)phenyl)-1,4-
dihydropyridine-3,5-dicarbonitrile (1a, 1.0 mmol), 
copper(II) sulfate pentahydrate solution (0.01 mmol) and 
sodium ascorbate (0.25 mmol); 1H NMR (DMSO–d6) δ 2.05 
s (6H, 2×CH3), 4.38 s (1H, –CH), 5.20 s (2H, –CH2), 5.25 s 
(2H, –CH2), 6.89 s (2H, 2×Ar-H), 7.03–7.05 d (1H, J = 7.32 
Hz, Ar-H), 7.33–7.36 t (1H, J = 7.36 Hz, Ar-H), 8.41 s (1H, 
Ar-H), 9.54 s (1H, –NH);  13C NMR (DMSO–d6) δ 17.74, 
60.69, 82.47, 113.13, 114.48, 115.04, 119.26, 120.25, 




Compound 3o was prepared from 4-
(azidomethyl)benzonitrile (1.2 mmol), 4-(3-methoxy-4-
(prop-2-yn-1-yloxy)phenyl)-2,6-dimethyl-1,4-
dihydropyridine-3,5-dicarbonitrile (1b, 1.0 mmol), 
copper(II) sulfate pentahydrate  solution (0.01 mmol) and 
sodium ascorbate (0.25 mmol);   1H NMR (DMSO–d6) δ 
2.05 s (6H, 2×CH3), 3.73 s (3H, –OCH3), 4.35 s (1H, –CH), 
5.14 s (2H, –CH2), 5.75 s (2H, –CH2), 6.77–6.79 m (1H, Ar-
H), 6.85–6.86 d (1H, J = 1.68 Hz, Ar-H), 7.17–7.16 d (1H, J 
= 8.32 Hz, Ar-H), 7.46–7.48 d (2H, J = 8.12 Hz, 2×Ar-H), 
7.85–7.87 d (2H, J = 8.16 Hz, 2×Ar-H), 8.34 s (1H, Ar-H), 
9.49 s (1H, Ar-H);  13C NMR (DMSO–d6) δ 17.73, 52.16, 
55.45, 61.64, 82.79, 110.92, 111.48, 113.76, 118.51, 119.35, 
119.76, 125.14, 128.70, 132.72, 137.30, 141.43, 143.16, 
146.38, 146.84, 148.98. 
Crystal Structure Determination 
Crystal data of 3d and 3e were made on a Rigaku SCX 
mini diffractometer using graphite monochromated Mo-Kα 
radiation. The crystal to detector distance is fixed at 52 mm 
with a detector. The data were collected at a temperature of 
20±1°C to a maximum 2θ value of 55.0° A total of 540 
oscillation images were collected. The first and second 
sweep of data was done using ω oscillations from ˗120.0 to 
60.0° in 1.0° steps. The exposure rate was 8.0 [sec/°]. The 
detector swing angle was ˗30.80°. The crystal-to-detector 
distance was 52.00 mm. The readout was performed in the 
0.146 mm pixel mode. Both crystals of 3d and 3e crystallize 
in triclinic space group P-1(#2). Figure 2 and 3 represents 
the ORTEP of the molecules 3d and 3e, respectively, with 
thermal ellipsoids drawn at 50% probability. 
Crystal Structure Determination and Refinements (3d) 
A colorless prism crystal of 3d having M.F. 
C26H24N6O2·C2H6OS and approximate dimensions of 0.455 
× 0.321 × 0.300 mm was mounted on a glass fiber. Data 
Reduction of the 13915 reflections that were collected, 6245 
were unique (Rint = 0.0551), equivalent reflections were 
merged. Data were collected and processed using Crystal 
Clear.36 The linear absorption coefficient µ, for Mo˗Kα 
radiation, is 1.582 cm-1. Empirical absorption correction was 
applied, which resulted in transmission factors ranging from 
0.445 to 0.954. The data were corrected for Lorentz and 
polarization effects. The structure was solved by direct 
methods37 and expanded using Fourier techniques. The non-
hydrogen atoms were refined anisotropically. Hydrogen 
atoms were refined using the riding model. Hydrogen atoms 
associated with heteroatoms were refined independently in 
the isotropic approximation. The final cycle of full-matrix 
least-squares refinement [SHELXL97, Σw(Fo2-Fc2)2 where w 
= Least Squares weights] on F2 was based on 6245 observed 
reflections and 343 variable parameters and converged. The 
standard deviation of observation of unit weight was 1.03 
and calculated by Σw(Fo2-Fc2)2/(No2-Nv)]1/2, where: No= 
number of observations Nv = number of variables. Unit 
weights were used. The maximum and minimum peaks on 
the final difference Fourier map corresponded to 0.67 and -
0.55 e Å-3 respectively. Neutral atom scattering factors were 
taken from Cromer and Waber.38 Anomalous dispersion 
effects were included in F Calculation39 the values for Δf' 
and Δf” were those of Creagh and McAuley.40 The values 
for the mass attenuation coefficients are those of Creagh and 
Hubbell.41 All calculations were performed using the crystal 
structure.42 Crystallographic software package except for 
refinement, which was performed using [Direct Methods 
(SHELXD)] SHELXL-97.43 Crystal Lattice Parameters a = 
7.9223(9) Å, b = 11.361(2) Å, c = 16.227(2) Å, α = 
73.440(4)°, β = 89.413(4)°, γ= 79.452(4)°, V = 1374.9(3) Å3, 
Z value is 2, Dcal = 1.258 g cm-3, F000 = 616.00, µ(Mo˗Kα) = 
2.054 cm-1, Radiation is Mo˗Kα (λ = 0.71075 Å). Final 
refinement parameters: R1 [I > 2σ(I)] = 0.0960, wR2 = 
0.3082), R (All reflections) = 0.1310, Goodness of Fit 
Indicator = 1.095, Max Shift/Error in Final Cycle = 0.001, 
Maximum peak in Final Diff. Map = 0.67 e Å-3, Minimum 
peak in Final Diff. Map = ˗0.55 e Å-3 X-ray diffraction 
results were deposited at the Cambridge Crystallographic 
Data Center (CCDC 1969216).  The X-ray crystal structure 
determination shows that the interatomic distances 1.355(5) 
Å for N2˗C20 is near to that of a typical Aromatic C–N bond 
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(1.47). The bond length for 1.153(6) Å for C9-N5 and 
1.145(7) Å for C8˗N6 are near to that of a typical C≡N 
Cyano bond length (1.16). The bond angles for C4˗C5˗C6, 
C2˗C3˗C4 which illustrate that 123.7(4)°, 124.2(3)° of C2, C3, 
C4, C5, C6 all adopt sp2 hybrid orbit to form C=C double 
bonds. The bond angles for C12˗O1˗C16 and C13˗O2˗C17 is 
117.1(4)° and 118.9(4)°, which illustrate that C12, O1, C16, 
C13, O2, C17  all adopt sp2 hybrid orbit to form C˗O˗C Single 
bond. In this molecule, N2˗N3˗N4 bond angle is 107.6(4)° of 
the 1,2,3-triazole core is planar. A study of torsion angles of 
N2, N3, N4, C18 is 0.6(5) and C19, N2, N3, N4 is ˗0.3 (5)°. 
Crystal Structure Determination and Refinements (3e) 
A colorless prism crystal of 3e having M.F. 
C26H24N6O3·C2H6OS and approximate dimensions of 0.670 
× 0.560 × 0.560 mm was mounted on a glass fiber. Data 
Reduction of the 14263 reflections that were collected, 6382 
were unique (Rint = 0.0248), equivalent reflections were 
merged. Data were collected and processed using Crystal 
Clear.36 The linear absorption coefficient µ, for Mo˗Kα 
radiation, is 1.603 cm-1. Empirical absorption correction was 
applied, which resulted in transmission factors ranging from 
0.684 to 0.914. The data were corrected for Lorentz and 
polarization effects. The structure was solved by direct 
methods37 and expanded using Fourier techniques. The non-
hydrogen atoms were refined anisotropically. Hydrogen 
atoms were refined using the riding model. Hydrogen atoms 
associated with heteroatom were refined independently in 
the isotropic approximation. The final cycle of full-matrix 
least-squares refinement [SHELXL97, Σw(Fo2-Fc2)2 where w 
= Least Squares weights] on F2 was based on 6382 observed 
reflections and 352 variable parameters and converged. The 
standard deviation of observation of unit weight was 1.51 
and calculated by Σw(Fo2-Fc2)2/(No2-Nv)]1/2, where: No= 
number of observations, Nv = number of variables. Unit 
weights were used. The maximum and minimum peaks on 
the final difference Fourier map corresponded to 1.87 and 
˗0.71 e Å-3, respectively. Neutral atom scattering factors 
were taken from Cromer and Waber.38 Anomalous 
dispersion effects were included in F Calculation39; the 
values for Δf' and Δf" were those of Creagh and McAuley.40 
The values for the mass attenuation coefficients are those of 
Creagh and Hubbell.41 All calculations were performed 
using the crystal structure.42 Crystallographic software 
package except for refinement, which was performed using 
Direct Methods (SHELXD and SHELXL˗97).43 Crystal 
Lattice Parameters a = 9.570(1) Å, b = 10.577(2) Å, c = 
14.595(2) Å, α = 73.440(4)°, β = 89.413(4)°, γ = 79.452(4)°, 
V = 1374.9(3) Å3, Z value is 2, Dcal = 1.258 g cm-3, F000 = 
616.00, µ(Mo˗Kα) = 2.054 cm-1, Radiation is Mo˗Kα (λ = 
0.71075 Å). Final refinement parameters: R1 [I > 2σ(I)] = 
0.1057, wR2 = 0.3850, R (All reflections) = 0.1315, 
Goodness of Fit Indicator = 1.512, Max Shift/Error in Final 
Cycle = 0.004, Maximum peak in Final Diff. Map = 1.87 e 
Å-3, Minimum peak in Final Diff. Map = ˗0.71 e Å-3. X-ray 
diffraction results were deposited at the Cambridge 
Crystallographic Data Center (CCDC 1996628).  The X-ray 
crystal structure determination shows that the interatomic 
distances 1.434(5) Å for N4˗C20 is near to that of a typical 
Aromatic C–N bond (1.47). The bond length for 1.154(6) Å 
for C9˗N2 and 1.150(7) Å for C8˗N3 are near to that of a 
typical C≡N Cyano bond length (1.16). The bond angles for 
C2˗C3˗C4 and C4˗C5˗C6, which illustrate that 124.6(4)°, 
124.1(4)° of C2, C3, C4, C5, C6  all adopt sp2 hybrid orbit to 
form C=C double bonds. The bond angles for C12˗O2˗C17 
and C23˗O3˗C26 is 116.9(3)° and 118.4(4)°, which illustrate 
that C12, O2, C17, C23, O3, C26  all adopt sp2 hybrid orbit to 
form C˗O˗C Single bond. In this molecule, the N4-N5-N6 
bond angle is 106.4(3)° of the 1,2,3-triazole core is the 
planar aromatic ring.  A study of the torsion angles, 
asymmetric parameters and least-squares plane calculations 
reveals that the three-membered ring of 1,2,3 triazole 
C19˗N4˗N5˗N6 is –0.4(4)° and N4˗N5˗N6˗C18 is –0.398(5)° are 
showing that the 1,2,3 triazole ring in the same plane. A 
study of torsion angles of N2, N3, N4, C18 is 0.6(5) and C19, 
N2, N3, N4 is ˗0.3(5)°. 
 




R R1 MF MW M.P. (°C) Yield (%) 
3a 3 H –3–O2NPh C24H19N7O3 453.45 256–257 70 
3b 3 H –3–ClPh C24H19ClN6O 442.90 228–229 72 
3c 3 H –4–NCPh C25H19N7O 433.46 220–221 75 
3d 4 3–OMe –4–MePh C26H24N6O2 452.50 264–265 68 
3e 4 3–OMe –4–MeOPh C26H24N6O3 468.50 268–269 71 
3f 4 3–OMe –4–FPh C25H21FN6O2 456.47 258–259 70 
3g 4 3–OMe –4–NCPh C26H21N7O2 463.49 270–271 73 
3h 3 H –2–O2NPh C24H19N7O3 453.45 250–251 68 
3i 3 H –CH2Ph C25H22N6O 422.48 260–261 67 
3j 3 H –4–MePh C25H22N6O 422.48 240–241 70 
3k 4 3–OMe –2–O2NPh C25H21N7O4 483.47 266–267 61 
3l 4 3–OMe –CH2Ph C26H24N6O2 452.50 268–269 69 
3m 3 H –4–BrPh C24H19BrN6O 487.35 202–203 69 
3n 3 H –CH2CN C20H17N7O 371.39 240–241 65 
3o 4 3–OMe –CH2(4-NC)Ph C27H23N7O2 477.51 272–273 75 
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RESULTS AND DISCUSSIONS 
The general route for the synthesis of 1,2,3-triazole-1,4-
dihydropyridine-3,5-dicarbonitrile derivatives (3a-3o) was 
developed with the reaction of 1a-1o alkynes with alkyl and 












Scheme 1. The general route for the synthesis of 1,2,3-triazole-1,4-
dihydropyridine-3,5-dicarbonitrile derivatives.  
The yield and melting points of prepared derivatives are 
given in Table 1. The structure of compounds 3d and 3e are 
given in Figures 2 and 3, respectively.  The other structural 








Figure 2. PLATON version of 3d with data block ellipsoid plot 










Figure 3. PLATON version of 3e with data block ellipsoid plot 
drawn at 50% probability (CCDC 1996628). 
Antimicrobial activity of synthesized 1,2,3-triazole derivatives 
Results of antibacterial activity of 1,2,3-triazole 
derivatives are represented in Table 1 and Figure 4. For S. 
flexneri, nine of the compounds show good potency. 
Compounds 3b and 3d displayed more potency with MIC 
value of 100 μg mL-1 due to the presence of 3-Cl and 4-Me 
groups respectively, while compounds 3a and 3e displayed 
twofold lower MIC (200 μg mL-1) compared to standard due 
to the presence of 3-O2N and 4-OMe group attached to 
triazole ring. In more, compounds 3i, 3k, 3l, and 3n (400 μg 
mL-1) were found to be equipotent compared to the standard 
antibiotic Tetracycline. Compounds 3h, 3j, and 3f displayed 
prominent activity having MIC values of 50 μg mL-1 similar 
to Tetracycline against P. aeruginosa and P. vulgaris 
respectively and this potency was observed due to the 
presence of 2-NO2, 4-Me and 4-F groups attached to the 
triazole rings of 3h, 3j, and 3f respectively. Comparatively, 
the derivative of 1,2,3-triazolyl-1,4-dihydropyridine having 
the propargyloxy group at the ortho position of the phenyl 
ring inhibited P. mirablis and K. pneumoniae with the MIC: 
70 μg mL-1.30 
The MIC value of compound 3i was 12.5 μg mL-1, which 
is twofold lower than Tetracycline (25 μg mL-1) against S. 
marcescens that is due to the methylene group attached to 
the triazole ring. The MIC value of compound 3f was found 
to be similar to Tetracycline against E. aerogenes. The 
compound 3e was the only one that is active against E. coli 
(MIC: 50 μg mL-1) due to the presence of 4-OMe group 
attached to the triazole ring. 
The meta-analysis of antibacterial activity 
A meta-analysis of our experimental findings of 
antibacterial activity was done by Orange3-3.27.1-
Miniconda software. As shown in Figures 5 and 6, if we 
compare the observations among compounds with different 
groups, it can be seen that various functional groups at the 
various position of core structure inhibited different test 
organisms with varying MICs. Compound 3k (3-MeO at R) 
inhibited K. Pneumoniae and S. flexneri with MIC: 400 μg 
mL-1 that is lower than MIC shown by compound 3h. On the 
other hand, compound 3h (˗H at R) inhibited P. aeruginosa 
with MIC: 50 μg mL-1 that is much lower than the MIC 
given by compound 3k. Compound 3h also inhibited P. 
vulgaris with MIC: 50 μg mL-1 that is much lower than the 
MIC given by 3k (MIC: 1000 μg mL-1).In comparison to 
standard antibiotic Tetracycline, compound 3h inhibited P. 
aeruginosa with similar MIC: 50 μg mL-1. Compounds 3i 
and 3l have common functional group ˗CH2Ph at R1 but a 
different functional group at R, i.e., ˗H and ˗OMe. Inhibitory 
activity of both compounds was nearly similar for all 
organisms, but compound 3i (˗H) inhibited S. marcescens 
with MIC 12.5 μg mL-1 that compared to 3l (˗OMe group) 
with MIC: 400 μg mL-1. Besides, for K. pneumoniae MIC 
value of 400 μg mL-1 was observed with compound 3i while 
>1000 μg mL-1 was observed with compound 3l. 
Furthermore, compounds 3a and 3h are different from the 
functional group at the R1 position, i.e., ˗3˗O2N and 
˗2˗O2NPh, respectively. Compound 3a with ˗3˗O2NPh 
inhibited S. typhi and S. paratyphi with MIC of 200 μg mL-1 
and 100 μg mL-1 compared to 3h that inhibited both 
organisms with >1000 μg mL-1.  
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Figure 4. MIC Determination of compounds 3a-3o 
 
Compound 3a also inhibited K. pneumoniae and S. 
flexneri with MIC: 200 μg mL-1 compared to MIC: 1000 μg 
mL-1 given by compound 3h. Compound 3a (MIC: 200 μg 
mL-1) was shown to be more potent against S. flexneri 
compared to standard antibiotic Tetracycline (MIC: 400 μg 
mL-1). 
If we compare the compounds 3d and 3j, it can be 
observed that 3d inhibited S. typhi and S. paratyphi with 
MIC: 100 and 200 μg mL-1 respectively that is lower than 
the MIC >1000 μg mL-1 given by compound 3j. Compound 
3d also inhibited K. pneumoniae, B. subtilis, and S. flexneri 
with lower MIC (100 μg mL-1) compared to MIC (1000 μg 
mL-1) given by 3j. Compound 3j having ˗H at R position 
inhibited P. aeruginosa with MIC: 50 μg mL-1 that is much 
lower than MIC >1000 μg mL-1 given by compound 3d. 
Compound 3j showed equal potency with the standard for P. 
aeruginosa by inhibiting it with MIC: 50 μg mL-1 that is 
similar to the MIC: 50 μg mL-1 given by standard 
Tetracycline. Compound 3d (MIC 100 μg mL-1) was found 
to be more potent than standard (MIC: 400 μg mL-1) against 
S. flexneri while equipotent to the standard against K. 
pneumoniae with MIC 100 μg mL-1. Among compounds 3c 
and 3g, both are having common functional group ˗4-NCPh 
at R1 but different functional groups (˗H and 3˗MeO 
respectively) at R position. Compound 3c inhibited B. 
subtilis with MIC: 50 μg mL-1 compared to MIC  200 μg 
mL-1 given by compound 3g.  
Compound EC ST SP EA KP SM BS PA PV SF 
MIC (µg mL-1) 
3a - 200 100 100 200 400 200 200 100 200 
3b - 100 200 200 100 100 100 - 1000 100 
3c - 100 50 100 1000 200 50 - 100 1000 
3d - 100 200 200 100 100 100 - 1000 100 
3e 200 200 100 100 200 400 200 200 100 200 
3f - - 100 50 50 400 400 100 50 50 
3g - 200 50 200 - 400 200 - 200 - 
3h - - - 200 - 400 1000 50 200 - 
3i - - - 400 400 12.5 1000 - 400 400 
3j - - - 200 1000 200 1000 50 1000 1000 
3k - - - 100 400 400 1000 - 1000 400 
3l - - - 200 - 400 1000 - 400 400 
3m - - - 200 1000 200 1000 100 1000 1000 
3n - - - 400 400 400 400 100 400 400 
30 - - - 400 1000 400 1000 - 200 1000 
Tetracycline 12.5 12.5 12.5 50 100 25 - 50 50 400 
Penicillin - - - - - - 100 - - - 
Legend: EC – E. coli, SP – S. typhi,  SP – S. paratyphi, EA – E. aerogenes, KP – K. pneumoniae, SM – S. marcescens, BS – B. subtilis, 
PA – P. aeruginosa,  PV – P. vulgaris, SF – S. flexneri. 
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Figure 5. A meta-analysis of antibacterial activity based on functional groups of triazoles. 
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Figure 6. A meta-analysis of antibacterial activity of various synthesized triazole compounds (3a-3o). 
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Compound 3e was the only compound (˗4˗MeOPh) that 
inhibited E. coli with MIC: 200 μg mL-1 between 
compounds 3d, 3e, 3f, 3g, 3k, 3l and 3o having common 
3˗MeO at R but different functional groups at R1. From the 
literature, it was found that cyano, phenacyl, and benzyl 
derivatives of 1,2,3-triazolyl-1,4-dihydropyridine hybrids 
were  potent  against  Escherichia  coli with MIC: 30 μg 
mL-1.30 Some fluorinated chalcone-triazole hybrids having -
OMe functional group was also reported to be active against 
E. coli with MIC value of 0.0032 μmol mL-1.27 
Compound 3e (MIC 200 μg mL-1) was also found to be 
more potent against S. flexneri compared to standard (MIC 
400 μg mL-1). Among the compounds 3g and 3o (common 
3˗OMe at R but ˗4˗NCPh at R1), compound 3g inhibited S. 
typhi and S. paratyphi with MIC 200 and 50, respectively. 
Between the compounds, 3f and 3m, compound 3f (3˗OMe 
at R and ˗4 FPh at R1) inhibited S. typhi, E. aerogenes, K. 
pneumoniae, P. vulgaris, S. flexneri with MIC 100, 50, 50, 
50 and 50 μg mL-1respectively that is lower than the MIC 
obtained by compound 3m (˗H at R and ˗4BrPh at R1). 
Compound 3f was found to equipotent to standard against 
P. vulgaris and E. aerogenes with MIC: 50 μg mL-1 while 
more potent compared to standard (MIC 400 μg mL-1 and 
100 μg mL-1) against S. flexneri and K. pneumoniae (MIC: 
50 μg mL-1). Between the compounds, 3g and 3o that 
possesses common ˗3˗OMe but ˗4˗CNPh and ˗4˗CNCH2Ph 
groups at R1 position exhibited almost similar activity 
against test organisms except for 3g that inhibited S. typhi 
and S. paratyphi with MIC: 200 and 50 μg mL-1 respectively, 
which is lower than the MIC (>1000 μg mL-1) given by 
compound 3o. 
CONCLUSION 
This study reports the successful synthesis of 1,2,3-
triazole-1,4-dihydropyridine-3,5-dicarbonitrile derivatives 
(3a-3o) in good yields and antibacterial activity of these 
derivatives containing triazole moiety against a wide range 
of bacterial strains. Besides, both crystal structures of 3d 
and 3e were herein reported for the first time. The in vitro 
antibacterial activity study revealed that all the compounds 
tested showed potent antibacterial activity which support the 
importance of these compounds as candidates for 
therapeutically efficient agents against bacteria. Among all 
compounds, 3e inhibited all test bacterial strains.  
This probably occurs due to the presence of –4–MeOPh 
group in the structure of compound 3e. The lowest MIC was 
displayed by compounds 3j and 3h due to the presence of –
4–MePh and –2–O2NPh groups at the fourth and second 
positions, respectively. These results confirmed that the 
integration of various functional groups to the 1,2,3-triazole 
moiety was greatly beneficial for the antibacterial activities, 
which could not only intensify the inhibition remarkably but 
also broaden their antimicrobial spectrum. These 
compounds are found to be promising for future 
antibacterial drugs.  
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Three distyryl-containing compounds, namely, 2-((cyanomethyl)thio)-4,6-distyrylnicotinonitrile (2), 3-amino-4,6-distyrylthieno[2,3-
b]pyridine-2-carbonitrile (3) and 2-((2-cyanoethyl)thio)-4,6-distyrylnicotinonitrile (4) have been prepared and characterized by elemental 
and spectroscopic analyses. The three compounds contain the pyridine moiety and are considered neonicotinoids analogues. Because 
neonicotinoids were considered the most effective pesticides, the biological activity of the distyryl-containing compounds as potential 
insecticides against cowpea aphid, Aphis craccivora Koch was evaluated. The agricultural bioactivity results of these compounds showed 
that the insecticidal activity varied from good to moderate against cowpea aphid insects. 
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Introduction 
It is known that heterocyclic compounds, especially 
pyridine derivatives, are widely used and different important 
applicationsfor these compounds have been previously 
reported.1-6 So, the chemists around the world focused on 
the synthesis and the applications of these compounds. 
Some neonicotinoids contain pyridine moiety in their 
structure. Different advantages of neonicotinoids 
insecticides such as their high efficacy with lack cross-
resistance, low mammalian toxicity, a novel mode of action 
specific for (nAChRs) and protection of great range of 
crops, resulted in a large use of these compounds in the field 
of crop protection at the present time.7-13 
Genotoxic effect, oxidative stress, DNA damage, and 
clastogenic effect are different results that were found when 
the exposure to imidacloprid as neonicotinoid insecticide 
was monitored in some modern researches after long-term 
exposure of rabbits to that insecticide.14-17 So, in view of the 
above results, the work in this paper was planned to prepare 
some neonicotinoids analogues compounds and screening 
their toxicological activity as insecticides against cowpea 
aphid, Aphis craccivora Koch (Homoptera: Aphididae) 
hoping to be with a higher insecticidal activity and lower 
toxicity. 
Experimental 
Melting points of the prepared compounds were 
determined by the means of a Fisher-Johns apparatus. IR 
spectra and elemental analyses were determined by a Pye-
Unicam SP3-100 spectrophotometer using the KBr disk 
technique and a Vario EL C, H, N, S analyzer, respectively. 
1H NMR, 13C NMR, and DEPT 135 spectra measurement 
was accomplished via a Bruker 400 MHz spectrometer in 
the presence of TMS as an internal reference. Chemical 
shifts are given in δ (ppm). The purity of the synthesized 
compounds was checked by TLC. 3-Cyano-4,6-
distyrylpyridin-2(1H)-thione (1) was prepared according to 
the reported method.5 The neonicotinoid insecticide 
(acetamiprid, purity > 98 %) was purchased from Sigma-
Aldrich (France). Batches of cowpea aphid were gathered 
from faba bean, Vicia faba L., growing on the fields of the 
experimental farm of Assiut University. Compounds 2-4 and 
acetamiprid were screened for their insecticidal activity 
against the gathered cowpea aphids. 
2-((Cyanomethyl)thio)-4,6-distyrylnicotinonitrile (2). 
A mixture of compound (1) (2 g, 0.006 mol), 
chloroacetonitrile (0.006 mol), and fused sodium acetate 
(0.6 g, 0.007 mol) in ethanol (25 mL) was heated under 
reflux for 30 min. The formed precipitate was collected and 
recrystallized from ethanol-dioxane mixture (1:2) as pale 
yellow crystals of compound 2. Yield 89 %. m. p. 121-122 
°C. IR (ν) (KBr): 3026 (C-H aromatic), 2978, 2931, 2848 
(C-H aliphatic), 2246 (C≡N aliphatic), 2211 (C≡N 
conjugated), 1634 (C=N) cm-1. 1H NMR (DMSO-d6, 400 
MHz): δ = 7.20-8.08 (m, 15H, 2CH=CH and Ar-H), 4.36 (s, 
2H, CH2). 13C NMR (DMSO-d6, 100 MHz): δ = 162.45, 
159.37, 149.51, 137.68, 136.12, 135.56, 130.44, 129.90, 
129.44, 128.07, 126.48, 118.10, 116.10, 115.19, 102.07, 
16.39. DEPT 135 (DMSO-d6, 100 MHz): δ = 136.12 (CH), 
135.56 (CH), 130.44 (CH), 129.90 (CH), 129.43 (CH), 
128.06 (CH), 126.48 (CH), 115.19 (CH), 16.39 (CH2).  
Anal.Calcd. for C24H17N3S: C, 75.96; H, 4.52; N, 11.07; S, 
8.45. Found: C, 75.97; H, 4.49; N, 11.06; S, 8.47. 
3-Amino-4,6-distyrylthieno[2,3-b]pyridine-2-carbonitrile (3)  
In addition to the procedure reported before,18 compound 
(3) was synthesized here by suspending of compound (2) 
(0.005 mol) in sodium ethoxide solution (0.5 g of sodium in 
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31 mL of absolute ethanol) and heating for 5 min under 
reflux. The formed product after cooling was collected and 
recrystallized from ethanol-dioxane mixture (1:2) as orange 
crystals of compound 3. Yield 90 %.m. p. 156-157 °C. IR 
(ν) (KBr): 3383, 3314, 3199 (NH2), 3019 (C-H aromatic), 
2917 (C-H aliphatic), 2198 (C≡N) cm-1. 1H NMR (DMSO-
d6, 400 MHz): δ = 7.31-7.86 (m, 16H, 2CH=CH, NH of NH2 
and Ar-H), 6.18 (s, 1H, NH of NH2). 13C NMR (DMSO-d6, 
100 MHz): δ= 160.43, 156.61, 151.90, 144.76, 144.31, 
135.19, 129.35, 129.21, 128.11, 128.05, 127.79, 127.34, 
123.00, 117.25, 115.87, 76.23. DEPT 135 (DMSO-d6, 100 
MHz): δ = 129.35 (CH), 129.20 (CH), 128.11 (CH), 128.05 
(CH), 127.79 (CH), 127.34 (CH), 123.00 (CH), 117.24 
(CH). The mass spectrum of compound 3 showed a 
molecular ion peak at m/z = 379.2 (M+, 29.47 %) which is in 
agreement with its molecular formula (C24H17N3S). 
Anal.Calcud. for C24H17N3S: C, 75.96; H, 4.52; N, 11.07; S, 
8.45. Found: C, 75.98; H, 4.47; N, 11.09; S, 8.46.  
2-((2-Cyanoethyl)thio)-4,6-distyrylnicotinonitrile (4)  
A mixture of compound (2) (2 g, 0.006 mol), acrylonitrile 
(0.006 mol) and fused sodium acetate (0.6 g, 0.007 mol) in 
ethanol (25 mL) was heated under reflux for 3 h. The 
formed precipitate was collected and recrystallized from 
ethanol-dioxane mixture (1:2) as yellow crystals of 
compound 4. Yield 88 %. m. p. 158-159 °C. IR (ν) (KBr): 
3024 (C-H aromatic), 2917, 2849 (C-H aliphatic), 2250 
(C≡N aliphatic), 2211 (C≡N conjugated) cm-1. 1H NMR 
(DMSO-d6, 400 MHz): δ = 7.19-7.92 (m, 15H, 2CH=CH 
and Ar-H), 3.51-3.54 (t, 2H, CH2CN), 2.99-3.02 (t, 2H, 
SCH2). 13C NMR (DMSO-d6, 100 MHz): δ = 162.17, 
157.40, 149.83, 138.63, 136.81, 135.67, 130.36, 129.82, 
129.43, 128.05, 126.97, 119.63, 115.45, 114.72, 102.54, 
25.98, 18.12. DEPT 135 (DMSO-d6, 100 MHz): δ = 136.80 
(CH), 135.67 (CH), 130.36 (CH), 129.82 (CH), 129.43 
(CH), 128.05 (CH), 126.97 (CH), 114.71 (CH), 25.98 (CH2), 
18.12 (CH2). Anal.Calcd. for C25H19N3S: C, 76.31; H, 4.87; 
N, 10.68; S, 8.15. Found: C, 76.49; H, 4.86; N, 10.69; S, 
8.17. 
Laboratory bioassay 
The insecticidal activity of the prepared compounds was 
evaluated via leaf dip bioassay method.19 Laboratory 
screening data are reported here for the title compounds to 
find out the concentrations that are required to kill 50 % 
(LC50) of the gathered insects. Number of six concentrations 
of each synthesized compound plus 0.1 % Triton X-100 
(surfactant) was used. 20 adults and 20 nymphs of cowpea 
aphids, almost of the same size, were dipped 3 times in 
every concentration for ten seconds. The cowpea aphids 
were dried at RT for 0.5 h. Cowpea aphids control batches 
were also used. The aphids after drying were transferred to 
Petri dishes (9 centimeters diameter) and grasped for 24 and 
48 h at photoperiod of 12:12 (light/ dark), 22 ± 2 °C and 60 
± 5 % relative humidity. Aphids mortality was counted after 
24 and 48 h of test by means of a binocular microscope. The 
aphids that not capable of coordinating forward movement 
were considered dead. Toxicological activity check of the 
title compounds was repeated twice, and the results were 
corrected using Abbott’s formula.20 Slope values and 
median lethal concentrations (LC50) of the prepared 
compounds were calculated through a probit regression 
analysis program and recorded in ppm.21 
RESULTS AND DISCUSSION 
The synthesis of the title compounds was started from (1) 
which was prepared according to the reported method.5 
Refluxing of compound 1 with chloroacetonitrile in ethanol 
containing slightly excess amounts of fused sodium acetate 
for 30 min resulted in the formation of 2-
((cyanomethyl)thio)-4,6-distyrylnicotinonitrile (2). The 
latter compound underwent intramolecular Thorpe-Ziegler 
cyclization upon refluxing in ethanol containing catalytic 
amounts of sodium ethoxide for 5 min to give the 
corresponding thienopyridine compound 3-amino-4,6-
distyrylthieno[2,3-b]pyridine-2-carbonitrile (3) (Scheme 1).  
Spectroscopic data and elemental analyses of compounds 
2 and 3were in agreement with their proposed structure. IR 
spectrum of compound 2 showed absorption bands at 2246 
and 2211 cm-1 characteristic for (C≡N aliphatic) and (C≡N 
conjugated) groups. The absorption band of (C≡N 
conjugated) of compound 2 was disappeared when cyclised 
to give the thienopyridine 3 and was replaced by 3383 and 
3199 cm-1 for NH2. 1H NMR spectrum (DMSO-d6, 400 
MHz) of compound 2 showed singlet signal at 4.36 for 
(CH2) group. The signal of (CH2) group of compound2 in 
the 1H NMR spectrum was disappeared when cyclised to 









Scheme 1. Synthesis of distryl compounds. 
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Table 1. Insecticidal activity of acetamiprid and compounds 2-4 against the cowpea aphid nymphs after 24 and 48 h of treatment. 
24 h after treatment 48 h after treatment 
Compd. Slope ± SE LC50 (ppm) Toxic ratio Slope ± SE LC50 (ppm) Toxic ratio 
Acetamipri
 
0.34±0.02 0.045 1 0.42±0.03 0.006 1 
2  0.44±0.03 0.064 0.703 0.48±0.03 0.013 0.462 
3  0.38±0.03 0.097 0.464 0.49±0.04 0.018 0.333 
4  0.41±0.03 0.052 0.865 0.48±0.03 0.010 0. 600 
 
Table 2. Insecticidal activity of acetamiprid and compounds 2-4 against the cowpea aphid adults after 24 and 48 h of treatment. 
24 h after treatment 48 h after treatment 
Compd. Slope ± SE LC50 (ppm) Toxic ratio Slope ± SE LC50 (ppm) Toxic ratio 
Acetamipri
 
0.24±0.02 0.225 1 0.32±0.03 0.023 1 
2  0.36±0.02 0.322 0.699 0.39±0.03 0.035 0.657 
3  0.39±0.03 0.754 0.298 0.45±0.03 0.049 0.469 
4  0.36±0.02 0.282 0.798 0.41±0.03 0.034 0.676 
 
DEPT 135 (DMSO-d6, 100 MHz) spectrum of compound 2 
showed characteristic signal at 16.39 for (CH2) group. The 
signal of (CH2) group of compound2 in the DEPT 135 
spectrum was disappeared when cyclised to give compound 
3. The mass spectrum of compound 3 showed a molecular 
ion peak at m/z = 379.2 (M+, 29.47 %) which is in 
agreement with its molecular formula (C24H17N3S). 
Reflux of compound 1 with acrylonitrile in ethanol 
containing slightly excess amounts of fused sodium acetate 
for 3 h resulted in the formation of 2-((2-cyanoethyl)thio)-
4,6-distyrylnicotinonitrile (4) (Scheme 1). The chemical 
structure of compound 4 was confirmed by elemental and 
spectral analyses.IR spectrum of compound 4 showed 
absorption bands at 2250 and 2211 cm-1 characteristic for 
(2C≡N) groups. 1H NMR spectrum (DMSO-d6, 400 MHz) 
of compound 4 showed two triplet signals at 3.51-3.54 and 
2.99-3.02 for (2CH2) groups. DEPT 135 (DMSO-d6, 100 
MHz) spectrum of compound 4 showed characteristic 
signals at 25.98 and 18.12 for (2CH2) groups. 
Insecticidal activity test for the cowpea aphid nymphs.  
Compounds 2, 3, and 4 were investigated for their 
insecticidal activities against the nymphs of the collected 
aphids, and the results are presented in table 1. The 
insecticidal activity results indicated that, after 24 h of  
treatment compounds 2, 3, and 4 exhibited high to low 
insecticidal activity against the cowpea aphid nymphs and 
the LC50 values ranged from 0.052 to 0.097 ppm, whereas 
the LC50 value of acetamiprid was 0.045 ppm. Whilst after 
48 h of treatment, the insecticidal activity of compounds 2, 
3, and 4 against cowpea aphid nymphs varied from strong to 
weak with LC50 values assorted from 0.01 to 0.018 ppm, but 
the LC50 value of acetamiprid was 0.006 ppm. These results 
indicate that compounds 2 and 4 have a high insecticidal 
activity close to that of acetamiprid insecticide against 
cowpea aphid nymphs after 24 and 48 h of test.  
Insecticidal activity test for the adults of cowpea aphid  
Compounds 2, 3, and 4 were investigated also for their 
insecticidal activity against the adults of the collected 
aphids, and the results are presented in table 2. From the 
results obtained after 24 h of insecticidal activity test, it was 
found that the compounds 2, 3, and 4 have strong to weak 
activity and LC50 values ranged from 0.282 to 0.754 ppm, 
while0.225 ppm was the LC50 value of acetamiprid. 
Compound 4 possess a high insecticidal activity, and its 
LC50 value is 0.282 ppm. After 48 h of the agricultural 
bioactivity test as insecticides, the insecticidal activity of 
compounds 2, 3, and 4 against cowpea aphid adults varied 
from high to low with LC50 values ranged from 0.034 to 
0.049 ppm, whilst the LC50 value of acetamipridwas 0.023 
ppm. Thus, compounds 2 and 4 showed a high insecticidal 
activity close to that of acetamiprid insecticide against 
cowpea aphid adults after 24 and 48 h of treatment. 
Structure-action relationship 
It is interesting to note that the insecticidal activity of the 
compound 2-((2-cyanoethyl)thio)-4,6-distyrylnicotinonitrile 
(4) with two cyano groups in its structure is more than that 
of the compound 2-((cyanomethyl)thio)-4,6-
distyrylnicotinonitrile (2) that contains also two cyano 
groups in its structure, which may be due to the presence of 
the chain (CH2CH2CN) in compound 4 instead (CH2CN) in 
compound 2. The insecticidal activity of the opened form of 
compounds 2 is more than that of its closed form, the 
compound 3-amino-4,6-distyrylthieno[2,3-b]pyridine-2-
carbonitrile (3), which may be due to the presence of two 
cyano group in the former and one cyano group in the latter. 
CONCLUSION 
Three distyryl-containing compounds, which are 
considered neonicotinoid analogs, were prepared. The 
agricultural bioactivity as potential insecticides against 
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cowpea aphid, Aphis craccivora Koch for these compounds 
was investigated. The data obtained from this investigation 
proved that these compounds have insecticidal activities 
varied from good to moderateagainst cowpea aphids in 
comparison of acetamiprid insecticide as a reference. 
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QUALITY CONTROL PARAMETERS OF PRICKLES OF 
BOMBAX CEIBA LINN. 
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Bombax ceiba Linn. is a deciduous tree known as Red silk cotton tree.  Bombax ceiba stem, stem bark and prickle are used for the treatment 
of rheumatism, swellings, asthma and inflammation of the legs. The stem bark of Bombax ceiba is official in the ayurvedic Pharmacopoeia 
of India recommends its use in acne. Prickles are also used and recommended in anti-acne marketed formulation. However, limited work was 
carried out on the prickle toward establishing quality control parameters. Studies were therefore carried out to determine the phytochemical 
and pharmacognostic profile of prickle of Bombax ceiba Linn. The study, including determination of macroscopic, microscopic characters, 
ash values, extractive values, loss on drying, phytochemical screening, total phenolic content, TLC and HPTLC fingerprinting were carried 
out. Successive extracts were prepared using soxhlet extraction. The phytochemical analysis of extracts revealed the presence of tannin, 
saponin, phenol, carbohydrate, steroids, triterpenoids and flavonoids. Total phenolic and tannin content of methanol extract was found 
327.78±1.09mg GAE/gm equivalent and 4.98±0.22%w/w, respectively. The mobile phase showing distinct spots in TLC was found in 
Toluene: Ethyl acetate (9.5:0.5) and (9:1) for petroleum ether and methanol extracts, respectively. HPTLC fingerprinting shows 8 & 3 peaks 





[a] School of Pharmacy, R K University, Kasturbadham, 
Bhavnagar Highway, Rajkot. 360020. Gujarat, India. 
[b] Vice-Chancellor, Gujarat Technological University, Near 
Visat Three Roads, Visat Gandhinagar Highway, 
Chandkheda, Ahmedabad. 382424 Gujarat, India.  
INTRODUCTION 
Bombax ceiba L. is a tall deciduous tree, buttressed at base, 
belongs to the Bombacaceae family.1 Bombax ceiba scientific 
synonyms are Bombax malabaricum and Salmalia 
malabarica. The plant is also known as a silk-cotton tree, 
shalmali and shemlo. The plant is used for the treatment of 
gastrointestinal, skin diseases, gynecological, urinogenital 
disorders, general debility, diabetes and impotence. The plant 
parts like root, stem, stem bark and prickle are used for the 
treatment of rheumatism, swellings, bone fracture, asthma, 
snake bite, edema, hotness and inflammation of legs in 
several parts of Indian continent.2 The bark of Bombax ceiba 
(B. ceiba) is official in The Ayurvedic Pharmacopoeia of 
India and it recommends its use in the treatment of acne.3 
Prickles of B. ceiba have been employed to treat acne face in 
many tribal communities.3 According to Charak Samhita, the 
plant is among the top ten drugs to treat sepsis, bowel 
regulator and tissue regenerator.4 According to Sushrut 
Samhita stem bark is useful in removing acne, hemorrhagic 
disorders, wound healing and in burns.5   Patnakar has studied 
the in-vitro and in-vivo anti-acne potential of bark and thorns 
and results shown that an alcoholic extract of bark and thorns 
possess anti-acne potential.6 It is interesting to note that 
prickles of B. ceiba are now an important ingredient of 
Himalaya’s acne-n-pimple cream. 7  However, limited work 
has been carried out on the prickle toward establishing its 
physio-chemical & pharmacognostic quality control 
parameters like total tannin, total phenolic, total ash, loss on 
drying, TLC and HPTLC fingerprinting.8,9  Therefore, the 
present research of Bombax ceiba prickle was taken up to 
establish quality control parameters of prickle, which will 
help in the identification of crude drug as well as in the 
standardization of the formulation. In our present 
investigation, we have carried out macroscopic, microscopic, 
ash values, extractive values, fluorescence analysis, 
phytochemical screening, total tannin, phenolic content, 
qualitative TLC as well as HPTLC analysis of prickle of 
Bombax ceiba plant.  
MATERIALS AND METHODS 
Chemical and reagents  
Gallic acid, Folin Ciocalteu reagent, and methanol were 
purchased from S.D. Fine Chemicals ltd. Mumbai, India. 
Whatman (Florham Park, NJ) No. 1 filter paper was used for 
the filtration of the samples. All other chemicals and solvents 
used were purchased from Merck Chemicals, Mumbai, India. 
10 X 10 cms HPTLC aluminum plate precoated with silica 
gel 60 F254 (0.2mm thickness) of Merck Pvt. Ltd. (India) were 
used for HPTLC analysis. 
Collection of plant material, extraction and sample preparation  
Prickles of Bombax ceiba (B. ceiba) were collected in the 
month of August-September 2007, from Gir Forest, Junagadh, 
Gujarat. The identity of the plant was also confirmed by the 
Department of Botany, Christ College, Saurashtra University, 
Rajkot. And Herbarium voucher specimen no. 
SU/DPS/Herb/07-08/2 was deposited at the Department of 
Pharmaceutical Sciences, Saurashtra University, Rajkot.  
 
Quality control parameters of Bombax ceiba prickle          Section C-Research paper 
Eur. Chem. Bull. 2021, 10(1), 39-45  https://doi.org/10.17628/ecb.2021.10.39-45 40 
Sun-dried Prickle of Bombax ceiba was powdered by 
pulverizer and passed through 40 # sieve and stored in an 
airtight bottle. The powdered materials were used for further 
investigation. The powder of the drug, weighing about 150 g, 
was successively extracted in soxhlet apparatus with solvents 
of increasing polarity as follows, petroleum ether, benzene, 
chloroform, acetone, methanol and water. All extracts were 
concentrated by distilling the solvent and the extracts were 
dried on a water bath at 50 °C. Dried extracts were used 
further for fluorescence analysis, phytochemical screening, 









Figure 1. Prickles of Bombax ceiba 
Macroscopy and microscopy 
In organoleptic evaluation, various sensory parameters of 
the prickle, such as color, odor, taste, shape and texture of the 
prickle were recorded. Fresh prickles were taken for 
microscopic studies. Sun-dried Prickles of Bombax ceiba 
were powdered by a pulverizer. Powder passed through 40 # 
sieve was used to study microscopical characters. For the 
microscopical studies, transverse sections of prickle were 
prepared and stained as per the standard procedure.10,11 The 
powder microscopy was performed according to the method 
described by Khandelwal.12 
Physico-chemical investigations 
The dried prickle powder was used for the determination of 
loss on drying, ash values, extractive values, foaming index 
and swelling index.13 
Fluorescence analysis 
Then consistency, percentage yield, fluorescence 
examination of all successive extracts by color in daylight and 
ultraviolet light 366 nm were also studied which may help to 
confirm the purity of the drug.14 
Preliminary phytochemical investigation 
For the preliminary phytochemical investigation of prickle, 
extracts were done according to methods described in 
Harborne (1973) and Kokate (1997).15,16 The different 
extracts obtained by successive solvent extraction were tested 
separately for the presence of various phytoconstituents, viz. 
alkaloids, glycosides, carbohydrates, Phenolics and tannins, 
phytosterols, fixed oils and fats, proteins and amino acids, 
flavonoids, saponins, gums and mucilage.  
Determination of total tannin content  
Total tannin content was estimated for methanol extract of 
prickle of Bombax ceiba by the method described in Indian 
Pharmacopoeia, 1996.17,18 Accurately weighed 0.08 g of 
methanol extract of Bombax ceiba prickle powder were 
heated gently with 100 ml of water. From this 100 ml solution, 
10 ml was taken into another conical flask. 10 ml of indigo 
carmine solution and 300 ml water were added to the flask. 
This solution was heated at 60-70 °C and then titrated with 
0.1 N KMnO4 until royal blue color changes to bottle green 
and then titrated dropwise until the solution becomes bottle 
green to golden yellow in color. Similarly, Blank reading was 
taken by using 10 ml of the indigo carmine solution alone 
with 300 ml of water. Total tannin content was calculated 
using the following formula.  
 
          (1) 
 
where,  
ϕ=% of total tannin content,  
A = blank reading,  
B = test reading, 
msample= sample weight in g, 
N=normality of KMnO4 solution  
Determination of total phenolic content 
The total phenolic content of methanol extract of prickle 
was determined by the Folin-Ciocalteu method.19 10 mg of 
methanol extract of prickle was dissolved in 10 ml of 
methanol to get 1 mg/ml sample solution for the test.  500 µL 
of the sample was taken in a 25 ml volumetric flask. To this, 
10 ml of water and 1.5 ml of Folin-Ciocalteu reagent were 
added. The above mixture was kept for 5 min. and then 4ml 
of 20 % sodium carbonate solution was added and the volume 
was made up to 25 ml with distilled water. The mixture was 
kept for 30 min. And the absorbance of the blue color 
developed was recorded at 765 nm in UV- visible 
spectrophotometer Shimadzu, UV-1700, Japan. The total 
phenolic content was calculated from the calibration curve of 
Gallic acid plotted by using the above procedure. The total 
phenolic content was expressed in terms of mg GAE/g of dry 
extract equivalent to Gallic acid.  
Statistical analysis All the experiments were carried out in 
triplicate, and the results were expressed as mean ± SEM. 
Thin layer chromatography analysis 
TLC analysis was carried out according to the method 
described by Harborne.20 Methanol and petroleum ether 
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development of the mobile phase for thin-layer 
chromatography analysis. Glass plates were coated with silica 
gel G and allowed to dry followed by activation of plates in 
hot air oven at 110 ̊C for 10min. Pilot TLC was developed for 
methanol extract and petroleum ether extract by preparing 
various mobile phases using various solvents like toluene, 
chloroform, n-butanol, ethyl acetate, methanol and distilled 
water in different proportion. 1mg/ml of extracts were 
prepared and spotted onto the TLC plates. After the 
development of TLC with the mobile phase, plates were air-
dried. Detection of Rf values was done in UV light 366 nm, 
and after spraying with anisaldehyde sulphuric acid followed 
by heating at 110 °C for 10 min. The movement of the active 
compound was expressed by its retention factor (Rf) values, 
calculated as: 
 
          (2) 
 
where 
 Dsolute = distance traveled by solute 
 Dsolvent=distance traveled by solvent front 
HPTLC Fingerprinting profile 
HPTLC fingerprint profile was developed for methanol and 
petroleum ether extract of prickle of Bombax ceiba. Samples 
were prepared by dissolving dried methanol and petroleum 
ether extract of prickle in methanol and petroleum ether to 
obtained a concentration of 5 μg/ml. 10μl of sample solution 
was applied on 10 X 10Cms HPTLC aluminum plate 
precoated with silica gel 60 F254 (0.2 mm thickness) of Merck 
Pvt. Ltd. (India). The most recent automatic device, 'CAMAG 
LINOMAT-5' was used for the present analysis. The plates 
were developed with mobile phase Toluene: Ethyl acetate 
(9:1) and Toluene: Ethyl acetate (9.5:0.5) for Methanolic 
extract and Petroleum ether extract of prickle, respectively.  
The plate was scanned at UV 366 nm (CAMAG TLC 
SCANNER 3). Rf values of each compound that were 
separated on the plate were recorded.21  
RESULTS AND DISCUSSION  
Macroscopy and microscopy 
Prickles were present surrounding the stem and stem 
branches. Prickles were a conical shape, sharp and hard. 
Prickle color was reddish-brown to grey. The size of the 
prickle was found 0.5 cm to 2 cm bottom diameter and 1cm 
to 1.5 cm in height. (Figure 1) It does not have any 
characteristic odor. 
Microscopy study of prickle showed the presence of stone 
cells, numerous clusters of prism shape calcium oxalate 
crystals, epidermal cells and no. of brown-colored, double-
walled, polygonal cork cells with the size of 30 ± 1.5 µm and 










Figure 2. Microscopy of prickle of Bombax ceiba. a) Transverse 
section of prickle, b) & c) Powder microscopy, where D Cr- Double-
wall polygonal cork cell, Co- Cluster of prism shape calcium oxalate 
crystal, Cb - Cells with orange content, Cr- Cork cell in powder 
study. 
Physico-chemical investigation 
Physio-chemical investigation of Bombax ceiba prickle 
powder was carried out according to WHO guidelines13. 
Results of parameters such as loss on drying, ash values, 
extractive values, foaming index and swelling index are as 
depicted in Table 1.   
Table 1. Physico-chemical investigation of prickles of Bombax 
ceiba. 
No. Parameters Average values * 
Prickle 
1 Loss on drying 4.60±0.23  %w/w 
2 Total ash 3.50±0.11  %w/w 
3 Acid insoluble ash 0.35±0.05  %w/w 
4 Water-soluble ash 1.60±0.10  %w/w 
5 Alcohol extractive value 19.20±0.22  %w/w 
6 Hot water extractability 16.50±0.16  %w/w 
7 Coldwater extractability  11.40±0.19  %w/w 
8 Foaming index 111 
9 Swelling index 4.64±0.14 mL 
Results are presented in Mean±SEM (n=3). Values given here are 
expressed as % w/w of air-dried material. 
Fluorescence analysis 
A powdered prickle of Bombax ceiba was subjected to 
successive solvent extraction and the consistency, percentage 
yield, fluorescence examination of all successive extracts by 
color in daylight and ultraviolet light at 366 nm were recorded. 
The results of fluorescence analysis are presented in Table 2.  
Methanol successive solvent extract of prickle revealed the 
highest extractive value of 12.16 %w/w followed by acetone 
and petroleum ether extract, whereas water, chloroform and 
benzene extracts were of low % yield value. Characteristic 
colors and fluorescent properties recorded can be used for 
identification and authentication of different extracts 
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Table 2. Fluorescence analysis for prickle of Bombax ceiba. 
PEP- Petroleum ether (60-80ºC) extract of Bombax ceiba prickle, BEP-Benzene extract of Bombax ceiba prickle, CEP- Chloroform extract 
of Bombax ceiba prickle, AEP-Acetone extract of Bombax ceiba prickle, MEP- Methanol extract of Bombax ceiba prickle, WEP-Water 
extract of Bombax ceiba prickle 
Table 3. Preliminary phytochemical analysis of prickle of Bombax ceiba. 
No. Class of compound PEP BEP CEP AEP MEP WEP MPBC 
1 Alkaloids - - - - - - - 
2 Cardiac Glycoside - - - - - - - 
3 Phenolics/Tannins - - - + + + + 
4 Flavonoids - - - + + + + 
5 Saponins - - - - + + + 
6 Fixed oils & Fats - - - - - - - 
7 Proteins & Amino acids - - - - - - - 
8 Gums/mucilage - - - - - - - 
9 Volatile oil - - - - - - - 
10 Carbohydrates - - - - + + + 
11 Phytosterols/ Triterpenoids + + + - - - + 
- Negative, + - Positive, PEP- Petroleum ether (60-80ºC) extract of Bombax ceiba prickle, BEP-Benzene extract of Bombax ceiba prickle, 
CEP- Chloroform extract of Bombax ceiba prickle, AEP-Acetone extract of Bombax ceiba prickle, MEP- Methanol extract of Bombax ceiba 
prickle, WEP-Water extract of Bombax ceiba prickle, MPBC- Crude methanol extract of Bombax ceiba prickle 
 
Preliminary phytochemical investigation 
Successive extracts of prickle of Bombax ceiba were then 
subjected to phytochemical screening by various qualitative 
chemical tests. Results of phytochemical screening of 
successive extracts of prickle powder were depicted in Table 
3.  
Preliminary qualitative chemical tests of prickle have 
shown the presence of phenolics, tannins, flavonoids, 
saponins, carbohydrates and phytosterols/ triterpenoids. The 
methanol extract of prickle of Bombax ceiba revealed the 
presence of the highest number of phytoconstituents e.g., 
phenolics, tannins, flavonoids, saponins, carbohydrates and 
phytosterols/ triterpenoids.  
Total tannin content  
The total tannin content of Bombax ceiba methanol extract 
of prickle was determined by the Lowenthal Permanganate 
titration method17,18. The method relies on the oxidation of 
phenolics by potassium permanganate solution in the 
presence of indigo carmine as a 'redox indicator' to show the 
endpoint. The total tannin content of prickle was found 
4.98±0.22 %w/w, as shown in Table 4. 
 
 
Table 4. The total tannin content of the prickle of Bombax ceiba. 
No. Sample  Mean±SEM % w/w 
1 MPBC 4.98±0.22 
The values given here are expressed as % w/w of dry weight. MPBC 
– methanol extract of prickle of Bombax ceiba, values are expressed 
as Mean±SEM, where, n=3 
Table 5. Estimation of total phenolic content for methanol extract of 
prickle of Bombax ceiba in µg mg-1 gallic acid equivalent 
Sample Total phenolics ) Mean ± SEM 
I II III 
MPBC 325.60 328.87 328.87 327.78±1.09 
MPBC–Methanol extract of prickle of Bombax ceiba, values are 
expressed as Mean (µg mg-1 gallic acid equivalent)±SEM, where 
n=3 
Determination of total phenolic content 
The total phenolic content of the methanol extract of prickle 
was determined by Folin-Ciocalteu method19. Table 5 showed 
the total amount of phenolic content present in the methanol 
extract of Bombax ceiba prickle. 1mg of methanol extract of 
prickle of Bombax ceiba contains 327.78±1.09 µg gallic acid 
equivalent of phenols.  
 
 
No. Extract Colour Consistency Yield,  %w/w 
Under daylight Under UV light (366 nm) 
1 PEP Light yellow Yellowish green Dry non-sticky 6.30 
2 BEP Yellow Yellow Dry non-sticky 2.48 
3 CEP Dark yellow Dark yellow Sticky 1.00 
4 AEP Brown Light brown Sticky 12.00 
5 MEP Dark brown Magenta Sticky 12.16 
6 WEP Orange-brown Dark brown Dry non-sticky 2.82 
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Table 6. Thin-layer chromatography of petroleum ether and methanol extract of Bombax ceiba. 
Extract and solvent system Detection under UV  366 nm light Detection after spraying of 
anisaldehyde/sulphuric acid reagent 
Spot no. Color  Rf Spot no. Color  Rf 
Petroleum ether extract of 
prickles, toluene:ethyl 
acetate (9.5: 0.5) 
1 Pink  0.33 1 Violet  0.20 
2 Fluorescent 
yellow  
0.43 2 Violet  0.36 
3 Pink  0.48 3 Dark Violet  0.60 
 
Methanol extract 
of prickles, toluene:ethyl 
acetate (9: 1) 
1 Fluorescent 
Green  
0.05 1 Navy blue 0.13 
2 Blue  0.2 2 Grey  0.16 
3 Fluorescent 
Green  
0.55 3 Violet  0.41 
- - - 4 Violet 0.56 
- - - 5 Violet  0.66 
- - - 5 Green  0.71 
- - - 6 Greenish blue  0.82 
- - - 7 Blue  0.99 
 
Thin layer chromatography analysis 
The methanol and petroleum ether extracts were  obtained 
by Soxhlet solvent extraction process. Extracts were 
subjected to thin-layer chromatography (TLC) to optimize the 
mobile phase for further HPTLC fingerprinting.  Different 
composition of the different mobile phases was tested in order 
to obtain high resolution and reproducible spots. The mobile 
phases developed for petroleum ether and methanol extract 
were toluene: ethyl acetate (9.5:0.5) and toluene: ethyl acetate 
(9:1), respectively. The number of spots found, their color in 
UV 366 nm and in daylight after spraying and related Rf 









Figure 3. Thin-layer chromatography of Bombax ceiba prickle after 
spraying in visible light a) - methanol extract with toluene: ethyl 
acetate (9:1) and b)- petroleum ether extract with toluene: ethyl 
acetate (9.5:0.5). 
HPTLC Fingerprinting profile 
HPTLC fingerprinting was performed for both methanol 
and petroleum ether extracts of prickle of Bombax ceiba using 
mobile phase toluene: ethyl acetate (9:1) and toluene: ethyl 
acetate (9.5:0.5), respectively. Eight peaks were detected 
upon HPTLC of petroleum ether extract of Bombax ceiba 
prickle at 366nm using mobile phase toluene: ethyl acetate 
(9.5:0.5), while three peaks were detected upon HPTLC of 
methanol extract of Bombax ceiba prickle at 366 nm using 
mobile phase toluene: ethyl acetate (9:1). Rf values for ethyl 
acetate extract for peak 1 to 8 were found 0.07, 0.14, 0.25, 
0.31, 0.36, 0.43, 0.5 and 0.75 respectively.  Rf values for 
methanol extract for peaks 1 to 3 were found 0.07, 0.16 and 
0.53, respectively.  Peaks, their Rf values, area under curve 
and area % for petroleum ether and methanol extract of 
prickle of Bombax ceiba are depicted in Table 7 and Table 8.  
2D chromatogram, 3D chromatogram and HPTLC fingerprint 
profile of petroleum ether extract of Bombax ceiba prickle are 
shown in Figure 4, 5 and 6 respectively. 2D chromatogram, 
3D Chromatogram and HPTLC fingerprint profile of 
methanol extract of Bombax ceiba prickle are shown in 
Figures 7, 8 and 9. 
Table 7. HPTLC fingerprinting of petroleum ether extract of 
Bombax ceiba prickle. 
Peak Rf Area under curve Area % 
1 0.07 7884 13.77 
2 0.14 4656 8.13 
3 0.25 986.5 1.72 
4 0.31 1858 3.24 
5 0.36 3155 5.51 
6 0.43 8001 13.97 
7 0.5 1842 3.22 
8 0.75 28892 50.44 
Table 8. HPTLC fingerprinting of methanol extract of Bombax 
ceiba prickle. 
Peak Rf Area under curve Area % 
1 0.07 13671 84.57 
2 0.16 919.8 5.69 
3 0.53 1575 9.74 
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Figure 4. HPTLC 2D chromatogram of petroleum ether extract of 












Figure 5. HPTLC 3D chromatogram of petroleum ether extract of 












Figure 6. HPTLC profile of petroleum ether extract of Bombax 












Figure 7. HPTLC 2D chromatogram of methanol extract of Bombax 












Figure 8. HPTLC 3D chromatogram of methanol extract of Bombax 










Figure 9. HPTLC profile of methanol extract of Bombax ceiba 
prickle at 366nm (toluene:ethyl acetate 9:1). 
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CONCLUSION  
Standardization of herbal drugs can be used as an important 
scientific tool to ensure the quality of the crude drug, extracts 
and formulation prepared from crude drugs. The present 
study was planned to establish pharmacognostic standards for 
prickle of Bombax ceiba so as to have a reliable scientific 
parameter to authenticate the prickles, prickle powder, and 
extracts. The macroscopical and microscopical study 
provided important data to identify crude as well as a powder 
form of prickle of Bombax ceiba. Preliminary phytochemical 
screening revealed the presence of phenolics, tannins, 
flavonoids, saponins, carbohydrates and phytosterols/ 
triterpenoids in the extracts of prickle of Bombax ceiba. 
Further total phenol and total tannin content of methanol 
extract can be used as an important standardization parameter 
for the alcoholic formulation of prickle of Bombax ceiba. The 
physico-chemical analysis provided important data on loss on 
drying, ash values, extractive values, foaming index and 
swelling index of prickle of Bombax ceiba that can be used to 
authenticate it in raw as well as powder form. TLC and 
HPTLC fingerprinting have provided important data for both 
polar and non-polar extracts, which can be further useful for 
standardization of both types of extracts used to prepare 
formulation.  
The present study can be specifically useful for 
authentication of the raw material of the prickles, 
identification in powder and raw form and in the detection of 
adulteration, which will ultimately benefit the people who use 
Bombax ceiba prickle formulations.  
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Abraham model L solute descriptors have been determined for an additional 33 linear C7-C14 alkynes based on published gas 
chromatographic retention indices for solutes eluted from capillary columns coated with squalane and apiezon L stationary phases.  
Standard molar enthalpies of vaporization and sublimation at 298 K are calculated for the 33 linear alkynes using the reported solute 
descriptors and our recently published Abraham model correlations.  Calculated vaporization enthalpies derived from the Abraham model 
compare very favourably with values based on a popular atom-group additivity model.   
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INTRODUCTION 
Thousands of new organic and organometallic compounds 
are either discovered or synthesized each year by the 
scientific community and chemical manufacturing sector.  
New chemicals (such as medical drugs, pesticides, 
herbicides) are synthesized to address specific needs or are 
discovered during the characterization of chemical 
constituents of natural products.  Practical utilization of 
newly discovered and newly synthesized compounds 
requires knowledge of their physical, toxicological and 
thermodynamic properties. Experimental measurements of 
properties are often expensive and time-consuming.  It is not 
feasible for experimental measurements to be performed on 
every newly discovered and newly synthesized organic and 
organometallic compound.  Predictive methods are often 
used to estimate physical and thermodynamic properties in 
the absence of measured experimental quantities. 
The Abraham solvation parameter model is among the 
better of the predictive linear free energy relationships 
developed during the past 30 years.  The model has been 
shown to provide reasonably accurate predictions for a wide 
range of solute transfer processes.  Specific solute properties, 
SP, for which predictive expressions have been reported 
include: the logarithms of the water-to-organic solvent and 
gas-to-organic solvent partition coefficients, log P and log 
K,1-7 logarithms of blood-to-body tissue/fluid partition 
coefficients, log Pblood/tissue,8-12 logarithms of the median 
lethal concentration of various organic compounds to 
aquatic organisms, log LC50,13-16 enthalpies of solvation of 
organic vapors and inorganic gases in organic solvents, 
∆Hsolv,17-27 logarithms of molar solubility ratios,28-31 
isothermal gas chromatographic retention factors and 
retention indices, RI, Draize eye scores and eye irritation 
thresholds,32-34 nasal pungency,32,35-37 skin permeabili-
ties,38,39 and several other biological response solute 
properties.40,41  More recently, the model was successfully 
extended to the prediction of enthalpies of vaporization42 
and sublimation,43 vapor pressures of liquid and crystalline 
organic and organometallic compounds,44 and isobaric heat 
capacities.45 
The popularity of the Abraham model results from the 
model’s simplistic mathematical forms (eqns.1 and 2), 
coupled with the fact that a single set of solute descriptors 
(E, S, A, B, V and L) is used in every predictive application.  
One does not have to compute a different set of solute 
descriptors for each individual property that one wishes to 
predict.  The common mathematical form that results from 
having one set of descriptor values facilitates comparisons 
between the different solute transfer processes using either 
the Euclidean distance formula or Principal Component 
Analysis.  Such comparisons have been presented in several 
earlier publications. 
SP = cp + ep·E + sp·S + ap·A + bp·B + vp·V  (1) 
SP = ck + ek·E + sk·S + ak·A + bk·B + lk·L  (2) 
Unlike strictly empirical predictive methods the Abraham 
model is grounded on a firm understanding of molecular 
interactions.  Each term on the right-hand side of eqns. 1 and 
2 represents a different type of solute-solvent interaction 
that governs solute transfer between two condensed phases, 
eqn. (1), or solute transfer from the gas phase to a condensed 
phase, eqn. (2).  Molecular interactions are quantified in the 
Abraham model as the product of a solute descriptor times 
the complementary condensed phase/solvent property (cp, ep, 
sp, ap, bp, vp, ck, ek, sk, ak, bk, and lk).  Solute descriptors are 
identified by the uppercase alphabetic characters in eqns. (1) 
and (2), and are defined as follows: E corresponds to the 
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molar refraction of the given solute in excess of that of a 
linear alkane having a comparable molecular size, S is a 
combination of the electrostatic polarity and polarizability of 
the dissolved solute, A and B quantify the respective 
hydrogen-bond donating and hydrogen-bond accepting 
abilities of the solute, V refers to the solute’s McGowan 
molecular volume and L denotes the logarithm of the 
solute’s measured gas-to-hexadecane partition coefficient at 
298.15 K. The lowercase alphabetic characters on the right-
hand side of eqns. (1) and (2) denote the complementary 
properties of the solute transfer process, and their numerical 
values are determined through regression analysis of 
experimental partition coefficient data, molar solubility 
ratios, gas chromatographic retention factors and retention 
indices, and other measured solute properties as illustrated 
in earlier publications.28-31,46-48  Readers are referred to 
several review articles49-52 for a more detailed discussion of 
the Abraham model and its predictive applications. 
Continued development of the Abraham model requires 
determining solute descriptor values for more chemical 
compounds and developing correlation expressions for 
additional transfer processes/properties of chemical and 
biological significance.  Our recent efforts in this area have 
been to publish predictive Abraham model correlations for 
vapor pressures, enthalpies of vaporization and sublimation 
and heat capacities of organic and organometallic 
compounds.  Concurrent with developing the fore-
mentioned predictive expressions we have calculated solute 
descriptors for several high-energy nitrogen compounds,53 
several adamantane derivatives54 and approximately 300 
different monoalkylated and polymethylated linear 
alkanes.55,56 
The current communication is devoted to obtaining a 
complete set of solute descriptor values for linear C7-C14 
alkynes so that we can predict both their physical and 
thermodynamic properties.  Our private database of solute 
descriptors has numerical values of E, S, A, B and V for the 
complete set of linear C7 – C14 alkynes.  L-descriptor values, 
however, are available for only a small fraction of the C7-
C14 alkynes.  Numerical values of the E and V solute 
descriptors, listed in Table 1 were calculated based on the 
alkynes refractive index and molecular structure (atomic 
sizes and number of chemical bonds) as described 
elsewhere50-52. The S, A and B descriptors were estimated 
from known experimental-based values for non-1-yne, dec-
1-yne, dodec-1-yne, and the smaller C4-C8 alkynes for which 
a L-descriptor value is given.  The tabulated values of the L-
solute descriptors were computed from experimental 
partition coefficient data.  We note that the S, A and B 
solute descriptors of alkynes are numerically very small, and 
their contribution to the solute transfer processes defined by 
eqns. (1) and (2) are also small. The L solute descriptor, on 
the other hand, is much larger and its numerical value 
cannot be reasonably estimated by comparisons with other 
linear alkyne molecules.  We note that an earlier version of 
our private solute descriptor database is available on the 
public UFZ-LSER website57 (referenced as Abraham 
Absolv), and that the website will have numerical L solute 
descriptors values for several of the linear alkyne molecules 
whose solute descriptor values are not given in Table 1.  The 
reference given for the L-descriptor in the website is LSER 
Dataset 2017 for CompTox users.  Numerical values for the 
L solute descriptors referenced as LSER Dataset 2017 might 
be estimated values based on a derived mathematical 
correlation between other Abraham model solute descriptors 
or other estimation scheme.  The website for UFZ-LSER 
Database does have provisions for estimating solute 
descriptors from a molecule’s canonical Smiles code. Our 
past experience has been that solute descriptors obtained 
from actual experimental data provide superior predicted 
values than solute descriptors calculated entirely by 
estimation methods. 
In this study we calculate the L solute descriptors of the 
larger alkyne molecules from the published isothermal gas 
chromatographic retention index data of Rang and co-
workers.58  The authors measured the retention indices of 
linear C6-C14 alkynes on capillary columns coated with 
squalane, apiezon L, polyphenyl ether and polyethylene 
glycol 4000 stationary phases. The computational 
methodology will be the same as that used in our two recent 
papers published in this journal,55,56 which reported the 
numerical values of the L solute descriptors for 
approximately 300 large monoalkylated and polymethylated 
linear alkanes. 
CALCULATION OF ABRAHAM MODEL 
SOLUTE DESCRIPTORS  
The computational methodology that we will use to 
calculate the L solute descriptor involves establishing an 
Abraham model relationship (eqn.3): 
RI = cri + eri · E + sri · S + ari · A + bri · B + lri · L (3) 
using the measured Kovats retention indices, RI, for those 
alkane, alkene, and alkynes solutes for which we already 
have a complete set of solute descriptors.  In order to have a 
sufficient number of experimental data points to establish 
meaningful Abraham model correlations we augmented the 
retention index datasets for the squalane and apiezon L 
stationary phases with experimental values determined by 
Sojak et al.59 for linear C6-C14 alkenes on a squalane 
stationary phase, and with experimental values determined 
by Vigdergauz et al.60 and Sojak et al.61 for several 
miscellaneous organic compounds on an apiezon L 
stationary phase.  In total we had 100 and 44 experimental 
data points to use in the regression analyses for constructing 
the Abraham model correlations for the squalane and 
apiezon L stationary phases, respectively. The numerical 
values of the solute descriptors for the alkanes, alkenes and 
miscellaneous organic compounds used in constructing the 
Abraham model correlations are tabulated in Table 2. 
Numerical values of the solute descriptors for the smaller 
alkyne solutes are listed in Table 1. 
We first establish an Abraham model correlation for 
describing the retention indices of alkane, alkene and alkyne 
solutes dissolved in the squalane stationary at 110 oC using 
the experimental RI values given in Table 3. Retention 
indices of linear alkanes are defined to be 100 times the 
number of carbon atoms. Squalane (more formally named 
2,6,10,15,19,24-hexamethyltetracosane) is a saturated 
hydrocarbon, and would not be capable of hydrogen-bond 
formation (ak = 0 and bk = 0) and dipole-dipole interactions 
(sk = 0). Our published correlation1 for describing gas-to-
liquid partition coefficients into squalane at 298.15 K shows   
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Table 1.  Abraham model solute descriptors of alkynes taken from our private solute descriptor database. 
Compound E S A B Bo V L 
But-1-yne 0.178 0.250 0.120 0.100 0.100 0.5862 1.520 
But-2-yne 0.261 0.230 0.000 0.210 0.210 0.5862 1.856 
Pent-1-yne 0.172 0.230 0.120 0.120 0.120 0.7271 2.010 
Pent-2-yne 0.241 0.290 0.000 0.200 0.200 0.7271 2.236 
Hex-1-yne 0.166 0.220 0.100 0.120 0.120 0.8680 2.510 
Hex-2-yne 0.236 0.300 0.000 0.150 0.150 0.8680 2.765 
Hex-3-yne 0.224 0.300 0.000 0.150 0.150 0.8680 2.659 
Hept-1-yne 0.160 0.230 0.090 0.100 0.100 1.0089 3.000 
Hept-2-yne 0.237 0.300 0.000 0.150 0.150 1.0089  
Hept-3-yne 0.232 0.300 0.000 0.150 0.150 1.0089  
Oct-1-yne 0.155 0.220 0.090 0.100 0.100 1.1498 3.521 
Oct-2-yne 0.225 0.300 0.000 0.150 0.150 1.1498 3.850 
Oct-3-yne 0.210 0.300 0.000 0.150 0.150 1.1498  
Oct-4-yne 0.208 0.300 0.000 0.150 0.150 1.1498 3.609 
Non-1-yne 0.150 0.220 0.090 0.100 0.100 1.2907 4.019 
Non-2-yne 0.225 0.300 0.000 0.150 0.150 1.2907  
Non-3-yne 0.204 0.300 0.000 0.150 0.150 1.2907  
Non-4-yne 0.207 0.300 0.000 0.150 0.150 1.2907  
Dec-1-yne 0.143 0.220 0.090 0.100 0.100 1.4316 4.537 
Dec-2-yne 0.217 0.300 0.000 0.150 0.150 1.4316  
Dec-3-yne 0.195 0.300 0.000 0.150 0.150 1.4316  
Dec-4-yne 0.205 0.300 0.000 0.150 0.150 1.4316  
Dec-5-yne 0.193 0.300 0.000 0.150 0.150 1.4316  
Undec-1-yne 0.139 0.220 0.090 0.100 0.100 1.5725  
Undec-2-yne 0.213 0.300 0.000 0.150 0.150 1.5725  
Undec-3-yne 0.196 0.300 0.000 0.150 0.150 1.5725  
Undec-4-yne 0.196 0.300 0.000 0.150 0.150 1.5725  
Undec-5-yne 0.191 0.300 0.000 0.150 0.150 1.5725  
Dodec-1-yne 0.133 0.220 0.090 0.100 0.100 1.7134 5.657 
Dodec-2-yne 0.207 0.300 0.000 0.150 0.150 1.7134  
Dodec-3-yne 0.190 0.300 0.000 0.150 0.150 1.7134  
Dodec-4-yne 0.190 0.300 0.000 0.150 0.150 1.7134  
Dodec-5-yne 0.190 0.300 0.000 0.150 0.150 1.7134  
Dodec-6-yne 0.190 0.300 0.000 0.150 0.150 1.7134  
Tridec-1-yne 0.136 0.220 0.090 0.100 0.100 1.8543  
Tridec-2-yne 0.209 0.300 0.000 0.150 0.150 1.8543  
Tridec-3-yne 0.209 0.300 0.000 0.150 0.150 1.8543  
Tridec-4-yne 0.209 0.300 0.000 0.150 0.150 1.8543  
Tridec-5-yne 0.209 0.300 0.000 0.150 0.150 1.8543  
Tridec-6-yne 0.209 0.300 0.000 0.150 0.150 1.8543  
Tetradec-1-yne 0.144 0.220 0.090 0.100 0.100 1.9952  
Tetradec-2-yne 0.206 0.300 0.000 0.150 0.150 1.9952  
Tetradec-3-yne 0.206 0.300 0.00 0.15 0.150 1.9952  
Tetradec-4-yne 0.206 0.300 0.000 0.150 0.150 1.9952  
Tetradec-5-yne 0.206 0.300 0.000 0.150 0.150 1.9952  
Tetradec-6-yne 0.206 0.300 0.000 0.150 0.150 1.9952  
Tetradec-7-yne 0.206 0.300 0.000 0.150 0.150 1.9952  
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Table 2.  Abraham model solute descriptors for alkanes, alkenes and miscellaneous organic compounds.  
Compound E S A B L V 
Hexane 0.000 0.000 0.000 0.000 2.668 0.9540 
Heptane 0.000 0.000 0.000 0.000 3.173  1.0949 
Octane 0.000 0.000 0.000 0.000 3.677 1.2358 
Nonane 0.000 0.000 0.000 0.000 4.182 1.3767 
Decane 0.000 0.000 0.000 0.000 4.686 1.5176 
Undecane 0.000 0.000 0.000 0.000 5.191 1.6585 
Dodecane 0.000 0.000 0.000 0.000 5.696 1.7994 
Tridecane 0.000 0.000 0.000 0.000 6.200 1.9403 
Tetradecane 0.000 0.000 0.000 0.000 6.705 2.0812 
Pentadecane 0.000 0.000 0.000 0.000 7.209 2.2221 
Hexadecane 0.000 0.000 0.000 0.000 7.714 2.3630 
Heptadecane 0.000 0.000 0.000 0.000 8.218 2.5039 
Octadecane 0.000 0.000 0.000 0.000 8.722 2.6448 
Hex-1-ene 0.078 0.080 0.000 0.070 2.572 0.9110 
cis-Hex-2-ene 0.143 0.080 0.000 0.070 2.684 0.9110 
trans-Hex-2-ene 0.122 0.080 0.000 0.060 2.655 0.9110 
cis-Hex-3-ene 0.128 0.080 0.000 0.070 2.664 0.9110 
trans-Hex-3-ene 0.126 0.080 0.000 0.060 2.659 0.9110 
Hept-1-ene 0.092 0.080 0.000 0.070 3.063 1.0519 
cis-Hept-2-ene 0.136 0.080 0.000 0.070 3.210 1.0519 
trans-Hept-2-ene 0.119 0.080 0.000 0.070 3.180 1.0519 
cis-Hept-3-ene 0.130 0.080 0.000 0.070 3.143 1.0519 
trans-Hept-3-ene 0.121 0.080 0.000 0.070 3.125 1.0519 
Oct-1-ene 0.094 0.080 0.000 0.070 3.568 1.1928 
cis-Oct-2-ene 0.135 0.080 0.000 0.070 3.683 1.1928 
trans-Oct-2-ene 0.123 0.070 0.000 0.070 3.668 1.1928 
cis-Oct-3-ene 0.125 0.060 0.000 0.070 3.663 1.1928 
trans-Oct-3-ene 0.119 0.060 0.000 0.060 3.647 1.1928 
cis-Oct-4-ene 0.133 0.080 0.000 0.070 3.607 1.1928 
trans-Oct-4-ene 0.114 0.080 0.000 0.070 3.593 1.1928 
Non-1-ene 0.090 0.080 0.000 0.070 4.073 1.3337 
cis-Non-2-ene 0.136 0.060 0.000 0.060 4.245 1.3337 
trans-Non-2-ene 0.119 0.060 0.000 0.060 4.188 1.3337 
cis-Non-3-ene 0.127 0.060 0.000 0.060 4.151 1.3337 
trans-Non-3-ene 0.119 0.060 0.000 0.060 4.148 1.3337 
cis-Non-4-ene 0.132 0.060 0.000 0.060 4.173 1.3337 
trans-Non-4-ene 0.116 0.060 0.000 0.060 4.141 1.3337 
Dec-1-ene 0.093 0.080 0.000 0.070 4.533 1.4746 
cis-Dec-2-ene 0.131 0.060 0.000 0.060 4.745 1.4746 
trans-Dec-2-ene 0.118 0.060 0.000 0.060 4.670 1.4746 
cis-Dec-3-ene 0.131 0.060 0.000 0.060 4.680 1.4746 
trans-Dec-3-ene 0.118 0.060 0.000 0.060 4.671 1.4746 
cis-Dec-4-ene 0.131 0.060 0.000 0.060 4.669 1.4746 
trans-Dec-4-ene 0.115 0.060 0.000 0.060 4.638 1.4746 
cis-Dec-5-ene 0.123 0.060 0.000 0.060 4.665 1.4746 
trans-Dec-5-ene  0.112 0.060 0.000 0.060 4.637 1.4746 
Undec-1-ene 0.091 0.080 0.000 0.070 5.023 1.6155 
cis-Undec-2-ene 0.134 0.060 0.000 0.060 5.258 1.6155 
trans-Undec-2-ene 0.117 0.060 0.000 0.060 5.192 1.6155 
cis-Undec-3-ene 0.125 0.060 0.000 0.060 5.178 1.6155 
trans-Undec-3-ene 0.115 0.060 0.000 0.060 5.150 1.6155 
cis-Undec-4-ene 0.129 0.060 0.000 0.060 5.168 1.6155 
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trans-Undec-4-ene 0.111 0.060 0.000 0.060 5.138 1.6155 
cis-Undec-5-ene   0.122 0.060 0.000 0.060 5.153 1.6155 
trans-Undec-5-ene 0.095 0.060 0.000 0.060 5.126 1.6155 
Dodec-1-ene 0.089 0.080 0.000 0.070 5.515 1.7564 
cis-Dodec-2-ene 0.132 0.060 0.000 0.060 5.766 1.7564 
trans-Dodec-2-ene 0.116 0.060 0.000 0.060 5.699 1.7564 
cis-Dodec-3-ene 0.132 0.060 0.000 0.060 5.692 1.7564 
trans-Dodec-3-ene 0.115 0.060 0.000 0.060 5.656 1.7564 
cis-Dodec-4-ene 0.123 0.060 0.000 0.060 5.667 1.7564 
trans-Dodec-4-ene 0.112 0.060 0.000 0.060 5.641 1.7564 
cis-Dodec-5-ene 0.116 0.060 0.000 0.060 5.653 1.7564 
trans-Dodec-5-ene 0.092 0.060 0.000 0.060 5.636 1.7564 
cis-Dodec-6-ene 0.120 0.060 0.000 0.060 5.655 1.7564 
trans-Dodec-6-ene 0.119 0.060 0.000 0.060 5.647 1.7564 
Tridec-1-ene  0.093 0.060 0.000 0.070 6.046 1.8973 
cis-Tridec-2-ene 0.131 0.060 0.000 0.070 6.261 1.8973 
trans-Tridec-2-ene 0.115 0.060 0.000 0.070 6.249 1.8973 
cis-Tridec-3-ene 0.122 0.060 0.000 0.070 6.255 1.8973 
trans-Tridec-3-ene 0.114 0.060 0.000 0.070 6.249 1.8973 
cis-Tridec-4-ene 0.127 0.060 0.000 0.070 6.172 1.8973 
trans-Tridec-4-ene 0.111 0.060 0.000 0.070 6.142 1.8973 
cis-Tridec-5-ene 0.110 0.060 0.000 0.070 6.146 1.8973 
trans-Tridec-5-ene 0.089 0.060 0.000 0.070 6.125 1.8973 
cis-Tridec-6-ene 0.119 0.060 0.000 0.070 6.144 1.8973 
trans-Tridec-6-ene 0.117 0.060 0.000 0.070 6.144 1.8973 
Tetradec-1-ene  0.090 0.060 0.000 0.070 6.536 2.0382 
cis-Tetradec-2-ene 0.130 0.060 0.000 0.070 6.840 2.0382 
trans-Tetradec-2-ene 0.114 0.060 0.000 0.070 6.743 2.0382 
cis-Tetradec-3-ene 0.121 0.060 0.000 0.070 6.755 2.0382 
trans-Tetradec-3-ene 0.113 0.060 0.000 0.070 6.719 2.0382 
cis-Tetradec-4-ene 0.126 0.060 0.000 0.070 6.776 2.0382 
trans-Tetradec-4-ene 0.110 0.060 0.000 0.070 6.731 2.0382 
cis-Tetradec-5-ene 0.114 0.060 0.000 0.070 6.753 2.0382 
trans-Tetradec-5-ene 0.086 0.060 0.000 0.070 6.696 2.0382 
cis-Tetradec-6-ene 0.118 0.060 0.000 0.070 6.762 2.0382 
trans-Tetradec-6-ene 0.116 0.060 0.000 0.070 6.726 2.0382 
cis-Tetradec-7-ene 0.109 0.060 0.000 0.070 6.734 2.0382 
trans-Tetradec-7-ene 0.091 0.060 0.000 0.070 6.713 2.0382 
Isopropylbenzene 0.602 0.490 0.000 0.160 4.084 1.1391 
Propylbenzene 0.604 0.500 0.000 0.150 4.230 1.1391 
1,3,5-Trimethylbenzene 0.649 0.520 0.000 0.190 4.344 1.1391 
1,2,4-Trimethylbenzene 0.677 0.560 0.000 0.190 4.441 1.1391 
1-Methyl-4-isopropylbenzene 0.607 0.490 0.000 0.190 4.590 1.2800 
1,2,3-Trimethylbenzene 0.728  0.610  0.000  0.190  4.565  1.1391 
1,2-Diethylbenzene 0.688 0.500 0.000 0.180 4.732 1.2800 
1,3-Diisopropylbenzene 0.605 0.460 0.000 0.200 5.170 1.5618 
1,2,3,5-Tetramethylbenzene 0.748 0.610 0.000 0.190 5.052 1.2800 
1,4-Diisopropylbenzene 0.616 0.470 0.000 0.200 5.315 1.5618 
1-Hexanol 0.210 0.420 0.370 0.480 3.610 1.0127 
1-Nonanol 0.193  0.420  0.370  0.480  5.120  1.4354 
Pentadec-1-ene 0.083 0.060 0.000 0.070 7.008 2.1791 
Hexadec-1-ene 0.081 0.080 0.000 0.070 7.586 2.3200 
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that the squalane solvent does have a non-zero ek coefficient.  
Analysis of the RI values in Table 3 in accordance with eqn. (3) 
yielded the following Abraham model expression. 
Table 3. Retention indices, ri (at 383 K) on a squalane stationary 
phase column, and Abraham model L solute descriptors for linear 
alkanes, alkenes and alkynes.  




Hex-1-yne 5.839  2.510  2.565  
Hex-2-yne 6.384  2.765  2.864  
Hex-3-yne 6.199  2.659  2.765  
Hept-1-yne 6.842  3.000  3.084  
Hept-2-yne 7.420   3.402  
Hept-3-yne 7.158   3.265  
Oct-1-yne 7.837  3.521  3.598  
Oct-2-yne 8.418  3.850  3.916  
Oct-3-yne 8.163   3.780  
Oct-4-yne 8.103  3.609  3.749  
Non-1-yne 8.841  4.019  4.118  
Non-2-yne 9.406   4.428  
Non-3-yne 9.147   4.289  
Non-4-yne 9.097   4.264  
Dec-1-yne 9.842  4.537  4.635  
Dec-2-yne 10.408   4.946  
Dec-3-yne 10.131   4.797  
Dec-4-yne 10.068   4.767  
Dec-5-yne 10.080   4.770  
Undec-1-yne 10.842   5.152  
Undec-2-yne 11.401   5.460  
Undec-3-yne 11.124   5.312  
Undec-4-yne 11.048   5.273  
Undec-5-yne 11.043   5.269  
Dodec-1-yne 11.844  5.657  5.670  
Dodec-2-yne 12.398   5.975  
Dodec-3-yne 12.114   5.824  
Dodec-4-yne 12.033   5.782  
Dodec-5-yne 12.017   5.773  
Dodec-6-yne 12.003   5.766  
Hexane 6.000  2.668  2.609  
Heptane 7.000  3.173  3.128  
Octane 8.000  3.677  3.646  
Nonane 9.000  4.182  4.164  
Decane 10.000  4.686  4.683  
Undecane 11.000  5.191  5.201  
Dodecane 12.000  5.696  5.720  
Tridecane 13.000  6.200  6.238  
Tetradecane 14.000  6.705  6.756  
Pentadecane 15.000  7.209  7.275  
    
Hexadecane 16.000  7.714  7.793  
Heptadecane 17.000  8.218  8.312  
Octadecane 18.000  8.722  8.830  
Hex-1-ene 5.840  2.572  2.545  
cis-Hex-2-ene 6.054  2.684  2.671  
trans-Hex-2-ene 5.964  2.655  2.619  
cis-Hex-3-ene 5.937  2.664  2.607  
trans-Hex-3-ene 5.906  2.659  2.590  
Hept-1-ene 6.835  3.063  3.064  
cis-Hept-2-ene 7.051  3.210  3.186  
trans-Hept-2-ene 6.987  3.180  3.149  
cis-Hept-3-ene 6.923  3.143  3.118  
trans-Hept-3-ene 6.874  3.125  3.091  
Oct-1-ene 7.829  3.568  3.579  
cis-Oct-2-ene 8.036  3.683  3.696  
trans-Oct-2-ene 7.973  3.668  3.661  
cis-Oct-3-ene 7.902  3.663  3.625  
trans-Oct-3-ene 7.880  3.647  3.612  
cis-Oct-4-ene 7.886  3.607  3.618  
trans-Oct-4-ene 7.841  3.593  3.590  
Non-1-ene 8.828  4.073  4.096  
cis-Non-2-ene 9.026  4.245  4.210  
trans-Non-2-ene 8.966  4.188  4.175  
cis-Non-3-ene 8.881  4.151  4.133  
trans-Non-3-ene 8.865  4.148  4.122  
cis-Non-4-ene 8.860  4.173  4.123  
trans-Non-4-ene 8.844  4.141  4.111  
Dec-1-ene 9.827  4.533  4.615  
cis-Dec-2-ene 10.022  4.745  4.725  
trans-Dec-2-ene 9.966  4.670  4.693  
cis-Dec-3-ene 9.864  4.680  4.643  
trans-Dec-3-ene 9.855  4.671  4.635  
cis-Dec-4-ene 9.834  4.669  4.627  
trans-Dec-4-ene 9.827  4.638  4.620  
cis-Dec-5-ene 9.821  4.665  4.619  
trans-Dec-5-ene  9.847  4.637  4.630  
Undec-1-ene 10.826  5.023  5.132  
cis-Undec-2-ene 11.019  5.258  5.242  
trans-Undec-2-ene 10.965  5.192  5.210  
cis-Undec-3-ene 10.858  5.178  5.157  
trans-Undec-3-ene 10.853  5.150  5.152  
cis-Undec-4-ene 10.811  5.168  5.133  
trans-Undec-4-ene 10.812  5.138  5.130  
cis-Undec-5-ene   10.789  5.153  5.120  
trans-Undec-5-ene 10.820  5.126  5.130  
Dodec-1-ene 11.834  5.515  5.654  
cis-Dodec-2-ene 12.023  5.766  5.762  
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trans-Dodec-2-ene 11.969  5.699  5.731  
cis-Dodec-3-ene 11.857  5.692  5.676  
trans-Dodec-3-ene 11.852  5.656  5.670  
cis-Dodec-4-ene 11.806  5.667  5.648  
trans-Dodec-4-ene 11.811  5.641  5.648  
cis-Dodec-5-ene 11.766  5.653  5.625  
trans-Dodec-5-ene 11.811  5.636  5.643  
cis-Dodec-6-ene 11.760  5.655  5.623  
trans-Dodec-6-ene 11.801  5.647  5.644  
Tridec-1-ene  12.835  6.046  6.174  
cis-Tridec-2-ene 13.022  6.261  6.280  
trans-Tridec-2-ene 12.970  6.249  6.249  
cis-Tridec-3-ene 12.851  6.255  6.189  
trans-Tridec-3-ene 12.851  6.249  6.187  
cis-Tridec-4-ene 12.798  6.172  6.163  
trans-Tridec-4-ene 12.803  6.142  6.162  
cis-Tridec-5-ene 12.750  6.146  6.134  
trans-Tridec-5-ene 12.803  6.125  6.157  
cis-Tridec-6-ene 12.725  6.144  6.123  
trans-Tridec-6-ene 12.781  6.144  6.152  
Tetradec-1-ene  13.832  6.536  6.690  
cis-Tetradec-2-ene 14.015  6.840  6.794  
trans-Tetradec-2-ene 13.969  6.743  6.767  
cis-Tetradec-3-ene 13.841  6.755  6.702  
trans-Tetradec-3-ene 13.846  6.719  6.703  
cis-Tetradec-4-ene 13.777  6.776  6.670  
trans-Tetradec-4-ene 13.793  6.731  6.675  
cis-Tetradec-5-ene 13.720  6.753  6.638  
trans-Tetradec-5-ene 13.784  6.696  6.664  
cis-Tetradec-6-ene 13.686  6.762  6.621  
trans-Tetradec-6-ene 13.757  6.726  6.657  
cis-Tetradec-7-ene 13.667  6.734  6.609  
trans-Tetradec-7-ene 13.745  6.713  6.645  
 
RI/100 = 0.967(0.058) – 0.458(0.245) E + 1.929(0.008) L 
            (4) 
(N = 100, SD = 0.111, R2 = 0.998, F = 30284)  
where N is the number of experimental data points, SD is the 
standard deviation, R2 is the squared correlation coefficient, 
and F is the Fisher F-statistic. Standard errors in the 
equation coefficients are given in parentheses immediately 
following the respective coefficient.   
We first establish Equation (4) provides a reasonably 
accurate mathematical description of the gas 
chromatographic elution behaviour of the 100 alkane, alkene 
and alkyne solutes on the squalane stationary phase.  
Through suitable mathematical rearrangement of eqn. (4) 
 
L = [(RI/100) – 0.967 + 0.458 E]/1.929   (5) 
one can calculate the L solute descriptors of the remaining 
20 C7-C12 alkynes for which RI values are available on a 
squalane stationary phase. The numerical values of our 
calculated L solute descriptors are given in the last column 
of Table 3.  The average error and average absolute error 
between the L values in our database and those calculated 
based on eqn. (5) are AE = -0.001 and AAE = 0.043, 
respectively. We do note that the tabulated numerical values 
of the L solute descriptor based on eqn. (5) differ somewhat 
from the numerical values given UFZ-LSER Database57 that 
are referenced to LSER Dataset 2017. 
Rang and coworkders58 also determined the isothermal 
Kovats retention indices of linear C7-C14 alkynes on 
capillary columns coated with apiezon L, polyphenyl ether 
and polyethylene glycol 4000 stationary phases at elevated 
temperatures.  Of particular interest are the chromatographic 
measurements for the linear tridecynes and tetradecynes for 
which we do not have numerical values of the L solute 
descriptors.  A search of the published chemical and 
engineering literature found Kovats retention indices60,61 for 
isopropylbenzene, propylbenzene, 1,3,5-trimethylbenzene, 
1,2,4-trimethylbenzene, 1-methyl-4-isopropylbenzene, 
1,2,3-trimethylbenzene, 1-hexanol, 1,2-diethylbenzene, 1,3-
diisopropylbenzene, 1,2,3,5-tetramethylbenzene, 1,4-
diisopropylbenzene, 1-pentadecene, 1-hexadecene, 1-
heptadecene, and 1-nonanol on an apieizon L stationary 
phase column at 423 K.  Including the retention index data 
of Rang et al.58 for the linear decynes, undecynes and 
dodecynes for which we just computed L solute descriptors 
(see Table 3), there are 44 experimental data points to use in 
constructing an Abraham model correlation.  This should be 
sufficient to develop a meaningful Abraham model 
correlation for describing the retention behaviour of organic 
compounds on an apiezon L stationary phase. It takes 
between 30 to 40 experimental values to develop an 
Abraham model correlation. 
Analysis of the experimental data in the second column of 
Table 4 yielded the following Abraham model expression: 
 
RI/100 = 0.686(0.066) + 2.788(0.161) E – 2.011(0.199) S 
+2.115(0.197) A + 1.988(0.011) L   (6) 
(N = 44, SD = 0.088, R2 = 0.999, F = 9996) 
Preliminary analysis showed that the bk · B term made a 
negligible contribution to the RI/100 calculation (with sk 
being –0.029) and this term was removed from the final 
regression. Eqn. (6) provides a reasonably accurate 
mathematical description of the observed gas 
chromatographic elution behavior of the 44 organic solutes 
on the apiezon stationary phase.   
 
L = [(RI/100) – 0.686 – 2.788 E + 2.011 S – 2.115 A]/1.988 
          (7) 
Through suitable mathematical rearrangement of eqn. (6), 
one can calculate the L solute descriptors of the linear 
tridecynes and tetradecynes for which RI values are 
available on an apiezon stationary phase. The numerical 
values of our calculated L solute descriptors are given in the 
last column of Table 4. The average error and average 
absolute error between the L values in our database and 
those calculated based on eqn. (5) are AE = 0.001 and AAE 
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= 0.026, respectively. Solute descriptors for the linear 
tridecynes and tetradecynes are contained in the UFZ-LSER 
Database, however, numerical values can be estimated based 
on the molecule’s canonical Smiles code.  We were not able 
to find sufficient RI data for solutes eluted from polyphenyl 
ether and polyethylene glycol 4000 stationary phases to 
develop Abraham model correlations. 
Table 4.  Retention indices, RI (at 423 K) on an Apiezon L phase 
column, and Abraham model L solute descriptors for linear alkanes, 
linear alkynes and miscellaneous organic compounds used in the 
construction of eqn. (7). 




Dec-1-yne 9.972  4.537 4.597 
Dec-2-yne 10.506  4.946 4.939 
Dec-3-yne 10.174  4.797 4.803 
Dec-4-yne 10.108  4.767 4.755 
Dec-5-yne 10.129  4.770 4.783 
Undec-1-yne 10.952  5.152 5.096 
Undec-2-yne 11.508  5.460 5.448 
Undec-3-yne 11.169  5.312 5.302 
Undec-4-yne 11.099  5.273 5.267 
Undec-5-yne 11.092  5.269 5.270 
Dodec-1-yne 11.952  5.657 5.607 
Dodec-2-yne 12.505  5.975 5.958 
Dodec-3-yne 12.164  5.824 5.811 
Dodec-4-yne 12.086  5.782 5.771 
Dodec-5-yne 12.074  5.773 5.765 
Dodec-6-yne 12.060  5.766 5.758 
Tridec-1-yne 12.955   6.108 
Tridec-2-yne 13.506   6.459 
Tridec-3-yne 13.158   6.284 
Tridec-4-yne 13.071   6.240 
Tridec-5-yne 13.055   6.232 
Tridec-6-yne 13.026   6.218 
Tetradec-1-yne 13.957   6.600 
Tetradec-2-yne 14.507   6.967 
Tetradec-3-yne 14.149   6.787 
Tetradec-4-yne 14.069   6.746 
Tetradec-5-yne 14.039   6.731 
Tetradec-6-yne 14.011   6.717 
Tetradec-7-yne 14.002   6.713 
Hexane 6.000  2.668 2.673 
Heptane 7.000  3.173 3.176 
Octane 8.000  3.677 3.679 
Nonane 9.000  4.182 4.182 
Decane 10.000  4.686 4.685 
Undecane 11.000  5.191 5.188 
Dodecane 12.000  5.696 5.691 
Tridecane 13.000  6.200 6.194 
Tetradecane 14.000  6.705 6.697 
Pentadecane 15.000  7.209 7.200 
Hexadecane 16.000  7.714 7.703 
Heptadecane 17.000  8.218 8.206 
Octadecane 18.000  8.722 8.709 
Isopropylbenzene 9.550  4.084 4.110 
Propylbenzene 9.860  4.230 4.273 
1,3,5-Trimethylbenzene 10.127  4.344 4.365 
1,2,4-Trimethylbenzene 10.370  4.441 4.488 
1-Methyl-4-
isopropylbenzene 10.540  4.590 4.601 
1,2,3-Trimethylbenzene 10.701  4.565 4.634 
1,2-Diethylbenzene 10.870  4.732 4.664 
1,3-Diisopropylbenzene 11.440  5.170 5.026 
1,2,3,5-
Tetramethylbenzene 11.690  5.052 5.103 
1,4-Diisopropylbenzene 11.880  5.315 5.242 
Hexan-1-ol 8.420  3.610 3.627 
Nonan-1-ol 11.360  5.120 5.130 
Pentadec-1-ene 14.888  7.008 7.088 
Hexadec-1-ene 15.881  7.586 7.611 
Heptadec-1-ene 16.876  8.031 8.113 
aSolute descriptors for heptadec-1-ene are: E = 0.080; S = 0.080; A 
= 0.000; B = 0.080; V = 2.4609; and L = 8.031 
PREDICTION OF MOLAR ENTHALPIES OF 
VAPORIZATONI OF LINEAR ALKYNES 
Now that we have calculated the L solute descriptors of 
C7-C14 linear alkynes we wish to illustrate how the 
numerical values can be used by the scientific community 
and manufacturing sector to predict unmeasured physical 
and chemical properties.  Of the properties for which we 
have reported Abraham model correlations enthalpies of 
vaporization seem the most logical choice for the linear 
alkynes.  Large alkynes have very limited solubility in water. 
The likelihood that the scientific community will want to 
predict the compounds’ water-to-organic solvents and lethal 
molar concentrations towards aquatic organisms is small.  
Even if large alkynes were to be accidentally released in the 
environment their aqueous molar concentration would be 
too small to do significant harm to fish and other aquatic 
organisms.  Large alkynes are not medicinal compounds and 
there is little demand in the pharmaceutical community to 
estimate their distribution in the body.   
Knowledge of gas chromatographic Kovats retention 
indices of linear alkynes would aid practical analytical 
chemists in selecting an appropriate stationary phase to 
separate alkynes from other hydrocarbons that might be 
present in petroleum-based samples. These calculations are 
essentially the reverse of the calculations that we just 
employed in calculating the L-solute descriptors.  There 
would not be much in the way of new information by 
performing more repetitive-like calculations.  After 
considerable thought we decided to illustrate the practical 
applications by predicting enthalpies of vaporization as 
these quantities might be needed in the design of high 
temperature industrial processes.  Enthalpies of vaporization 
describe how the vapor pressure of a compound varies with 
temperature. 
Our published Abraham model correlation42 (eqn. 8) 
 
∆Hvap,298K (kJ mol-1) = 6.100 – 7.363 E + 9.733 S + 4.025 A 
+ 2.123 B + 9.537 L – 1.180 S S + 77.871 A B  –5.781 
Iamine –  14.783 Inon-α,ω-diol – 17.873 Iα,ω-diol   (8) 
(with N = 703, SD = 2.09, R2 = 0.986, F = 4925.6)  
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provides reasonably accurate predictions of the standard 
molar enthalpies of vaporization, ∆Hvap,298K, as evidence by 
the correlation’s standard deviations of SD = 2.09 kJ mol-1, 
which is slightly larger than the experimental uncertainty 
associated with the measured ∆Hvap,298K, values.  For the 
linear C7-C14 alkynes considered in the current study only 
the first eight terms on the right-hand side of eqn. (8) 
contribute to the calculations.  The last three terms in eqn. 
(8) pertain to organic compounds having amino- and 
hydroxyl-functional groups.  Results of our ∆Hvap,298K 
predictions are reported in the second column of Table 5. 
Table 5.  Comparison of the Enthalpies of Vaporization, ∆Hvap,298K 
(kJ mol-1), Predicted by the Abraham Model, eqn. (8), and the 





Hept-2-yne 39.93 40.23 
Hept-3-yne 38.66 40.23 
Oct-3-yne 43.74 44.81 
Non-2-yne 49.81 49.39 
Non-3-yne 48.63 49.39 
Non-4-yne 48.37 49.39 
Dec-2-yne 54.80 53.97 
Dec-3-yne 53.54 53.97 
Dec-4-yne 53.18 53.97 
Dec-5-yne 53.30 53.97 
Undec-1-yne 57.57 56.52 
Undec-2-yne 59.73 58.55 
Undec-3-yne 58.45 58.55 
Undec-4-yne 58.07 58.55 
Undec-5-yne 58.07 58.55 
Dodec-2-yne 64.69 63.12 
Dodec-3-yne 63.37 63.12 
Dodec-4-yne 62.97 63.12 
Dodec-5-yne 62.89 63.12 
Dodec-6-yne 62.83 63.12 
Tridec-1-yne 66.71 65.68 
Tridec-2-yne 69.29 67.71 
Tridec-3-yne 67.62 67.71 
Tridec-4-yne 67.20 67.71 
Tridec-5-yne 57.13 67.71 
Tridec-6-yne 66.99 67.71 
Tetradec-1-yne 71.34 70.26 
Tetradec-2-yne 74.16 72.29 
Tetradec-3-yne 72.44 72.29 
Tetradec-4-yne 72.05 72.29 
Tetradec-5-yne 71.91 72.29 




We were unable to find experimental ∆Hvap,298K data in the 
published chemical literature to compare our calculated 
values against.  What we offer in the way of a comparison is 
to compare our calculated values against the calculated 
values of a popular group-additivity method proposed by 
Naef and Acree62 that has been shown to predict ∆Hvap,298K 
values for a wide range of organic and organometallic 
compounds to within a standard deviation of SD = 4.30 kJ 
mol-1 for 3,460 compounds.  The basic method sums the 
contributions that each atomic group makes to the given 




where Ai is the number of occurrences of the ith atom group, 
Bj is the number of times each special group occurs, ai and bj 
are the numerical values of each atom group and special 
group, and C is a constant. 
The atom group-additivity method, proposed by Naef and 
Acree,62 fragments linear alkyne molecules into two types of 
sp hybridized carbon atoms and two types of sp3 hybridized 
carbon atoms.  Each carbon atom type is based on the 
number of each type of atoms bonded to the carbon atom.  
One of the so carbon atom-groups will be bonded to one 
hydrogen atom (HC#) and the second carbon atom type will 
be bonded to zero hydrogen atoms (CC#).  The symbol “#” 
was used by Naef and Acree to denote a carbon-carbon atom 
triple bond.  In the case of the sp3 hybridized carbon atoms 
one carbon atom is bonded to three hydrogen atoms and one 
carbon atom (CH3 group), and the second carbon atom type 
is bonded to two hydrogen atoms and two carbon atoms 
(CH2 group). There is also one special group that is defined 
as the number of carbon atoms in the unsaturated 
hydrocarbon molecule.   
In eqn. (10) below we have filled in the numerical group 
values and constants for predicting ∆Hvap,298K of linear 
alkynes: 
∆Hvap,298K (kJ mol-1) = 3.07 nCH3 + 4.67 nCH2 + 2.42 nHC#  
+ 6.05 nCC# – 0.09 ncarbon unsat + 8.61   (10) 
Examination of the numerical entries in the last two 
columns of Table 5 reveals that the predictions based on the 
Abraham model are similar to predictions based on the 
group-additivity model of Naef and Acree.61  Except for the 
1-alkynes the group-additivity method though is not able to 
distinguish between the placement of the triple bond in the 
molecule, and gives the same predicted values for a given 
molecular formula.  In other words, the predicted values of 
all 2-tetradecyne through 7-tetradecyne molecules are the 
same. The group additivity model also does not distinguish 
between “cis” and ‘trans” isomers.  This limitation is a 
common feature of most group-additivity and group 
contribution methods.  The Abraham model, on the other 
hand, would provide different predicted values for the 
different alkyne isomers, and does not require fragmentation 
of the molecule into atom groups or functional groups. 
Fragmentation of molecules into functional groups can be 
difficult at times, particularly in the case of more complex 
molecules having many different functional groups.  
i i j j
i j
Aa B b+ +∑ ∑Property = constant
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CONCLUSION 
Numerical values of the Abraham model L solute 
descriptor have been reported for the first time for 33 linear 
C7-C14 alkynes. The numerical values were determined by 
regression analysis of published isothermal gas 
chromatographic retention indices on squalane and apiezon 
L stationary phases. Calculated L solute descriptors 
completed our set of solute descriptors for linear C7-C14 
alkynes.  Prior to this study our private database of 
descriptor values contained only the E, S, A, B and V solute 
descriptors for these 33 alkyne molecules.  Solute 
descriptors were used to predict the standard molar 
enthalpies of vaporization based on a previously published 
Abraham model correlation.42 The predicted values compare 
very favourably with calculated values based on an atom-
group additivity model.62 Unlike the additivity model the 
Abraham model provides different predicted values of 
∆Hvap,298K for each linear alkyne isomer that structurally 
differ from each other by the placement of the triple bond in 
the molecule.   
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ELEMENTS, ALKALOIDS AND ANTIOXIDANT VALUE OF 
CHELIDONIUM MAJUS L. AND THE EXTRACTS OBTAINED BY 
DIFFERENT EXTRACTION METHODS 
Klára Szentmihályi,[a]* Ilona Szőllősi-Varga[b] and Mária Then[c] 
 
Keywords: Chelidonium majus L., alkaloids, flavonoids, metal ions, antioxidant value, supercritical fluid extraction. 
The active components of Chelidonium majus (greater celandine) is based on its sensitive and effective biologically active agents. The 
active components of greater celandine extracts and, therefore, their usability depends on the extraction methods. This project was to 
evaluate and compare the components in the extracts obtained by different new and traditional extraction methods. The extracts were 
obtained by aqueous and alcoholic extraction, supercritical fluid extraction, pressing-centrifugation method, microwave extraction and were 
examined for alkaloids, elements, and antioxidant activity. The rhizome has the highest tannin, polyphenol, and alkaloid content, while 
aerial parts of the plant show the highest flavonoid contents and antioxidant activities. The extracts also contain metal ions contributing to 
the favourable therapeutic effects that can be mainly Cu, Fe, Mn, Cr, and Zn. The traditional pressed extracts rich in alkaloids confirm their 
usage for the treatment of warts and these extracts also contain Cu and Fe in concentrations that are effective against viruses. 
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INTRODUCTION 
Greater celandine (Chelidonium majus L., Figure 1) is a 
member of the Papaveraceae family. Alkaloid rich orange-
colored latex flows out from broken stems and roots. The 
dried latex is available in the herb-trade or its products in 
pharmacies for internal and external use and in cosmetic 
shops for external use.1 This proves the increasing use of the 









Figure 1. Rhizome and flowering plant of Chelidonium majus L. 
Greater celandine is found in the vicinity of human 
habitations as a weed. It grows wild in the whole of Europe 
and almost everywhere in Asia and today, even in North 
America as well. Besides effective bioactive alkaloid 
components (coptisine, chelidonine, chelerythrine, 
sanguinarine, berberine, protropine, etc.), greater celandine 
contains flavonoids, chelidonine acid, resin, fruit acids 
(malic acid, citric acid, tartaric acid), vitamin C, volatile oil 
and metals as well.2,3 The main use of greater celandine is 
externally against warts and corns, internally for healing 
liver and gallbladder diseases.4 Bioactive components of the 
plant extracts have wide range effects as they have 
antioxidant, spasmolytic, anti-inflammatory, antimicrobial, 
antiviral, antifungal, antitumor activity and cytotoxic 
properties.5-9 
Folk medicine indicates the antiviral activity of fresh 
plants and mainly to its alkaloids in freshly flowing out latex, 
which is used externally.10,11 But after drying it, the latex  
loses its effective compound, which is responsible for the 
killing of warts. Other microbiological effects of the latex 
still remain that is why it becomes an important effective 
substance of the tooth-paste and the mouth-wash as well.12,13  
For internal use of the medicinal drugs, the most often 
applied method is the tea making against gall bladder and 
liver problems. Nevertheless, other extraction methods are 
also applied, e.g., tinture. In the case of greater celandine 
pressing method for obtaining fresh latex with sensitive 
quaternary nitrogen agent content is the traditional 
extraction. Since the main bioactive components of greater 
celandine can change and their concentrations decrease with 
time, we examined different technological methods to study 
and get extracts of same or similar bioactive agent content 
as present in fresh plant or pressed latex. The metal elements 
are also found in the plant and extracts. These elements 
supposed to contribute to the favorable therapeutic effect. 
Therefore, the metal ion concentration in the drug and some 
extracts were measured as well to detect the soluble element. 
Antioxidant activity is connected to the polyphenolic 
compounds such as flavonoids.14 Although there is no 
positive correlation between them in all cases, the higher 
antioxidant activity always implies a higher content of 
antioxidant type compound. 
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The primary objective was to study the C. majus L latex 
and different extracts for organic and inorganic agents as 
well as for antioxidant activity. A further objective was to 
compare and evaluate the measured parameters in different 
parts of the plant and extracts critically in the view of the 
main indication field. 
MATERIALS AND METHODS 
The samples studied were greater celandine plants freshly 
collected from the Botanical Garden of Budapest in the 
flowering state in May. After identification of the plant, a 
sample was placed in the plant warehouse of the Institute of 
Pharmacognosy (213/07). All kinds of measurement and 
extract were made from the fresh plant right away after 
collection except the element content determination for 
which the samples were dried (Sample numbers: 778-780). 
For the supercritical fluid extraction (SFE), the solvent 
was technical grade carbon dioxide obtained from Répcelak 
Gas Trade (Hungary). Alcohol (96 %), propylene glycol 
solvents, nitric acid (37 %), hydrogen peroxide (30 %) were 
high purity grade and were purchased from Reanal Ltd 
(Budapest, Hungary). Chelidonine was purchased from 
Merck Ltd (Germany) while berberine obtained from 
Sigma-Aldrich (Hungary). High purity water (18.3 MΩ.cm) 
was made by Millipore equipment (Merck Ltd). 
ICP multi-element standards (CPAchem Ltd; Stara Zagora, 
Bulgaria) were used as standard solutions. 
Preparation of extracts 
The aqueous extract was made from 6 g plant sample with 
100 mL of deionized boiling water. After standing 24 h, it 
was filtered.  
For the pressed method, a fresh plant (100 g) was pressed 
with a pressing machine obtaining 17.6 g latex (Sample 
number: SB.CH-12/5). 
For the pressed with water method, fresh plant (53.28 g) 
was pressed with seizing fluid of water and centrifuged, 
obtaining 37.52 g filtrate (Sample number: SB.H-12/6).  
Alcoholic extract was made from 5 g sample with 100 mL 
of alcohol (96 %). The suspension was kept for 3 days. Then 
it was filtered (Sample number: TM.CH-A/96). 
SFE with water, propylene glycol and alcohol was made 
in a high-pressure flow-up stream extraction system 
(University of Veszprém) similarly, as was published earlier. 
Nevertheless, some parameters (e.g., temperature) and plant 
to solvent ratio are different.15,16 SFE with water was made 
from 62.5 g fresh wet plant with 237 g of carbon dioxide at 
35 oC and 250 bar. The extract (6.5882 g, 10.54 %) was 
received in 100 mL of water (Sample number: IV-62). SFE 
with propylene glycol was prepared from 97.65 g plant with 
198 g carbon dioxide in the first step obtaining 6.55 g 
extract (6.71 %). At the second step, the plant residue was 
extracted once more with 280 g carbon dioxide and 51.50 g 
propylene glycol. The cumulated extract was 25.99 g 
solution (Sample number: IV-63). SFE with alcohol (96 %) 
was prepared from 31.48 g plant with 290 g of carbon 
dioxide in the first step. The extract yield was 1.8478 g 
(5.87 %). After this, the residue was extracted again with 96 
g carbon dioxide and 10.90 g alcohol. The cumulated extract 
was 8.59 g solution (Sample number: IV-61).  
Microwave extraction was carried out in a MarsX 
apparatus. The fresh plant (1 g) was extracted in 10 mL of 
deionized water at 100 oC for 3x3 min. with 500 W (Sample 
number: MW.CH-32). 
The amount of fresh plant used for different extraction 
methods, and the gained extracts are summarized in Table 1. 
The extracts are stable for a long time in the refrigerator. 
Table 1. Amount of initial greater celandine and the gained 
extracts. 




Tea 6 100 mL 
Pressed latex 100 17.6 g 
Pressed latex with 
water 
53.28 37.52 g 
Alcoholic (96 %) 5 100 mL 
SFE with water 62.5 100 mL 
SFE with propylene 
glycol 
97.65 25.99 g 
SFE with alcohol 31.48 1.85 g 
Microwave with water 1 10 mL 
Measurements of organic compounds  
Total flavonoid content was measured by 
spectrophotometry at 420 nm according to the German 
Pharmacopoeia (DAB10), after formation aluminum 
complex .17,18 
The polyphenol content was measured by 
spectrophotometry according to the Singleton and Rossi 
method.19 The absorbance of the samples was read at 760 
nm with a Hitachi U-2000 spectrophotometer. Three parallel 
measurements of each sample were made against a blank 
that was prepared under the same conditions as the samples. 
Gallic acid was used as a reference solution, and the results 
were expressed in gallic acid equivalent. Tannic acid content 
was determined according to the description of Hungarian 
Pharmacopoeia (Ph.Hg.VIII.).20 
Total alkaloid content was determined by spectrometry at 
570 nm after complex formation with chromotropic acid 
according to the guideline of the German Pharmacopoeia 
(DAB10), and it was expressed in chelidonine content.18 
This method is official in the Hungarian Pharmacopoeia and 
the European Pharmacopoeia (Ph. Eur. 5) as well.20,21 
Alkaloid components from the samples were determined 
by thin-layer chromatographic techniques with densitometry 
after extraction with methanol since this is an appropriate 
method for celandrine alkaloids nowadays as well.22 
Separation of coptisine and berberine from the other 
alkaloids, then the measurement of the samples was 
performed on precoated silicagel (Kieselgel60 F254).  
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Table 2. Bioactive agent content and ± standard deviation (%, g 100 g-1, n=3) in the plant parts of fresh greater celandine. 
Part Flavonoid Tannin Polyphenol Alkaloid  
     
Rhizome 0.120±0.008 9.21±0.12 15.90±0.96 1.98±0.020 
Stem 0.278±0.005 6.25±0.21 11.99±0.58 0.582±0.110 
Leaf 0.404±0.008 6.54±0.16 13.38±0.45 0.691±0.025 
Herb 0.392±0.004 6.26±0.27 11.71±0.39 1.85 ±0.02 
 
Table 3. Amount of alkaloid components with ± standard deviation (%, g 100 g-1, n=3) in the plant parts of fresh greater celandine. 
Part Berberine, % Coptisine, % Chelidonine, % 
Rhizome 0.024±0.004 0.072±0.004 1.28±0.02 
Stem 0.012±0.002 0.063±0.003 0.45±0.03 
Leaf 0.065±0.004 0.021±.0.001 0.52±0.03 
Herb 0.0024±0.0003 0.023±0.010 0.44±0.02 
 
Eluent was 1-propanol, formic acid and water (90:1:9) 
recommended by Wagner and  Bladt.23 The standard was 
1 % solution of chelidonine and berberine. For the 
quantitative examination, the extent of the spot was 
measured by the densitometer (Shimadzu 169). Other 
alkaloid content (coptisine) was expressed in chelidonine 
content. 
Measurements of inorganic elements  
The concentration of elements in samples was determined 
by inductively coupled plasma optical emission 
spectrometry (ICP-OES). The instrument was Spectro 
Genesis ICP-OES (Kleve, Germany). The plant samples 
were digested in an open digestion system with a mixture of 
HNO3 (5 mL) and H2O2 (2 mL) then made up to 25 mL with 
deionized water.24 In the case of extracts, the solvents were 
evaporated first, then it was digested as the plant samples. 
Three parallel solutions were made from each sample and 
the measurements for the micro- and macroelement (Al, B, 
Ba, Ca, Cd, Cr, Co, Cu, Fe, Hg, K, Li, Mg, Mn, Mo, Na, Ni, 
P, Pb, S, Ti, V, Zn) were performed three times. The 
elements whose concentrations were below the detection 
limit in all samples were omitted from the tables.    
Antioxidant value by FRAP method 
The FRAP (the ferric reducing ability of plants) 
measurement was carried out by the following modified 
Benzie and Strain method.25 Blank is FRAP reagent, the 
sample is 1.5 mL FRAP reagent and 50 μL sample solution 
then monitoring at 593 nm up to 5 min in 1 cm light path at 
37 oC. An aqueous solution of known FeSO4.7H2O was used 
for calibration, and the result was calculated according to 
the calibration curve.26 For measuring of the samples, 
extractions were made from 1.5 g powdered dry latex with 
200 mL of water. After standing at room temperature for 30 
min, it was filtered than measured with FRAP reagent.27,28 
The extracts were measured with FRAP reagent. The 
antioxidant values of samples expressed in µmol L-1, since 
they refer to the solutions made. 
FRAP reagent: The reagent solution contains 25 mL 
acetate buffer (300 mmol L-1, pH 3.6; 3.1 g sodium acetate 
trihydrate and 16 mL acetic acid in 1000 mL distilled water), 
2.5 mL TPTZ solution (10 mmol/l 2,4,6-tripyridyl-S-triazine 
in 40 mmol L-1 HCl ) and 2.5 mL FeCl3.6H2O solution (20 
mmol L-1 FeCl3.6H2O in distilled water).  
Statistical analyses 
The calculations of means and standard deviation as well 
as the statistical analysis were performed using Microsoft 
Office Excel 2016 and Statistica 7 (StatSoft Inc., Tulsa. 
USA) software. A significant difference was set at P<0.05. 
RESULTS AND DISCUSSION 
Organic agents of greater celandine drug 
According to the officially accepted spectroscopic 
determination of the total active substance content, greater 
celandine has significant active substance content (Table 2). 
Greater celandine is a plant with valuable active ingredients, 
flavonoids, alkaloids, polyphenols, and tannins. The tannin, 
polyphenol, and alkaloid content of the rhizome is 
particularly outstanding, which is significantly (P<0.05) 
higher than that of the other parts of the plant. Flavonoids, 
on the other hand, were found to be significantly higher 
(P<0.05) amounts in the leaf and herb, although they were 
not in extremely high concentrations (Table 2). The highest 
alkaloid content is accumulated in the rhizome, but it is also 
significant in the other parts of the plant. Although the plant 
is of alkaloid content mainly, the tannin and polyphenol 
contents in all parts are outstanding also and according to 
the correlation calculation, the tannin content (Table 2) is a 
significant positive correlation with the polyphenol content 
(R=0.955, P<0.05).  The active agents in the plant and plant 
parts of greater celandine are in good accordance with the 
data in the literature,29,30 and the highest alkaloid content 
was measured in the rhizome that is not surprising. 
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The amount of alkaloid components was determined by 
HPLC and densitometry. The results showed that 
chelidonine is the major alkaloid component, whereas 
coptisine is present in smaller amounts (Table 3). The 
alkaloid composition also varies according to the plant parts, 
but the main alkaloid chelidonine is present in all parts of 
the plant. The amount of alkaloid components was 
correlated well with the results obtained by HPLC31 and is in 
good agreement with earlier data in the literature.32 
Elements in greater celandine drug 
The element content in the parts of greater celandine is 
represented in Table 4. The concentration of most elements 
is in the order of average plant concentration. An exception 
to this is that the concentration of Al, Cr, Fe, and Ti in 
rhizome is high.  
There are significant differences (P<0.05) between most 
of the element content (Al, B, Ba, Ca, Cu, Fe, Mg, Mn, Ti, 
and Zn) in the plant parts of greater celandine. The highest 
Al, Fe, and Ti concentration is found in the rhizome. The 
stem accumulates B, K, and P to the greatest extent. The leaf 
contains the highest amount of Ba, Ca, Cr, Cu, Mg, Na, S, 
and Zn, while the herb is rich in Mn. The stem contains 
most elements (Ba, Ca, Cr, Cu, Fe, Mg, Mn, Na, S, Ti, Zn) 
in the lowest concentration compared to the other parts of 
the plant (Table 4). The results for rhizome and herb are 
similar to those that we get in an earlier experiment for 
plants obtained from different places and years.3 
Table 4. Element content ± standard deviation (µg g-1 of dry 
weight, n=3) in the dried plant parts of greater celandine.  
Element Rhizome Stem Leaf Herb   
   Al 1054±13 260.7±5.0 195.8±5.6 184.1±2.7 
B 22.69±0.32 71.81±0.66 29.10±4.41 19.92±0.52 
Ba 21.82±0.47 8.32±0.06 22.02±0.16 16.61±0.16 
Ca 15540±39 4785±12 22690±96 11723±72 
Cr 2.04±0.48 0.593±0.428 2.22±0.19 2.01±0.18 
Cu 17.56±0.21 12.12±0.15 19.83±0.42 13.34±0.21 
Fe 814.7±14.8 77.55±1.92 234.0±2.2 216.2±1.7 
K 36828±610 52346±1136 38369±504 32285±161 
Li 0.864±0.360 < dl < dl < dl 
Mg 1821±56 836.3±10.2 2132±57 1729±29 
Mn 27.57±0.47 9.64±0.10 16.86±0.26 42.60±5.01 
Na 297.9±4.6 218.1±4.5 522.1±10.7 298.8±2.0 
P 3514±31 4911±60 3557±44 3887±515 
Pb 1.86±0.43 < dl 1.56±0.79 < dl 
S 1405±32 893.4±10.3 2006±7 1478±10 
Ti 18.23±1.98 2.99±0.06 5.69±0.29 4.99±0.62 
Zn 31.04±0.22 27.85±0.46 52.64±0.78 45.53±0.14 
<dl  under detection limit 
The element content in the parts of greater celandine is 
similar to the average plant concentration except in the case 
of Al, Cr, Fe and Ti where the concentration of rhizome is 
high compared to the average plant concentration (< 200 µg 
g-1, < 1 µg g-1, < 30 µg g-1, < 10 µg g-1, respectively. The Cr 
and Fe concentrations of leaf and herb are also high, and the 
concentration of Ca and S in the stem is less than the 
average plant concentration (10-30000 µg g-1 and 1000-5000 
µg g-1, respectively).33 The combined high concentrations of 
Al, Cr, Fe, and Ti in the rhizome indicate soil contamination, 
suggesting that the soil was not properly washed out of the 
sample.34 The partly parallel change of these elements is 
signed by the positive correlation of Al-Fe, Al-Ti, and Fe-Ti 
(R=0.957, 0.971 and 0.998, P<0.05). 
The coptisine content showed a tight correlation with the 
Cr, Cu, and Mg content in the drug (-0.989; 0.976 and -
0.972; P<0.05). This is confirmed by other analytical 
measurements and mathematical calculations35 that the 
alkaloid metabolism is regulated by some elements, for 
example, Mg, Cr and Zn. 
Antioxidant activity of greater celandine drug 
The antioxidant activity of the plant parts is shown in 
Table 5. The highest antioxidant value is connected to the 
leaf, and the lower ones are to the rhizome. There are a lot 
of compounds with antioxidant properties in the plant, such 
as vitamin C, vitamine E, flavonoids, carotenoids, 
polyphenols.36 Better antioxidant value can be connected, 
for example, to the extracts or antioxidants with higher 
flavonoid (e.g., quercetin or rutin) and polyphenol content.14 
Leaves with the highest flavonoid content (Table 2) showed 
the highest antioxidant value, while the rhizome the least. 
Nevertheless, according to the correlation calculation, the 
antioxidant value is not correlated with the flavonoid or 
polyphenol content, rather a positive correlation was found 
with Zn content (R=0.979) at P<0.05. Zn is also of 
antioxidant property,37 but the clear connection of the 
antioxidant value of greater celandine with its Zn content 
needs more data and further examinations. 
Table 5. Antioxidant activity of the plant parts of dried greater 
celandine measured by FRAP method. 







Organic agents in the greater celandine extracts  
Although the rhizome contains the highest amount of 
alkaloids, the aerial part of the plant also has a significant 
amount of it, and the herb is more easily collected and does 
not contain higher concentrations of unwanted elements 
from soil. Therefore the herb of the plant was used for 
extraction. 
The dry material and total alkaloid content of the extracts 
are presented in Table 6. Here it can be seen the differences 
that give more information for extraction as a method. The 
highest dry material and alkaloid content can be connected 
to the pressed latex, while the other extracts have similar but 
lower dry material content. Since the dry material content 
greatly depends on the amount of solvent as well, the yield 
of dry material may show more relevant information about 
the organic components of the extracts. According to this, 
the tea and alcoholic extract contain the highest amount of 
organic agents (20.18 and 20.24 %, respectively) followed 
by microwave extraction with water (9.88 %).  
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Table 6. Dry material content (%, w V-1, n=3) in the greater celandine extracts, as well as the yields of dry material and alkaloids (wt. %, g 
100 g-1). 
 Method Dry material content,  g in 100 mL 
The yield of dry 
material, wt. % 
Total alkaloid content, %, g 
chelidonine 100 mL-1 extract 
Yield of 
alkaloid, wt. % 
Tea 1.211±0.025 20.18 0.060±0.015 54.4 
Pressed latex 2.915±0.012 0.513 1.98±0.06 18.8 
Pressed latex withwater 1.293±0.036 0.258 1.09±0.05 41.5 
Alcoholic extract (96 %)  1.012±0.011 20.24 0.0164±0.02 17.7 
SFE with water 1.087±0.026 1.74 0.266±0.004 23.0 
SFE with propylene glycol 1.270±0.029 0.338 0.072±0.002 1.03 
SFE with alcohol 1.112±0.031 0.494 0.211±0.003 3.11 
Microwave extraction with water 0.988±0.013 9.88 0.049±0.001 26.5 
 
First of all, we were interested in the total amount of 
effective substances in the extracts of fresh plants. The total 
alkaloid contents expressed in chelidonine of the different 
solutions are very different because of the different method 
applied, and the dissolution of bioactive compounds change 
with the seizing fluid and solvent, so it was observed the 
difference e.g., between the alkaloid content of aqueous and 
alcoholic extracts (Table 6). The tea, the alcoholic extract 
and the microwave extract contain the less amounts of total 
alkaloids. This means that the alkaloid dissolution at 
different rates depends on other parameters as well. If an 
alkaloid yield is calculated from the initial alkaloid content 
of fresh herb, we can see that more than half (54.4 %) of the 
alkaloid content of the plant is gained by tea making, 41.5 % 
is gained by pressed latex with water. By the use of water at 
pressed latex, we got a diluted extract for alkaloid, but the 
alkaloid yield increased from 18.8 % to 41.5 %. These 
results show that the pressed latex and the pressed latex with 
water gave extract rich in alkaloids, while the tea and the 
pressed latex with water gained the highest amount of total 
alkaloid from the plant. The SFE almost independently from 
the servant solvent seems not to be a good method for 
obtaining alkaloid rich extracts and alkaloid gaining. 
The results obtained for the extraction strengthen our 
earlier examination on this topic that the extracts (latex, tea, 
microwave, SFEs) have significant effective compounds and 
elements, although the different parameters applied in the 
extractions did not give an outstanding difference in the 
results.15,38 According to the correlation calculations, the dry 
material content has a high positive correlation with the total 
alkaloid content (R=0.907, P<0.05). 
However, the amounts of individual components was also 
important for us. That's why the alkaloid combinations of 
extracts were observed by thin-layer chromatography and 
densitometry. The separation of the components was 
achieved by Wagner’s recommended eluents.23 The main 
alkaloid component contents in the extracts are summarized 
in Table 7. It can be seen that the main alkaloids are 
coptisine and chelidonine. The loss of alkaloids is high in 
the case of pressed latex since only trace amounts of 
alkaloids present in the latex (0.05-5.2 %). Nevertheless, 
this extract contains alkaloids in high concentrations. By 
supercritical fluid extraction (SFE), we didn't get 
homogeneous solutions, and the SFE extracts show rare 
alkaloid composition. They contain only a small amount of 
berberine, coptisine, and chelidonine (Table 7).  
Table 7. Main alkaloid content (wt. %,) in the extracts measured 
by TLC and densitometry, and the dissolution rate of alkaloid 
components (%) in parenthesis. 
 Method Berberine Coptisine Chelidonine 
Tea 0.01 (69) 0.11 (80) 0.059 (2.2) 
Pressed latex 0.15 (5.2) 0.45 (1.0) 0.42 (0.05) 
Pressed latex 
(H2O) 
0.13 (38) 0.352 (11) 0.350 (0.6) 
Alcoholic extract 
(96 %)  
0.01 (83) 0.04 (35) 0.94 (43) 
SFE (water) 0.071 (4.7) 0.136 (9.5) 0.12 (0.44) 
SFE (propylene 
glycol) 
0.009 (1.0) 0.063 
(0.73) 
0.24 (0.15) 




0.01 (42) 0.112 (49) 0.034 (0.77) 
Alkaloid combinations of extracts represent a rare alkaloid 
dispertion mainly with coptisine and chelidonine, although 
the high berberine content of fresh latex seems to the reason 
for its anti-inflammatory and antiviral activity.39 The 
dissolution of alkaloid components from the drug into the 
extracts varies to a large extent by extracts.  
In some cases, a high amount of loss was observed mainly 
in pressed latex and SFEs, while the tea making and 
extraction with alcohol seem to be a good method for 
gaining berberine and coptisine (Table 7). The total alkaloid 
content in the extracts is in correlation only with their 
berberine content (R=0.937, P<0.05). 
Inorganic elements in the greater celandine extracts 
The element concentrations of the examined extracts are 
in Table 8. In the drug, we found a significant amount of Cr 
and Mn compared to the average concentration of plants. 
The element concentrations in the extracts are not big in 
view of their absolute values except for K and Ca. But 
anyway, it is important to know that elements are also 
present in the aqueous, alcoholic extracts and the pressed 
latexes, and these elements may contribute to the therapeutic 
effect of extracts. 
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Table 8. Element content in the greater celandine extracts ± standard deviations (µg mL-1, n=3) and dissolution rate in parenthesis (%). 
Element Tea Pressed latex Pressed latex with 
water 
Alcoholic extract Microwave extract 
with water 
Al 4.26±0.60 (39) 4.47±0.19 (0.4) 2.83±0.08 (1.1) 0.84±0.06 (9.1) 1.43±0.07 (7.7) 
B 0.39±0.02 (33) 2.38±0.03 (2.1) 3.09±0.08 (10) 0.29±0.01 (29) 0.94±0.22 (47) 
Ba 0.21±0.01 (21) 0.31±0.01 (0.3) 0.28±0.01 (1.2) 0.06±0.01 (7.5) 0.08±0.01 (4.7) 
Ca 224±14 (32) 2028±10 (3.0) 589±15 (3.5) 139±3 (24) 488±23 (41) 
Cr 0.012±0.001(9.6) 0.04±0.01 (0.4) 0.04±0.01 (1.4) <dl <dl 
Cu 0.08±0.01 (9.8) 0.26±0.01 (0.4) 0.29±0.01 (1.5) 0.006±0.001 (0.9) 0.11±0.01 (8.1) 
Fe 0.73±0.04 (5.6) 2.97±0.07 (0.2) 5.11±0.06 (1.7) 0.22±0.01 (2.0) 1.69±0.14 (7.8) 
K 1518±18 (78) 7042±63 (3.8) 1928±42 (4.2) 261±4 (16) 1538±36 (47) 
Mg 42.3±2.6 (41) 420±9 (4.3) 134±1 (5.4) 33.5±0.7 (39) 54±5 (31) 
Mn 0.92±0.01 (36) 2.49±0.03 (1.0) 1.37±0.01 (2.3) 0.40±0.01 (19) 0.85±0.15 (20) 
Na 15.6±0.4 (87) 26.3±0.4 (1.5) 8.62±0.19 (2.0) 6.2±0.4 (41) 25.8±0.6 (86) 
P 179±9 (77) 612±2 (2.8) 64.3±0.9 (1.2) 40.0±0.5 (21) 38.1±1 (9.7) 
S 37.8±1.2 (43) 155±1 (1.8) 57.1±0.8 (2.7) 29.6±0.6 (40) 10.3±1 (6.9) 
Zn 0.10±0.01 (3.8) 2.97±0.03 (1.1) 0.94±0.01 (1.5) 0.04±0.01 (1.7) 0.08±0.01 (1.9) 
<dl below detection limit 
More than 70 % of the Na, K, and P content, about 40 % 
of the Al, Mg, and S content, more than 30 % of the B, Ba, 
Mn, Ca content are dissolved into the tea from the drug with 
the organic compounds. On an average, hardly 2-4 percent 
of the elements get to the pressed latex (e.g., 4.3 % Mg, 
3.8 % K, 3.0 % Ca, 2.8 % P, 1.8 % S and 1.5 % Na), and it 
can be seen a little bit higher dissolution in the case of 
pressed latex with water. The dissolution rate of elements 
was significant in the alcoholic and microwave extracts, but 
their concentrations do not reach the values of tea in most 
cases (Table 8). Altogether the highest element dissolution 
was observed into the tea while the micro amounts of 
microelements were present (e.g., 0.04 µg g-1 Cr) in the 
locally applied pressed latex but anyhow our organism 
needs micro amount from some elements40 and these small 
amounts depending on many factors and the circumstances 
can be transferred in high rate via the skin.41 
The element content of SFEs was not analyzed because of 
the limited amounts of extracts, which was used for the 
determination of main active agents. Therefore, the element 
content of the residue of SFEs was determined (Table 9). 
Some accumulation of Al, Cu, and Na can be seen in the 
residues of the SFEs, which means that only a little amount 
of element gets into the extracts from these elements. The 
Ba, Ca, Cr, K, Mg, K, P, S, and Zn contents of SFE residues 
are lower than that of the plant, which means that the 
extracts contain these elements in a relatively higher amount. 
In our earlier examination in another kind of SFE, we 
obtained similar results.15 
Some metals such as gold, copper, zinc, arsenic, silver, 
have antiviral activities and they effects are proved against 
several types of viruses, such as human immunodeficiency 
virus (HIV), herpes simples virus (HSV), hepatitis A, B, C,  
influenza.42-44 In general the reduced transition metals (e.g. 
Fe, Cu, Cr, Mn) have antiviral activity and cause oxidative 
stress via Fenton and Fenton-like reaction.24,45-47 It is also 
known for a long time that certain metals can act synergetic 
with other agents, bioactive molecules. Copper and gold kill 
microorganisms in the water in the presence of chloride.48 
The copper concentrations of the pressed extracts are of a 
similar order of magnitude, while the iron concentration is 
higher than that found to be effective (10 mM metal alone or 
in combination) against Streptococcus mutans.45 
Table 9. Element content of the residue of SFEs made from greater 




water propylene glycol alcohol 
Al 202.8±8.9 214.7±2.1 46.08±0.63 
B 14.31±0.53 13.5±3.2 10.11±0.22 
Ba 16.4±0.41 5.65±0.11 6.22±0.26 
Ca 9906±152 5625±48 3456±35 
Cr 1.97±0.61 0.618±0.109 2.11±0.29 
Cu 14.1±1.8 17.72±0.45 17.4±5.1 
Fe 218.3±9.2 115.7±0.6 77.95±2.50 
K 8361±181 14883±178 12708±272 
Mg 955.6±20.6 862.3±10.8 373.1±6.7 
Mn 20.01±0.36 11.22±0.05 5.82±0.12 
Mo 0.537±0.408 0.836±0.286 0.695±0.576 
Na 266.7±11.7 344.0±19.0 282.5±5.7 
P 996.0±11.7 1949±50 1093±32 
S 911.3±38.6 1822±42 484.4±8.6 
Ti 14.46±1.82 2.30±0.05 2.74±1.11 
Zn 37.11±0.66 39.00±0.98 58.80±1.06 
The copper concentration found to be effective against the 
HSV is 100 mg L-1, 46 and this copper concentration exists in 
the microwave extract and a little bit higher concentration in 
the pressed latex extracts (Table 8). There is no information 
yet on the effectiveness of metals against human papilloma 
viruses (HPV) that cause warts although the antiviral 
activity seems to occur by similar mechanism in all type of 
viruses.42 According to these the copper and iron 
concentration of pressed latex and pressed latex with water, 
beside their high alkaloid content, contribute certainly to 
their antiviral effect against warts and antibacterial activity.  
Antioxidant activity of greater celandine extracts 
The antioxidant activity of extracts shows that the highest 
values belong to the SFE prepared with alcohol (presumably 
due to its polyphenol content) and SFE with propylene 
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glycol while the pressed latex, pressed latex with water and 
microwave extraction with water show relatively low 
activity (Table 10). The antioxidant activity of extracts 
represents higher values mainly for SFEs compared to our 
earlier examinations for alcoholic extracts, where we found 
90.6 and 91.4 µmol L-1 antioxidant activity for 20 and 40 % 
alcoholic extracts of greater celandine and Nadova and co-
authors also published  potential antioxidant activity.27,49 So 
these extracts, mainly the SFEs have prominently high 
FRAP values.  
There is no correlation of FRAP values with any other 
parameters. This calculation is confirmed by Khodabande 
and coauthors, who examined the antioxidant activity of 
greater celandine by the FRAP method also, and they did 
not find any relationship with any parameters measured.50 
This means that in the extract there are many compounds, 
from which one part represents antioxidant activity, while 
the other has prooxidant property.  
According to these results it can be summarised that 
extracts with higher FRAP values presumable have higher 
content of antioxidant agents. 
Table 10. Antioxidant activity of the greater celandine extracts 
measured by FRAP method. 
 Test material FRAP value, µmol L-1 
Tea 299.5±2.8 
Pressed latex 132.8±5.6 
Pressed latex withwater 112.5±2.6 
Alcoholic extract (96 %) 289.5±2.8 
SFE with water 672.8±3.8 
SFE with propylene glycol 2895±3.1 
SFE with alcohol 3795±10 
Microwave extraction with water 92.9±3.3  
  
CONCLUSION 
The supercritical fluid extraction seems to result a 
biomass that can be modified according to the use or stored 
for further processing with water, alcohol, or propylene 
glycol. Although there is no data for element content of 
SFEs, the outstanding FRAP values of aqueous and 
alcoholic SFEs suggest that the active ingredients, such as 
flavonoids with their anti-inflammatory activities and 
berberine or Mg, Cr, and Zn, can do much in the treatment 
of acne-prone skin, microtrum skin surface. 
Since the greater celandine is a plant containing sensitive 
active ingredients, the pressed latex extracts are still the 
most suitable ones for gaining alkaloid rich preparations 
against warts. In addition to the high alkaloid content, these 
extracts also contain transition metals (e.g., Cu, Fe) in 
concentrations that are effective against viruses. In 
summarising the metal element content of the pressed 
extracts presumably contributes to the beneficial antiviral 
effect of greater celandine. The other methods made with 
water (tea, microwave extract) also give the extracts with 
relative high alkaloid and transition metal content. 
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SYNTHESIS OF NOVEL ANTI-INFLAMMATORY 
USNIC ACID-BASED IMIDAZOLIUM SALTS 
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Keywords:Usnic acid; imidazolium salts; anti-inflammatory activity; cytokine proteins; U937 cells. 
Ten novel usnic acid based imidazolium salts were synthesized by employing a two-step protocol. The anti-inflammatory 
potential of the newly synthesised compounds was evaluated in vitro against cytokine proteins TNF- α and IL-1 β secreted 
from U937 cells. Some of the imidazolium salts exhibited promising anti-inflammatory activity against the TNF-α and IL-1β 
with IC50 values ranging between 5.3 μM - 7.5 μM, which are many folds lower than that of the parent compound (>100 μM). 
Most significantly, substitution with electronegative groups in imidazolium salts of usnic acid found to be more potent and 
exhibiting enhanced anti-inflammatory activity. 
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INTRODUCTION 
Usnic acid, a natural dibenzofuran lichen metabolite, has 
attracted the attention as ‘Hot Natural Scaffold’ in view of 
its structural diversity and therapeutic potential. Usnic acid 
is reported to exhibit a wide range of biological activities 
such as anti-inflammatory, antioxidant as well as pro-
oxidant, antimicrobial, antiviral, antibiotic, and antitumor 
activities etc.1 It was isolated from different genera of 
lichens such as Usnea (Usneaceae), Lecanora 
(Lecanoraceae) and Cladonia (Cladoniaceae) in large 
quantity (up to 26%).2 It plays a crucial role in restricting 
prostaglandin and it acts like an anti-inflammatory drug.3 
The anti-inflammatory property of usnic acid4 has been 
shown by down-regulating the expression of TNF- α, MIP-2, 
IL-8, IL-6. Huang et al. have explored the mechanism of 
usnic acid against inflammation by encouraging the 
lipopolysaccharide from the RAW264.7 cell line. It acts in a 
dose dependent manner towards pro-inflammatory 
mediators and cytokines that leads to attenuate the IL-6, IL-
1β, iNOS, to COX-2 through dwindling the NFkB factor.5 
Usnic acid possesses a wide range of functional groups and 
associated with intramolecular hydrogen bonding between 
the functional groups. D. N. Sokolov et al. have analysed 
some usnic acid- amine hybrids of both enantiomers, against 
influenza virus A (H1N1)pdm09. Interestingly, (+)-usnic 
acid enamine derivatives explored with good antiviral 
activity than (-)-usnic acid –amine hybrids.6  Usnic acid 
consists of three rings such as A, B & C rings. Out of these, 
A and C rings are amenable for a wide range of chemical 
transformations by introducing pharmacophore moieties 
such as chalcones, thiazoles, aurones, enamines, coumarins, 
and flavones. Among these analogues, enamines have 
shown the best biological profiles.7 Enamines such as 
usenamines were identified as chemically and biologically 
diversified structures in lichens and exhibited a broad 
spectrum of biological activities.2 Bruno et al. explored the 
wound repairing mechanism of usnic acid enamine hybrids 
by employing in vitro and in vivo assays.8 Imidazole is a 
five-membered N-heterocyclic ring contains two nitrogen 
atoms and is an important pharmacophore in medicinal 
chemistry.9 Imidazolium salts are obtained by the alkylation 
of Imidazole nitrogen atoms.10 Zheng et.al reported two 
naturally occurring imidazolium salts such as lepidiline A & 
lepidiline B from Lepidium meyenii.11 These imidazolium 
salts and their hybrids possess multiple biological activities 
such as antimicrobial12, antitumour13, antioxidants, anti-
fibrotic, HIV-integrase inhibition etc.,.14 Yang et.al has 
reported the synthesis of a series of imidazolium salts 
bearing different functional groups by refluxing alkyl 
halides and imidazole in toluene. The resultant salts were 
tested against various cancer cell lines.15 With this 
background in view, the chemical transformation of usnic 
acid has now been done by incorporating pharmacophore 
moiety of imidazolium salts through the key bioactive 
enamine linkage to afford the desired usnic acid-based 
imidazolium salts and evaluation of the resultant products 
for their anti-inflammatory potential. 
EXPERIMENTAL 
Isolation of (+)- usnic acid (1) 
(+)-Usnic acid was isolated from the lichen Usnea 
longissima and Usnea orientalis as per our reported 
procedure.2 The lichen material was collected from NBRI, 
Lucknow, India. The lichen material (250+200 g) was air-
dried, powdered and extracted with n-hexane (3 L) using a 
Soxhlet extractor for 12 h. Concentration of the n-hexane 
extract under vacuum gave the residue (8.8 g), which was 
chromatographed over silica gel column to afford (+)-usnic 
acid (1) as pale yellow shining crystals, (8.6 g, mp: 204 oC, 
[α]D = +490o (CHCl3) in 1.91 % yield. IR (KBr) νmax : 2650-
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3254, 1692, 1632, 1541, 1454, 1374, 1357, 1288, 1190 cm-1; 
1H NMR (500 MHz, CDCl3): δ 1.76 (3H, s, H-10), 2.11 (3H, 
s, H-15), 2.66 (3H, s, H-12), 2.68 (3H, s, H-14), 5.98 (1H, s, 
H-4), 11.03 (1H, s, 9-OH), 13.34 (1H, s, 7-OH); 13C NMR 
(75 MHz, CDCl3): δ 7.47, 27.80, 31.19, 32.07, 59.01, 98.25, 
101.45, 103.89, 105.17, 109.22, 155.13, 157.42, 163.80, 
179.27, 191.63, 197.98, 200.23, 201.68; ESI-HRMS (m/z) 
[M+H]+ cacld for C18H17O7  345.0968, found 345.0970. 
Isolation of methyl barbatate (2) 
The molecule 2 has been achieved with successive 
treatment of Usnea longissima and Usnea orientalis with 
ethyl acetate solvent. Concentration of the ethyl acetate 
extract under vacuum gave the residue (1.3 g, 0.28 %), 
which was chromatographed over silica gel column to afford 
methyl barbatate (2) as colourless crystals, (1.3 g, mp: 187-
192 0C in 0.28 % yield.  IR (KBr) νmax: 2551-3452, 1738, 
1637, 1572, 1493, 1462, 1398, 1314, 1259, and 1228; 1H 
NMR (400 MHz, CDCl3):  2.16 (3H,S), 2.18 (3H,S), 2.47 
(3H,S), 2.61 (3H,S), 3.85 (3H,S), 3.86(3H,S), 6.54 (1H,S), 
6.62 (1H,S), 11.75 (1H,S); 13C NMR (75 MHz, CDCl3): 
8.86, 9.09, 20.18, 24.10, 55.69, 62.08, 108.11, 116.66, 
117.38, 117.75, 119.55, 135.45, 140.85, 154.10, 157.21, 
160.05, 163.81, 166.19, 174.85. ESI-HRMS (m/z) [M+H]+ 
calcd. for C20 H23 O7  375.1444, found 375.1444. 
Synthesis of compound 3 
A solution of compound 1(1.5 g, 4.360 mmol) and 3-(1H-
imidazol-1-yl)propan-1-amine (4.360 mmol) in methanol 
(12 mL) was stood at 60 ˛°C and refluxed for four hours 
under stirring conditions. The reaction mixture was then 
concentrated under reduced pressure and the resulting 
residue was chromatographed over silica gel column using 





Pale yellow solid (0.157 g, 48%); mp: 80-82 °C; IR (KBr 
νmax): 2650-3444, 1701, 1626, 1555, 1467, 1368, 1283, 1186 
cm-1; 1H NMR (300 MHz, CDCl3+DMSO-d6):  δ 1.71 (3H, s, 
H-10), 2.06 (3H, s, H-15), 2.24 (2H, m, H-17), 2.59 (3H, s, 
H-12), 2.68 (3H, s, H-14), 3.46 (2H, m, H-16), 4.17 (2H, t, J 
= 6.6 Hz,  H-18), 5.79 (1H, s, H-4), 7.01 (1H, S, H-4’), 7.07 
(1H, S, H-5’), 7.55 (1H, S, H-2’), 11.90 (1H, s, 9-OH), 
13.36 (1H, s, 7-OH), 13.51 (1H, brs, NH);13C NMR (75 
MHz, CDCl3+DMSO-d6): δ 6.9 (C-15), 17.6 (C-12), 29.6 
(C-17), 30.6 (C-14), 31.4 (C-10), 39.9 (C-16), 43.2 (C-18), 
56.5 (C-9b), 100.6 (C-6), 101.7 (C-4), 101.8 (C-2), 104.4 
(C-9a), 107.1 (C-8), 118.1 (C-5’), 129.3 (C-4’), 136.5 (C-2’), 
155.2 (C-5a), 157.6 (C-9), 162.7 (C-7), 173.4 (C-11), 174.7 
(C-4a), 189.5 (C-3), 197.6 (C-1), 200.1 (C-13); ESI-HRMS 
(m/z) [M+H]+ calcd. for C24H26N3O6  452.1816, found 
452.1798. 
General procedure for the synthesis of salts 
To a solution of compound 3 (0.1 g, 0.221 mmol) in dry 
toluene (5 mL) was added appropriate phenacyl bromide 
(0.221 mmol) and the resulting mixture were refluxed at 
80 °C for 4-12 hours under stirring. Colourless precipitate 
was formed in the round-bottom flask after reaction was 
completed. This precipitate was filtered and washed with 
toluene (3×10 mL), to achieve the imidazolium salts (4-13) 




Colourless solid (0.122 g, 85%); mp: 148-150 °C; IR 
(KBr.νmax): 2926-3411, 1700, 1623, 1555, 1460, 1366, 1281, 
1231, 1181 cm-1; 1H NMR (300 MHz, CDCl3+DMSO-d6): 
1.68 (3H, S) , 2.03 (3H, s), 2.34 (3H, s), 2.42 (2H, t, J= 
6.877), 2.65 (3H, s), 2.67 (3H, s), 3.74 (2H, broad peak), 
4.62 (2H, t, J= 6.877) , 5.74 (1H, s) , 6.18 (2H, s), 7.55 (2H,t, 
J=6.602) , 7.68 (1H, t, J= 6.877) , 7.74 (1H, s), 7.90 (1H, s), 
8.04 (2H, d, J= 6.602), 9.72 (1H, s), 11.96 (1H, s), 13.34 
(2H, broad peak). 13C NMR (75 MHz, CDCl3+DMSO-d6): 
6.72, 17.80, 28.92, 30.41, 31.14, 46.52, 54.96, 56.18, 100.41, 
101.59, 104.30, 106.74, 121.22, 123.78, 124.46, 127.59, 
128.31, 131.82, 132.79, 133.86, 137.13, 155.05, 
157.37,162.47,173.00, 174.82, 189.09, 189.80, 197.32, 
199.84. ESI-HRMS (m/z) [M+H]+ calcd. for C32H32N3O7  
570.2240, found 570.2241. 
(E)-1-(3-((1-(6-Acetyl-7,9-dihydroxy-8-methyl-1,3-dioxo-1,9b-
dihydrodibenzo[b,d]furan-2(3H)-ylidene)ethyl)amino)propyl)-
3-(2-(4-chlorophenyl)-2-oxo ethyl)-1H-imidazol-3-ium (5). 
Pale yellow solid (0.115 g, 76%); mp: 137-139 °C; IR 
(KBr) νmax: 2925-3414, 1700, 1625, 1554, 1465, 1372, 1283, 
1232, 1187 cm-1. 1H NMR (300 MHz, CDCl3+DMSO-
d6):1.67 (3H, s) , 2.02 (3H, s) , 2.33 (3H, s) , 2.41 (2H, t, J= 
6.877),  2.64 (3H, s), 2.66 (3H, s), 3.25 (2H, broad peak), 
3.69-3.78 (2H, m), 4.61 (2H,t, J=6.602), 5.74 (1H, s), 
6.21(2H, s), 7.52 (2H, d, J=8.253), 7.78 (1H, S), 7.93 (1H, s), 
8.03 (2H, d, J= 8.52), 9.69 (1H, s), 11.97 (1H, S), 13.34 (2H, 
broad peak). 13C NMR (75 MHz, CDCl3+DMSO-d6): 6.49, 
17.49, 20.35, 28.65, 30.16, 30.87, 46.19,54.61, 55.86, 
100.12, 101.25, 101.35, 104.02, 106.35, 120.98, 123.49, 
124.22, 127.12, 127.90, 128.28, 128.90, 131.05, 136.83, 
139.68, 154.78, 157.08, 162.17, 172.63, 174.48, 188.69, 
196.99, 199.54. ESI-HRMS (m/z) [M+H]+ calcd for 




Pale yellow solid (0.134 g, 87%); mp: 136-138 oC; IR 
(KBr) νmax : 2927-3410, 1705, 1623, 1556, 1465, 1351, 1282, 
1184 cm-1; 1H NMR (300 MHz, CDCl3+DMSO-d6): δ 1.68 
(3H, s) , 2.00 (3H, S), 2.36-2.45 (2H, m), 2.59 (2H, broad 
peak), 2.65 (3H, s), 2.67(3H, s), 3.70-3.79 (2H, m), 4.58 (2H, 
broad peak), 5.76 (1H, s), 6.27 (2H,S), 7.79 (1H, s), 7.94 
(1H, s),  8.27-8.42 (4H, m), 9.51 (1H, s), 12.02 (3H, s) , 
13.27 (3H, s) , 13.33 (3H, S). 13C NMR (75 MHz, 
CDCl3+DMSO-d6): δ 6.29, 17.24, 29.93, 30.65, 45.99, 54.85, 
55.60, 100.01, 101.14, 103.83, 106.03, 120.91, 123.29, 
128.58, 136.53, 137.10,149.49, 154.58, 156.85, 161.89, 
172.37, 174.27, 188.41, 188.95, 196.71, 199.35. ESI-HRMS 
(m/z) [M+H]+ calcd. for C32H31N4O9  615.2091, found 
615.2090. 
Usnic acid based imidazolium salts             Section A-Research paper 




Pale yellow solid (0.108 g, 72%); mp: 219-221 oC; IR 
(KBr) νmax: 2927-3420, 1698, 1627, 1551, 1467, 1367, 1286, 
1190 cm-1; 1H NMR (300 MHz, CDCl3+DMSO-d6): δ  1.69 
(3H, s), 2.03 (3H, s), 2.38-2.45 (2H, m), 2.66 (3H, s) , 2.67 
(3H, s), 3.71-3.78 (2H, m), 3.88 (3H, S) , 4.60 (2H, t, J= 
6.602), 7.47 (1H, t, J= 7.825),  7.53 (1H, bp)  , 7.62-.65 (2H, 
m), 7.71 (1H, s), 7.86 (1H, S), 9.65 (1H, s),  11.96 (1H, s), 
13.32 (1H, s), 13.34 (1H, s). 13C NMR (75 MHz, 
CDCl3+DMSO-d6): δ 6.74, 17.79, 28.91, 30.43, 31.14, 46.52, 
54.89, 54.89, 56.20, 100.44, 101.62, 104.31, 106.78, 112.2, 
120.02, 121.17, 123.76, 129.43, 134.07, 137.18, 155.07, 
157.37, 159.20, 162.50, 173.06, 174.84, 189.12,189.64, 
19.36, 199.86. ESI-HRMS (m/z) [M+H]+ calcd. for 





Colourless solid (0.132 g, 84%); mp: 196-198 °C; IR 
(KBr) νmax: 2925-3416, 1663, 1625, 1554, 1465, 1368, 1315, 
1283, 1242, 1189 cm-1; 1H NMR (400 MHz, 
CDCl3+DMSO-d6): δ  1.69 (3H, s), 2.03 (3H, s), 2.34 (2H, 
s), 2.37-2.47 (2H,m), 2.66 (3H, s), 2.67 (3H, s), 3.68-3.76 
(2H, m), 4.56 (2H, t, J= 6.602) , 5.77 (1H, s) , 6.13 (2H, s) , 
7.00 (1H, d, J=8.803), 7.61 (1H, s) , 7.73 (2H, S), 7.84 (1H, 
s), 8.01 (1H, d, J= 8.803),  8.61(1H, s), 9.53 (1H, S) , 11.97 
(1H, s), 13.35 (2H, m).13C NMR (75 MHz, CDCl3+DMSO-
d6): δ 6.58, 17.55,3.26, 46.28, 54.56, 55.99, 64.37, 100.26, 
101.46, 104.12, 106.51, 113.08, 117.94, 120.96, 123.51, 
127.23, 129.60, 132.79, 136.86, 154.89, 157.18, 162.29, 
166.22, 170.92, 172.85, 174.63, 187.81, 188.88, 197.12, 
199.68. ESI-HRMS (m/z) [M+H]+ calcd. for C33H33N4O9  





Colourless solid (0.145 g, 91%); mp: 204-206 °C; IR 
(KBr) νmax: 2927-3423, 1694, 1625, 1556, 1465, 1366, 1271, 
1191 cm-1; 1H NMR (400 MHz, CDCl3+DMSO-d6): δ 1.69 
(3H, s) , 2.04 (3H, s) , 2.22-2.30 (2H, m) , 2.38-2.47 (2H, m), 
2.66 (3H, s), 2.67 (3H, s) , 3.71-3.78 (2H, m), 4.28-4.37 (4H, 
m), 4.62 (2H, t, J=5.77),  5.75 (1H, s), 6.05 (2H, s), 7.03 (1H, 
d, J= 7.978), 7.61 (1H, s), 7.65 (2H, s), 7.83 (1H, S), 9.79 
(1H, s), 11.94 (1H, S), 13.35 (2H, bp). 13C NMR (75 MHz, 
CDCl3+DMSO-d6): δ 5.95,16.77, 27.83, 29.06, 29.54, 30.24, 
45.49, 53.59, 55.10, 68.76, 68.89, 99.45, 100.79, 103.43, 
105.44, 120.30, 122.34, 122.87, 127.10,136.23, 149.06, 
154.19, 154.79, 156.42, 161.46, 171.84, 173.76, 187.38, 
187.77, 196.16, 198.87. ESI-HRMS (m/z) [M+H]+ calcd. for 




Colourless solid (0.115 g, 78%); mp: 118-120 °C; IR 
(KBr) νmax: 2927-3415, 1699, 1623, 1555, 1465, 1368, 1282, 
1231, 1188 cm-1; 1H NMR (300 MHz, CDCl3+DMSO-d6): 
δ 1.67 (3H, s), 2.04 (3H, s), 2.39-2.48 (2H, bp), 2.65 (6H, s),  
3.74 (2H, bp),  4.62 (2H, bp) , 5.73 (1H, s), 6.21 (2H, s),  
7.18 (2H,bp), 7.68 (1H, s), 7.79 (1H, s), 8.11 (2H, bp), 9.83 
(1H, s), 11.90 (1H, s), 13.34 (2H, s). 13C NMR (100 MHz, 
CDCl3+DMSO-d6): δ 7.38, 18.11, 28.82, 30.91, 31.55, 46.67, 
55.17, 56.22, 100.75, 101.70, 102.22, 104.96, 106.25, 
116.00, 116.22, 121.97, 124.12, 130.33, 131.12, 131.22, 
137.42, 155.60, 157.52, 162.42, 172.92, 175.14, 188.77, 
189.77, 197.17, 200.71. ESI-HRMS (m/z) [M+H]+ cacld for 




Colourless solid (0.120 g, 82%); mp: 98-100 °C; IR (KBr) 
νmax: 2924-3414, 1697, 1623, 1555, 1464, 1368, 1282, 1236, 
1183 cm-1; 1H NMR (300 MHz, CDCl3+DMSO-d6): δ 1.69 
(3H, s) , 2.03 (3H, s), 2.34 (2H, s), 2.42 (6H, s), 3.75 (2H, 
bp), 4.63 (2H, t, J=6.327), 5.73 (1H, s), 6.12 (2H, s), 7.31 
(2H, d, J=7.427), 7.67 (1H, s), 7.85 (1H, s), 7.91 
(2H,d,J=7.427), 9.72 (1H, s), 11.94 (1H, s), 13.30 (1H, bp) , 
13.34 (1H, s). 13C NMR (75 MHz, CDCl3+DMSO-d6): δ 
6.88, 17.98, 21.18, 29.11, 30.57, 31.30, 46.68, 54.97, 56.37, 
100.59, 101.73, 104.45, 106.96, 121.36, 123.87, 127.85, 
129.13, 130.38, 137.28, 145.23, 155.20, 157.52, 162.52, 
162.66, 173.20, 175.00, 189.31, 189.40, 197.51, 200.02. 






Colourless solid (0.144 g, 93%); mp: 224-226 °C; IR 
(KBr) νmax : 2927-3414, 1693, 1625, 1554, 1467, 1365, 1282, 
1180 cm-1; 1H NMR (300 MHz, CDCl3+DMSO-d6): δ 1.65 
(3H, s ), 2.03 (3H, s), 2.34 (2H, s), 2.38-2.46 (2H,m), 2.62 
(3H, s), 2.66 (3H, s), 3.70-3.79 (2H,m), 4.62 (2H, t, 
J=5.777), 5.72 (1H, s), 6.30 (2H, s), 7.57-7.66 (3H,m), 7.75 
(1H, s), 7.88 (1H, s), 7.91-8.06 (4H,m), 8.70 (1H,S), 9.76 
(1H, s), 11.94 (1H, s), 13.30 (1H,s), 13.33 (1H,S).13C NMR 
(75 MHz, CDCl3+DMSO-d6): δ 6.88, 17.96, 29.05, 30.55, 
31.28, 46.70, 55.13, 56.13, 100.57, 101.71, 104.43, 106.94, 
121.35, 122.54, 123.92, 126.63, 127.14, 128.27, 128.76, 
129.25, 130.12, 130.33, 131.64, 135.36, 137.34, 155.16, 
157.49, 162.63, 173.20, 174.99, 189.30, 189.90, 197.49, 
199.99. ESI-HRMS (m/z) [M+H]+ calcd. for C36H34N3O7  
620.2397, found 620.2396. 
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Colourless solid (0.127g, 79%); mp: 97-99 oC; IR (KBr) 
νmax: 2926-3417, 1698, 1622, 1556, 1462, 1369, 1281,1231, 
1179 cm-1; 1H NMR (300 MHz, CDCl3+DMSO-d6): δ  1.68 
(3H, s), 2.04 (3H, S), 2.39-2.49 (2H,m), 2.59 (2H, s), 2.660 
(3H, s), 2.668 (3H, s), 4.15-4.22 (2H, m), 4.61 (2H, t, 
J=6.327),  5.75 (1H, s), 6.20 (2H, s), 7.68 (2H, d, J=7.978),  
7.73 (1H, s), 7.86 (1H, s), 7.94 (2H, d, J=7.703), 9.71 (1H, 
s), 11.45 (1H, s), 11.95 (1H, s) , 13.35 (2H, bp). 13C NMR 
(75 MHz, CDCl3+DMSO-d6): δ 6.37, 17.31, 17.33, 20.21, 
28.42, 29.00, 30.02, 30.73, 46.05, 54.42, 55.70, 99.99, 
101.24, 103.93, 106.17, 120.89, 123.38, 124.09, 127.00, 
127.77, 128.86, 131.12, 136.63, 154.68, 156.96, 162.01, 
172.51, 174.11, 174.37, 188.90, 188.54, 196.82, 199.42. 
ESI-HRMS (m/z) [M+H]+ calcd. for C32H31N3O7 648.1345, 
found 648.1354. 
RESULTS AND DISCUSSION   
Isolation of (+) - usnic acid and methyl barbatate from the 
fruticose lichen species Usnea longissima and Usnea orientalis. 
Usnic acid was isolated as the major metabolite from two 
fruticose Usnea lichen species viz. Usnea longissima (250 g) 
and Usnea orientalis (200 g) by soxhlet extraction using n-
hexane as solvent at 60 oC for 12 hours. Usnic acid was 
separated during soxhlet extraction as an insoluble substance. 
The insoluble substance was purified by column 
chromatography followed by recrystallisation from 
chloroform - hexane solvent mixture to afford (+)-usnic acid 











Chart 1.Extraction of Usnic acid from U. longissima and              
U. orientalis 
The IR spectrum, of usnic acid showed three peaks at 
1692, 1632 and 1630 cm-1 corresponding to C1, C6 and C2 
groups respectively. In its 1H NMR spectrum, five singlet’s 
appeared at δ 1.76, 2.11, 2.66, 2.68 and 5.98 confirms 9b-
CH3, 8-CH3, 2-COCH3, 6-COCH3 and 4-CH protons 
respectively. In its 13C NMR spectrum, three signals 
appeared at δ 201.68, 200.23 and 197.98 ppm corresponding 
to C2-carbonyl, C6-carbonyl and C1-carbonyl groups 
respectively. Further, its structure was confirmed by its 
HRMS spectrum, which showed the protonated molecular 
ion [M+H]+ at 345.0970 corresponding to the molecular 
formula C18H17O7. In addition to usnic acid, methyl 
barbatate (2) was also isolated from the fruticose lichens of 
usnea longisimma(0.36%) and usnea orientalis(0.8%)from 






Figure 1.Natural products isolated from Usnea longissima and 
Usnea orientalis. 
The IR spectrum of methyl barbatate showed peaks at 
3452, 1738 and 1637 cm-1 corresponding to hydroxyl and 
carbonyl functionalities. The 1H NMR spectrum of the 
compound showed six singlets at δ 2.16, 2.18, 2.47, 2.61, 
3.85, and 3.86. The first four values representing aromatic 
methyl groups and the preceding values corresponding to 
two methoxy groups. It also showed the signals 
corresponding to two aromatic protons at δ 6.54, and 6.62 
ppm. The 13C NMR spectrum of the compound showed peak 
δ 174.85 ppm corresponding to the ester carbonyl carbon 
and the peaks appeared between δ 8.86-62.08 ppm 
corresponding to aromatic methyl and methoxy carbons. 
Further, the structure was confirmed as methyl barbatate by 
its HRMS spectrum, which showed the protonated 
molecular ion [M+H]+ at 375.1444 corresponding to the 
molecular formula C20H23O7. 
Synthesis of novel (+)-usnic acid based imidazolium salts 
The protocols adopted for the synthesis of novel (+)-usnic 
acid based imidazolium salt hybrids are presented in 
Scheme 1. In the first step (+)- usnic acid (1) was treated 
with 3-(1H-imidazol-1-yl)propan-1-amine in methanol at  
60 °C to synthesise the corresponding enamine (3) in 48% 
yield as per our earlier reported procedure.16 Compound 3 
was thoroughly characterised by its spectroscopic data. In 
the 1H NMR spectrum of compound 3, three peaks appeared 
at δ 7.01, δ 7.07 and δ 7.55 corresponding to imidazole 
moiety. The 13C NMR spectrum while confirming these 
observations exhibited the characteristic carbon signals of 
imidazole moiety at δ 118.1, δ 129.3 and δ 136.5 ppm. In 
the second step, compound 3 was refluxed with various 
phenacyl bromides in toluene at 90 °C (Table 1) to afford 
the corresponding imidazolium salt derivatives (4-13) in 
very good to excellent (72-93%) yields (Scheme 1). 
Compounds 4-13 were thoroughly characterised by their 
spectral data (1H and 13C NMR, IR and HRMS). The IR 
spectra of compounds 4-13 showed the characteristic ester 
functionality between 1663-1705 cm-1.  
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(a) 3-(1H-imidazol-1-yl)propan-1-amine, methanol, reflux at 60 oC, 
48 %; (b) phenacyl bromide, toluene, heat at 90 °C, 72-93% 
Scheme 1. Synthesis of imidazolium salts from usnic acid (1) 
The 1H NMR spectra of the compounds showed the 
characteristic phenacyl methylene protons between δ 6.05-
6.30. The 13C NMR spectra of the compounds while 
confirming their structures exhibited the characteristic 
phenacyl methylene and carbonyl carbons between δ 55.10-
56.37 and δ 187.77-189.90 respectively. 
Table 1. Synthesis of compounds from 4 to 13. 
The anti-inflammatory activity of the synthesized 
compounds 4-13 was tested in vitro by estimating the 
amount of cytokines, TNF-α and IL-1β, secreted in the LPS 
challenged U937 cell lines on treatment with the test 
compounds. Though the parent compound 1 displayed weak 
anti-inflammatory activity, the majority of the synthesised 
hybrids showed promising anti-inflammatory activity 
against TNF- α at a concentration of 10 μM. As shown in 
Table 2, compound 5 (80.10%), exhibited good inhibitory 
potential against TNF-α and the compounds 6 (90.4%) and 
13 (85.5%) exhibited potential inhibitory activities against 
IL-1β. However, it is seen from the study that most of the 
compounds failed to show inhibition activity against IL-1β.  
Table 2. Anti-inflammatory activity of synthesised compounds in 
percentage of inhibition. 
Compound Inhibition, % 
TNF-α IL-1β 
1 4.84 -1.24 
3 -8.1 25.5 
4 50.9 16.7 
5 80.1 25.4 
6 17.3 90.4 
7 -3.6 44.0 
8 24.5 -24.6 
9 7.0 21.8 
10 -24.5 -3.5 
11 21.4 2.5 
12 31.9 24.9 
13 4.7 85.5 
Dexamethasone 81.4 80.5  
Table 3.IC50 values of synthesized compounds. 
Compounds with good TNF-α inhibitory activity were 
further screened to identify their IC50 values. As shown in 
Table 3, the above compounds proved to possess good anti-
inflammatory activity with IC50 values 5.3±0.005 μM (5), 
7.5±0.1 μM (6), and 6.8±0.5 μM (13), when compared to the 
parent compound 1 (>100 μM).  
The anti-inflammatory activities of the synthetic 
analogues were also found to be comparable with that of the 
standard dexamethasone [IC50: 4.18±0.1 (TNF-α); 2.9±0.05 
(IL-1β)]. From the close analysis of the results (Table 2 and 
3), it is evident that the introduction of enamine 
functionality at the C-2 position of (+)- usnic acid (5, 6 and 
13) increases the TNF- α & IL-1β inhibitory activity many 
folds (IC50: 5.3 μM - 7.5 μM). Interestingly, the synthesized 
imidazolium salts with electron-withdrawing groups on 
phenacyl moiety such as chloro, nitro and bromo groups (5, 
6 and 13) showed potent activity (IC50 : 5.3 μM - 7.5 μM) 
against TNF-α and IL-1β , whereas imidazolium salts with 
an aromatic or heteroaromatic substituent’s (4 and 8-12 ) 
showed weak activity. Most significantly, imidazoles 5 
(IC50: 5.3±0.005 μM), 6(IC50: 7.5±0.1 μM) and 13 (IC50: 
6.8±0.5 μM) found to be many folds more active than the 
parent compound (1). Because of significant activities 
exhibited by compounds 5, 6 and 13, they can be considered 
as lead compounds for further development to synthesise 
highly potent anti-inflammatory agent. 
Compound IC50, µM 
TNF-α  IL-1β 
1 >100 >100 
5 5.3±0.005 >100 
6 >100 7.5±0.1 




Compounds R Yield, % 
4 C6H5COCH2- 85 
5 4-ClC6H4COCH2- 76 
6 4-O2NC6H4COCH2- 87 
7 3-MeOC6H4COCH2- 72 
8 3-(H2NCO)-4-HOC6H3COCH2- 84 
9 3,4-[CH2(CH2O)2]C6H3COCH2- 91 
10 4-FC6H4COCH2- 78 
11 4-CH3C6H4COCH2- 82 
12 β-C10H7COCH2- 93 
13 4-BrC6H4COCH2- 79 
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CONCLUSION 
In total, ten novel hybrids of (+)-usnic acid based 
imidazolium salts were synthesized and evaluated for their 
anti-inflammatory potential against the cytokine proteins 
TNF-α and IL-1β secreted from U937 cells. The 
imidazolium salts (5, 6, and 13) exhibited promising anti-
inflammatory activity against the TNF-α and IL-1β with 
IC50 values ranging between 5.3 μM - 7.5 μM, which are 
many folds lower than that of the parent compound (>100 
μM). Most significantly, imidazolium salts with 
electronegative groups (5, 6 and 13) found to be more potent 
and exhibiting enhanced anti-inflammatory activity. Hence, 
these compounds can be considered as lead molecules for 
further fine tuning to make highly potent anti-inflammatory 
therapeutic agents. 
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